Revised In Commerce List tracking table

Revised In Commerce List (R-ICL) tracking table (Excel version – 215.8 K)

In the table below, a bold font and an asterisk (*) indicates that the entry's identifier is one which has been updated by Chemical Abstracts Service Registry Number (CAS RN).

The following acronyms are used throughout the table:

  • R-ICL: Revised In Commerce List
  • DSL: Domestic Substances List
  • TBD: To be determined

Read more information about the Results of prioritization, status and outcome for substances on the Revised In Commerce List.

If the substance status is “no commercial activity identified” in the R-ICL tracking table below, see the Canada Gazette, Part I: Vol. 156, No 8 – February 19, 2022: Notice of removal of substances with no commercial activity from the Revised In Commerce List.

R-ICL tracking table (Current as of February 2022)
Substances identifier Substance name Prioritization results Status  Outcome
ICLCN 001 Confidential name Higher priority based on available information - Human health concern Confidential names are not eligible for listing on R-ICL Removed from R-ICL
1.13.11.12 linoleate:oxygen 13-oxidoreductase Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey To be determined (TBD)
100085-35-6 Protein hydrolyzates, fibronectin Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
100085-62-9 Protein hydrolyzates, microorganism Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1001439-91-3 Amylopectin, enzyme-hydrolyzed Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
100209-19-6 Almond, ext., hydrolyzed Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
100209-41-4 Protein hydrolyzates, corn Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
100209-42-5 Protein hydrolyzates, cottonseed Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
100231-68-3 D-Glucoside, eicosyl Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
10025-06-6 Glycine, N-methyl-, (9Z)-9-octadecen-1-yl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
10028-15-6 Ozone Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
100286-90-6 [1,4'-Bipiperidine]-1'-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
10031-23-9 Radium bromide (RaBr2) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
10031-59-1 Sulfuric acid, thallium(1+) salt (1:?) Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
100358-63-2 .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, [R-(Z)]-12-hydroxy-9-octadecenoate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
10036-64-3 .alpha.-D-Glucopyranose, 2-(acetylamino)-2-deoxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
100403-19-8 Ceramides Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
100418-33-5 Ethanol, 2-[(4-methyl-2-nitrophenyl)amino]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
10043-83-1 Phosphoric acid, magnesium salt (1:?) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
100568-02-3 Benzenepropanamine, N-methyl-.gamma.-[4-(trifluoromethyl)phenoxy]-, (.gamma.S)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
100684-25-1 Protein hydrolyzates, wheat gluten Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
100684-29-5 Glycerides, vegetable-oil, hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
100684-33-1 Petrolatum (petroleum), clay-treated Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
100684-38-6 Residual oils (petroleum), clay-treated solvent-dewaxed Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
100684-49-9 Slack wax (petroleum), carbon-treated Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
1007304-55-3 Poly(oxy-1,2-ethanediyl), .omega.'-hydroxy-.omega.-[(1- oxoisooctadecyl)oxy]-.omega."-[[(5-oxo-2-pyrrolidinyl)carbonyl]oxy]- .alpha.,.alpha.',.alpha."-1,2,3-propanediyltris- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
1007-42-7 L-Histidine, hydrochloride (1:?) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
100843-69-4 Saccharide isomerate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
100986-85-4 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
10101-63-0 Lead iodide (PbI2) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
10118-90-8 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
101227-09-2 Fatty acids, C16-18, 2-hexyldecyl esters Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1012317-71-3 L-Lysinamide, N2-(1-oxohexyl)-L-lysylglycyl-L-histidyl-, acetate (1:?) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
10124-48-8 Mercury amide chloride (Hg(NH2)Cl) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
10124-49-9 Sulfuric acid, iron salt (1:?) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
101-26-8 Pyridinium, 3-[[(dimethylamino)carbonyl]oxy]-1-methyl-, bromide (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
101-31-5 Benzeneacetic acid, .alpha.-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (.alpha.S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
10139-47-6 Zinc iodide (ZnI2) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
101403-98-9 Fatty acids, palm kernel-oil Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
10161-34-9 Estra-4,9,11-trien-3-one, 17-(acetyloxy)-, (17.beta.)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
101827-46-7 1-Naphthalenemethanamine, N-[[4-(1,1-dimethylethyl)phenyl]methyl]-N-methyl-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
101831-37-2 Benzeneacetonitrile, 2,6-dichloro-.alpha.-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
10192-46-8 Boric acid (H3BO3), zinc salt (2:3) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
101993-72-0 Octadecanoic acid, ester with triglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
102051-00-3 9-Octadecenoic acid (9Z)-, triester with decaglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
102-29-4 1,3-Benzenediol, 1-acetate Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
10233-14-4 9-Octadecenoic acid (9Z)-, 2-[2-(2-hydroxyethoxy)ethoxy]ethyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
102397-69-3 .beta.-D-Mannopyranuronic acid, 1-O-(dihydroxymethylsilyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
102625-70-7 1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1026525-47-4 L-Glutamine, glycyl-L-arginylglycyl-L-.alpha.,-aspartyl-L-tyrosyl-L-isoleucyl-L-tryptophyl-L-seryl-L-leucyl-L-,.alpha.-aspartyl-L-threonyl Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
102785-61-5 Glauconite-1M Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
102785-62-6 Glauconite-2M1 Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
102785-63-7 Glauconite-1Md Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
10279-59-1 Phosphoric acid, aluminum sodium salt (8:2:3) Higher priority based on available information - Environmental and human health concern Clarification required TBD
102868-96-2 Zinc, bis[N-(acetyl-.kappa.O)-L-methioninato-.kappa.O]-, (T-4)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
10294-31-2 Gold iodide (AuI) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
10294-70-9 Tin iodide (SnI2) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
102-98-7 Mercurate(2-), [orthoborato(3-)-.kappa.O]phenyl-, hydrogen (1:2) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
103055-07-8 Benzamide, N-[[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]amino]carbonyl]-2,6-difluoro- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
10305-76-7 Phosphoric acid, aluminum sodium salt (8:3:1), tetrahydrate Higher priority based on available information - Environmental and human health concern Clarification required TBD
103129-82-4 3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester, (4S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
103-16-2 Phenol, 4-(phenylmethoxy)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
103213-20-3 Fatty acids, C18-unsatd., dimers, hydrogenated, di-iso-Pr esters Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
10326-21-3 Chloric acid, magnesium salt (2:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
1033319-29-7 Pichia anomala, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1034-01-1 Benzoic acid, 3,4,5-trihydroxy-, octyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1034015-50-3 Polysaccharides, sugarcane,3-(dimethyloctadecylammonio)-2-hydroxypropyl ethers,chlorides Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
103577-45-3 1H-Benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
10361-76-9 Peroxymonosulfuric acid, potassium salt (1:2) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
103622-85-1 3,6,9,12-Tetraoxatriacont-21-en-1-ol Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
103628-46-2 1H-Indole-5-methanesulfonamide, 3-[2-(dimethylamino)ethyl]-N-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
103628-48-4 Butanedioic acid, compd. with 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
103639-04-9 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-, hydrochloride, hydrate (1:1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
103667-50-1 2-Thiopheneacetic acid, 5-benzoyl-.alpha.-methyl-, (.alpha.S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
103810-94-2 Methanone, diphenyl-, dihydroxy deriv. Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
103819-44-9 Fats and Glyceridic oils, avocado, ethoxylated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
103819-46-1 Olive oil, ethoxylated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
103980-44-5 5-​Thia-​1-​azabicyclo[4.2.0]​oct-​2-​ene-​2-​carboxylic acid, 7-​[[(2Z)​-​2-​(2-​amino-​4-​thiazolyl)​-​2-​(methoxyimino)​acetyl]​amino]​-​3-​[[(2-​furanylcarbonyl)​thio]​methyl]​-​8-​oxo-​, hydrochloride (1:1)​, (6R,​7R)​- Higher priority based on available information - Environmental concern Clarification required TBD
104075-48-1 1H-Imidazole, 5-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
10417-86-4 Pregnane-3,11,20-trione, 21-hydroxy-, (5.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
10417-94-4 5,8,11,14,17-Eicosapentaenoic acid, (5Z,8Z,11Z,14Z,17Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
10418-03-8 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
104226-19-9 3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
104227-87-4 1,3-Propanediol, 2-[2-(2-amino-9H-purin-9-yl)ethyl]-, 1,3-diacetate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
104333-00-8 1,2-Propanediol, 3-[[2-nitro-4-(trifluoromethyl)phenyl]amino]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
104344-23-2 2-Propanol, 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-, (2E)-2-butenedioate (2:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
104365-75-5 2-Propenoic acid, homopolymer, ester with 1,2,3-propanetriol Higher priority based on available information - Environmental and human health concern Clarification required TBD
104486-81-9 L-talo-Non-2-enonic acid, 5,9-anhydro-2,3,4,8-tetradeoxy-8-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]-2-oxiranyl]methyl]-3-methyl-, 8-carboxyoctyl ester, calcium salt (2:1), (2E)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
104632-25-9 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, hydrochloride (1:2), (6S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
104673-29-2 Chitosan, N-(2-hydroxypropyl) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
10476-84-3 Octadecanoic acid, manganese salt (1:?) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
10476-86-5 Strontium iodide (SrI2) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
104-98-3 2-Propenoic acid, 3-(1H-imidazol-5-yl)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
104987-11-3 15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
*105613-48-7/ 10051-63-1 2-Butanone, 3,3'-[(2,2-dimethyl-1,3-propanediyl)diimino]bis-,2,2'-dioxime, (2E,2'E,3R,3'R)-rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
105618-03-9 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, ethyl methyl ester, (4S)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
10578-34-4 Benzoic acid, octadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
105816-04-4 D-Phenylalanine, N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
105857-23-6 Plasminogen activator (human tissue-type protein moiety) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
105859-93-6 Propanoic acid, 2,2-dimethyl-, tridecyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
105883-45-2 L-Tyrosine, N-acetyl-, dihydroxymethylsilyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
105883-49-6 Magnesium, bis[N-(acetyl-.kappa.O)-L-methioninato-.kappa.O]-, (T-4)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
105883-50-9 Manganese, bis[N-(acetyl-.kappa.O)-L-methioninato-.kappa.O]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
105883-51-0 Copper, bis[N-(acetyl-.kappa.O)-L-methioninato-.kappa.O]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
105883-52-1 Cobalt, bis[N-(acetyl-.kappa.O)-L-methioninato-.kappa.O]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
106233-09-4 Poly(oxy-1,2-ethanediyl),alpha.-hydro-.omega.-hydroxy-,mono-C16-18-alkyl ethers, phosphates Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
106266-06-2 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
106392-12-5 Oxirane, 2-methyl-, polymer with oxirane, block Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
106436-39-9 Propanoic acid, 2,2-dimethyl-, tridecyl ester, branched Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
106463-17-6 Benzenesulfonamide, 5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
106483-04-9 Octanoic acid, diester with 5-hydroxy-6-methyl-3,4-pyridinedimethanol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
106631-38-3 1-Naphthalenepropanol, .alpha.-ethenyldecahydro-.alpha.,5,5,8a-tetramethyl-2-methylene- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
106685-40-9 2-Naphthalenecarboxylic acid, 6-(4-methoxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
107133-36-8 1H-Indole-2-carboxylic acid, 1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)butyl]amino]-1-oxopropyl]octahydro-, (2S,3aS,7aS)-, compd. with 2-methyl-2-propanamine (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1072005-10-7 Decanoic acid, mixed diesters with octanoic acid and 1,3-propanediol Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
107615-51-0 9-Octadecenoic acid, 12-hydroxy-, monoester with hexaglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
107628-04-6 Poly(oxy-1,2-ethanediyl), .alpha.-[2-[(2-hydroxyethyl)amino]-2-oxoethyl]-.omega.-hydroxy-, mono-C13-15-alkyl ethers Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
107709-25-1 Starch, polymer with sodium 2-propenoate (1:1), graft Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1077-27-6 1,2-Dithiolane-3-pentanoic acid, (3S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
107753-78-6 Carbamic acid, N-[3-[[2-methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]-, cyclopentyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
107868-30-4 Androsta-1,4-diene-3,17-dione, 6-methylene- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
108050-54-0 Tylosin, 4A-O-de(2,6-dideoxy-3-C-methyl-.alpha.-L-ribo-hexopyranosyl)-20-deoxo-20-[(3R,5S)-3,5-dimethyl-1-piperidinyl]- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
108347-90-6 Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-benzoyl-.omega.-(octadecyloxy)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
108777-93-1 1,2,3-Propanetriol, homopolymer, octanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
108778-82-1 Beractant Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1093-16-9 Spiro[naphthalene-2(1H),2'-oxirane]-1-propanol, .alpha.-ethenyloctahydro-.alpha.,5,5,8a-tetramethyl- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
109423-22-5 Benzoic acid, 2-hydroxy-, 5-methyl-2-(1-methylethyl)cyclohexyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
109485-61-2 Nonane, 2,2,4,4,6,6,8-heptamethyl- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
1095-90-5 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl-, hydrochloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
109884-54-0 Isooctadecanoic acid, 2,2-dimethyl-1,3-propanediyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
109889-09-0 1H-Indazole-3-carboxamide, 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
11029-12-2 Anthocyanins, grape Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
110332-91-7 Oxirane, methyl-,polymer with oxirane, monoacetate, isohexadecyl ether, block Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
11061-68-0 Insulin (human) Higher priority based on available information - Environmental concern Clarification required TBD
110780-72-8 Biotite-3A1 ((Fe0.4-0.8Mg0.2-0.6)3K(Si3Al)[(OH)0.5-1F0-0.5]2O10) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1109-11-1 2,4,6,8,10,12,14,16-Heptadecaoctaenoic acid, 2,6,11,15-tetramethyl-17-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, ethyl ester, (2E,4E,6E,8E,10E,12E,14E,16E)- Higher priority based on available information - Environmental concern Clarification required TBD
11092-32-3 Aluminum oxide (AlO2) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
110942-02-4 2-133-Interleukin 2 (human reduced), 125-L-serine- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
111025-46-8 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
11108-73-9 Uranium alloy, base, U,Nb,Zr (Mulberry) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
11116-97-5 Calcium, (D-gluconato)(2-hydroxypropanoato)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
1112-38-5 Phosphorothioic acid, O,O-dimethyl ester Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
11128-98-6 Boric acid, ammonium salt Higher priority based on available information - Environmental and human health concern Clarification required TBD
11140-04-8 Octanoic acid, ester with 1,2,3-propanetriol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
111470-99-6 3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester, benzenesulfonate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1115-47-5 Methionine, N-acetyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1115-70-4 Imidodicarbonimidic diamide, N,N-dimethyl-, hydrochloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
1118558-33-0 Bidens pilosa, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1119-33-1 L-Glutamic acid, 5-ethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
111974-69-7 Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
111974-72-2 Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-, (2E)-2-butenedioate (2:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1119-87-5 1,2-Dodecanediol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1120-16-7 Dodecanamide Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
112362-50-2 3H-21,18-Nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, 26-[[2-(diethylamino)ethyl]sulfonyl]-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-, (3R,4R,5E,10E,12E,14S,26R,26aS)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
112385-09-8 2-Butenedioic acid (2Z)-, diisooctadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
112529-15-4 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-, hydrochloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
112593-95-0 Biotite-1M ((Fe0.4-0.8Mg0.2-0.6)3K(Si3Al)[(OH)0.5-1F0-0.5]2O10) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
112708-25-5 Tetraglycerol, mono-(9Z)-9-octadecen-1-yl ether Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
112809-51-5 Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
112811-59-3 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo- Higher priority based on available information - Environmental concern Clarification required TBD
112887-68-0 L-Glutamic acid, N-[[5-[[(3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
112965-21-6 1,3-Cyclohexanediol, 5-[(2E)-2-[(1R,3aS,4E,7aR)-1-[(1R,2E)-4-cyclopropyl-4-hydroxy-1-methyl-2-butenyl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-, (1R,3S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
113010-52-9 Benzoic acid, 4-amino-, ethyl ester, polymer with oxirane Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
113-07-5 2-Pyrrolidinone, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-, monohydrochloride Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
113089-59-1 Collagens, hydrolyzates, reaction products with 3-chloro-2-hydroxy-N,N,N-trimethyl-1-propanaminium chloride Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
*113170-55-1/108910-78-7 L-Ascorbic acid, 2-(dihydrogen phosphate), magnesium salt (2:3) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
113-21-3 Propanoic acid, 2-hydroxy-, ion(1-) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
113221-73-1 2-Naphthalenecarboxaldehyde, 5,6,7,8-tetrahydro-5,5,7,8,8-pentamethyl- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
113427-24-0 1-165-Erythropoietin (human clone .lambda.HEPOFL13 protein moiety), glycoform .alpha. Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
113431-53-1 2-Butenedioic acid (2E)-, diisooctadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
113431-54-2 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, triisooctadecyl ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
113507-06-5 Milbemycin B, 5-O-demethyl-28-deoxy-25-[(1E)-1,3-dimethyl-1-butenyl]-6,28-epoxy-23-(methoxyimino)-, (6R,23E,25S)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
1135-24-6 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
113617-63-3 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-5,6,8-trifluoro-1,4-dihydro-4-oxo-, rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
113665-84-2 Thieno[3,2-c]pyridine-5(4H)-acetic acid, .alpha.-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (.alpha.S)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
113806-05-6 Dibenz[b,e]oxepin-2-acetic acid, 11-[3-(dimethylamino)propylidene]-6,11-dihydro-, (11Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
113956-14-2 C.I. Pigment Red 259 Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
114040-31-2 L-Ascorbic acid, mono(dihydrogen phosphate), magnesium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
114355-43-0 9-Octadecenoic acid, 12-hydroxy-, (9Z,12R)-, ester with hexaglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
114733-90-3 Biotite-2M1 ((Fe0.4-0.8Mg0.2-0.6)3K(Si3Al)[(OH)0.5-1F0-0.5]2O10) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
114-80-7 Benzenaminium, 3-[[(dimethylamino)carbonyl]oxy]-N,N,N-trimethyl-, bromide (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
114870-03-0 .alpha.-D-Glucopyranoside, methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)- .alpha.-D-glucopyranosyl-(1→4)-O-.beta.-D-glucopyranuronosyl- (1→4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-.alpha.-D- glucopyranosyl-(1→4)-O-2-O-sulfo-.alpha.-L-idopyranuronosyl- (1→4)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen sulfate), sodium salt (1:10) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
114977-28-5 Benzenepropanoic acid, .beta.-[[(1,1-dimethylethoxy)carbonyl]amino]-.alpha.-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (.alpha.R,.beta.S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1151559-87-3 Protein hydrolyzates, Candida saitoana Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
115340-78-8 1-Propanaminium, 3-amino-N-ethyl-N,N-dimethyl-, N-apricot-oil acyl derivs., Et sulfates Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
115436-72-1 Phosphonic acid, P,P'-[1-hydroxy-2-(3-pyridinyl)ethylidene]bis-, sodium salt (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
115550-35-1 7H-Pyrido[3,2,1-ij][4,1,2]benzoxadiazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
115-76-4 1,3-Propanediol, 2,2-diethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
115956-13-3 1H-Indole-3-carboxylic acid, (6R,9aS)-octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, rel-, methanesulfonate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
116-38-1 Benzenaminium, N-ethyl-3-hydroxy-N,N-dimethyl-, chloride (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
116655-76-6 10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
116768-20-8 Biotite-3T ((Fe0.4-0.8Mg0.2-0.6)3K(Si3Al)[(OH)0.5-1F0-0.5]2O10)) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
117522-93-7 L-Proline, 5-oxo-, compd. with chitosan Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1176-08-5 Ethanamine, N,N-dimethyl-2-[2-(phenylmethyl)phenoxy]-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
1176232-55-5 Mimosa tenuiflora, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
117704-25-3 Avermectin A1a, 25-cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
117976-90-6 1H-Benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
118072-93-8 Phosphonic acid, P,P'-[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
118292-40-3 3-Pyridinecarboxylic acid, 6-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-, ethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
118390-30-0 Interferon .alpha.1 (human lymphoblast reduced), N-L-methionyl-22-L-arginine-76-L-alanine-78-L-aspartic acid-79-L-glutamic acid-86-L-tyrosine-90-L-tyrosine-156-L-threonine-157-L-asparagine-158-L-leucine- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
119068-77-8 2H-Pyran-2-acetic acid, tetrahydro-2,4-dihydroxy-6-[(1R)-1-[(2S,5R,7S,8R,9S)-9-hydroxy-2,8-dimethyl-2-[(2S,2'R,3'S,5R,5'R)-octahydro-2-methyl-5'-[(2S,3S,5R,6S)-tetrahydro-6-hydroxy-3,5,6-trimethyl-2H-pyran-2-yl]-3'-[[(2S,5S,6R)-tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl]oxy][2,2'-bifuran]-5-yl]-1,6-dioxaspiro[4.5]dec-7-yl]ethyl]-5-methoxy-3-methyl-, monosodium salt, (2R,3S,4S,5R,6S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
119068-78-9 Cholestane-3,7,12,24,26,27-hexol, 26-(hydrogen sulfate), sodium salt (1:1), (3.alpha.,5.beta.,7.alpha.,12.alpha.,24R,25S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
119141-88-7 1H-Benzimidazole, 6-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
119302-91-9 Pyrrolidinium, 1-[(2.beta.,3.alpha.,5.alpha.,16.beta.,17.beta.)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl]-1-(2-propenyl)-, bromide Higher priority based on available information - Environmental concern Clarification required TBD
119413-54-6 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, hydrochloride (1:1), (4S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
119481-72-0 Poly(oxy-1,2-ethanediyl), .alpha.-[2-(1-methylethoxy)-2-oxoethyl]-.omega.-hydroxy-, C12-15-alkyl ethers Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
119691-49-5 1-Eicosanol, 2-tetradecyl- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
1197-18-8 Cyclohexanecarboxylic acid, 4-(aminomethyl)-, trans- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
119831-19-5 Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside (4:1), dioctadecanoate Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
120011-70-3 1H-Inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-, hydrochloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
1200-22-2 1,2-Dithiolane-3-pentanoic acid, (3R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
120066-54-8 Gadolinium, [10-[2-(hydroxy-.kappa.O)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-.kappa.N1,.kappa.N4,.kappa.N7,.kappa.N10,.kappa.O1,.kappa.O4,.kappa.O7]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
120138-50-3 Virginiamycin S1, 4-[4-(dimethylamino)-N-methyl-L-phenylalanine]-5-[(2S,5R)-5-[[[(3S)-1-azabicyclo[2.2.2]oct-3-yl]thio]methyl]-4-oxo-2-piperidinecarboxylic acid]- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
12018-01-8 Chromium oxide (CrO2) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
120202-66-6 Thieno[3,2-c]pyridine-5(4H)-acetic acid, .alpha.-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (.alpha.S)-, sulfate (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
120279-96-1 4H-Thieno[2,3-b]thiopyran-2-sulfonamide, 4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, (4S,6S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
120373-24-2 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl]-, 1-methylethyl ester, (5Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
120486-24-0 Isooctadecanoic acid, triester with oxybis[propanediol] Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
120511-73-1 1,3-Benzenediacetonitrile, .alpha.1,.alpha.1,.alpha.3,.alpha.3-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
12068-50-7 Halloysite (Al2(Si2O7).2H2O) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
121032-29-9 9-(.beta.-D-Arabinofuranosyl)-6-methoxy-9H-purin-2-amine Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
121181-53-1 Colony-stimulating factor (human clone 1034), N-L-methionyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
12122-15-5 Nickel carbonate hydroxide (Ni5(CO3)2(OH)6) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
12126-59-9 Estrogens, conjugates Higher priority based on available information - Environmental concern Clarification required TBD
121268-17-5 Phosphonic acid, 2,2'-(4-amino-1-hydroxybutylidene)bis-, sodium salt, hydrate (1:1:3) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
121440-30-0 Isooctadecanoic acid, tetraester with oxybis[propanediol] Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
121546-77-8 Alcohols, C12-15 ethoxylate, sulfonate, sodium salt Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
121679-13-8 1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
121684-92-2 .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, acetate dioctadecanoate Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
121734-19-8 1,3-Benzenediamine, 4-methoxy-, sulfate Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
*12174-11-7/ 1337-76-4 Palygorskite ([Mg(Al0.5-1Fe0-0.5)]Si4(OH)O10.4H2O) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
121888-66-2 Quaternary ammonium compounds benzylbis(hydrogenated tallow alkyl)methyl, benzoate lauryl sulfate, salts with bentonite Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
121888-67-3 Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, bis(hydrogenated tallow alkyl)dimethylammonium salt with hectorite Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
121888-68-4 Quaternary ammonium compounds, benzyl(hydrogenated tallow alkyl)dimethyl, stearates, salts with bentonite Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
1219683-77-8 9-Octadecenoic acid, 12-hydroxy-, (9Z,12R)-, homopolymer, ester with pentaglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1220882-73-4 Kappaphycus alvarezii, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
122111-03-9 Cytidine, 2'-deoxy-2',2'-difluoro-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
122-11-2 Benzenesulfonamide, 4-amino-N-(2,6-dimethoxy-4-pyrimidinyl)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
12211-28-8 Proteinase, Bacillus subtilis, sutilains Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
12217-41-3 C.I. Basic Blue 22 Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
12217-43-5 9,10-Anthracenedione, 1-amino-4-[[4-[(dimethylamino)methyl]phenyl]amino]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
12221-52-2 C.I. Basic Red 22 Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
12222-04-7 C.I. Direct Blue 199 Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
122320-73-4 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
12244-16-5 Endellite (Al2(Si2O7).4H2O) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
122647-32-9 Methanesulfonamide, N-[4-[4-(ethylheptylamino)-1-hydroxybutyl]phenyl]-, (2E)-2-butenedioate (2:1) (salt) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
122703-32-6 D-Glucopyranoside, methyl, di-(9Z)-9-octadecenoate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
12298-43-0 Halloysite (Al2(Si2O7).xH2O) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
123005-57-2 Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside (3:1), ether with .alpha.-[3-(dodecyldimethylammonio)-2-hydroxypropyl]-.omega.-hydroxypoly(oxy-1,2-ethanediyl) chloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
123441-03-2 Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
1236-99-3 10H-Phenothiazine-10-propanamine, 2-methoxy-N,N,.beta.-trimethyl-, hydrochloride (1:1), (.beta.R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
123776-54-5 Butanedioic acid, sulfo-, 1-dodecyl ester, diammonium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
123776-56-7 1-Propanaminium, 3-(acetylamino)-N,N,N-trimethyl-, chloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
123-78-4 4-Octadecene-1,3-diol, 2-amino-, (2S,3R,4E)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
1239011-60-9 Phenylalaninamide, N2-acetyl-D-lysyl-L-alpha-aspartyl-L-valyl-3-hydroxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
123948-87-8 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
123997-26-2 Avermectin B1, 4"-(acetylamino)-4"-deoxy-, (4"R)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
124046-05-5 Benzenemethanaminium, N-(3-aminopropyl)-N,N-dimethyl-, N-babassu-oil acyl derivs., chlorides Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
124046-09-9 Benzenemethanaminium, N-(3-aminopropyl)-N,N-dimethyl-, N-wheat-oil acyl derivs., chlorides Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
124046-21-5 Amides, avocado-oil, N,N-bis(hydroxyethyl) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
124046-24-8 Amides, babassu-oil, N,N-bis(hydroxyethyl) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
124046-40-8 Amides, wheat germ-oil, N-[3-(dimethylamino)propyl], lactates Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
124046-50-0 Oils, almond, ethoxylated Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
124046-52-2 Palm kernel oil, ethoxylated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
12417-86-6 Stevensite ((Ca0.33-0.5Na0-0.33)0.33Mg3(Si3.67Al0.33)(OH)2O10) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1242417-48-6 Luffa cylindrica, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
124-43-6 Urea, compd. with hydrogen peroxide (H2O2) (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
124750-99-8 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
124832-26-4 L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
124832-27-5 L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
124937-52-6 Phenol, 2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methyl-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
124-94-7 Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11.beta.,16.alpha.)- Higher priority based on available information - Environmental concern Clarification required TBD
125-02-0 Pregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-(phosphonooxy)-, disodium salt, (11.beta.)- Higher priority based on available information - Environmental concern Clarification required TBD
125-04-2 Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, sodium salt (1:1), (11.beta.)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
125109-85-5 Benzenepropanal, .beta.-methyl-3-(1-methylethyl)- Higher priority based on available information - Environmental and human health concern Clarification required TBD
125317-39-7 Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-[(2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2.beta.,3.beta.,4.beta.,5.alpha.,12R,19.alpha.)-, (2R,3R)-2,3-dihydroxybutanedioate (1:2) (salt) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
125494-59-9 Cyclobutanemethanamine, 1-(4-chlorophenyl)-N,N-dimethyl-.alpha.-(2-methylpropyl)-, hydrochloride, hydrate (1:1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
125687-22-1 Poly (oxy-1,2-ethanediyl) ,.alpha.,.alpha.'-(2- carboxy-2-methyl-1,3- propanediyl) bis [.omega.-hydroxy-, polymer with 2,4-diisocyanato-1- methylbenzene Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
125-71-3 Morphinan, 3-methoxy-17-methyl-, (9.alpha.,13.alpha.,14.alpha.)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
1257857-19-4 Furcellaran, ammonium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1257964-88-7 Flavones, isoflavones, soya Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
12584-58-6 Insulin (swine) Higher priority based on available information - Environmental concern Clarification required TBD
125804-04-8 Docosanoic acid, compd. with N-[3-(dimethylamino)propyl]docosanamide (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
125804-08-2 Docosanoic acid, 2-octyldodecyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
125804-10-6 9,12-Octadecadienoic acid (9Z,12Z)-, dimer, compd. with (9Z,12Z)-N-[3-(dimethylamino)propyl]-9,12-octadecadienamide (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
125804-16-2 Docosanoic acid, isooctadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
125804-18-4 Isononanoic acid, tridecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1259528-20-5 Syrups, 4-O-.alpha.-D-glucopyranosyl-D-glucitol-high hydolyzed starch, hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1259528-21-6 Syrups, sorbitol-high hydrolyzed starch, hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
126094-21-1 D-Gluconamide, N-(3-methoxypropyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
126121-35-5 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2-bis(2-octyldodecyl) 3-(2-octyl-7-pentylheptyl) ester Higher priority based on available information - Human health concern Commercial activity identified To be assessed
126139-79-5 L-Tyrosine, N-(3-carboxy-2-hydroxy-1-oxopropyl)-, disodium salt, (S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
12619-70-4 Cyclodextrin Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
126-27-2 Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
12629-01-5 Somatotropin (human) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
12640-40-3 Bismuth oxide Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
126-44-3 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ion(3-) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1264-72-8 Colistin, sulfate (salt) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
12650-69-0 Nonanoic acid, 9-[[(2Z)-3-methyl-1-oxo-4-[(2S,3R,4R,5S)-tetrahydro-3,4-dihydroxy-5-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]-2-oxiranyl]methyl]-2H-pyran-2-yl]-2-buten-1-yl]oxy]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
126506-93-2 1,3,2-Dioxastibolane-4,5-dicarboxylic acid, 2-hydroxy-, 2-oxide Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
12651-23-9 Titanium hydroxide Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
126595-07-1 Propanoic acid, 3,3'-(1,3-dioxo-1,3-digermoxanediyl)bis-, homopolymer Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
12684-19-4 Lead iodide Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
126928-07-2 Isooctadecanoic acid, monoester with hexaglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
127061-56-7 L-Ascorbic acid, 2-[(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-YL hydrogen phosphate], potassium salt (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
127281-18-9 Glycerides, mixed decanoyl and octanoyl, reaction products with oxirane Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
127311-98-2 1-Propanaminium, 3-[[(9Z,12R)-12-hydroxy-1-oxo-9-octadecenyl]amino]-N,N,N-trimethyl-, chloride Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
12737-61-0 2-Propenoic acid, 2-methyl-, ester with 1,2,3-propanetriol, homopolymer Higher priority based on available information - Environmental and human health concern Clarification required TBD
127-40-2 .beta.,.epsilon.-Carotene-3,3'-diol, (3R,3'R,6'R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
127474-91-3 2,6-Naphthalenedicarboxylic acid, 2,6-bis(2-ethylhexyl) ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
127502-06-1 3,12-Dioxa-6,9-diphosphatetradecane, 6,9-bis(2-ethoxyethyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
127512-63-4 3,12-Dioxa-6,9-diphosphatetradecane, 6,9-bis(2-ethoxyethyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
12768-44-4 4H-1-Benzopyran-4-one, 3-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-,hydrogen sulfate, sodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
127770-27-8 Hexadecanoic acid, isohexadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
127779-20-8 Butanediamide, N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, (2S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
128-13-2 Cholan-24-oic acid, 3,7-dihydroxy-, (3.alpha.,5.beta.,7.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
128446-33-3 .alpha.-Cyclodextrin, 2-hydroxypropyl ethers Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
128665-25-8 Sorbitan, octadecanoate (2:3), poly(oxy-1,2-ethanediyl) derivs. Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
128729-28-2 2-Propanol, 1,3-bis[(4-aminophenyl)(2-hydroxyethyl)amino]-, hydrochloride (1:4) Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
128794-94-5 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
128895-87-4 Triglycerol, monohexadecyl ether Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
128973-71-7 Siloxanes and Silicones, .alpha.-D-mannopyranuronoyloxy Me, hydroxy-terminated Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
128973-73-9 Siloxanes and Silicones, Me[1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)acetyl]oxy, hydroxy-terminated Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
128973-74-0 Siloxanes and Silicones, (2S-trans)-[[4-hydroxy-2-pyrrolidinyl)carbonyl]oxy] Me, hydroxyl-terminated Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
129-06-6
2H-1-benzopyran-2-one, 4-Hydroxy-3-(-oxo-1-phenylbutyl)-sodium salt (1:1)
Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
129101-54-8 Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
129318-43-0 Phosphonic acid, P,P'-(4-amino-1-hydroxybutylidene)bis-, sodium salt (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
129423-55-8 Dodecanedioic acid, 1,12-bis(2-octyldodecyl) ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
129426-19-3 Hexadecanamide, N-[2-hydroxy-1-(hydroxymethyl)pentadecyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
129496-10-2  Milbemycin, oxime Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
129497-78-5 24H,26H-Benzo[b]porphine-9,13-dipropanoic acid, 18-ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-, monomethyl ester, (4R,4aS)-rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
129499-78-1 L-Ascorbic acid, 2-O-.alpha.-D-glucopyranosyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
129521-66-0 Lignite Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
129541-40-8 Tetradecanamide, N-[3-(dimethylamino)propyl]-, phosphate (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
129618-40-2 6H-Dipyrido[2,3-b:3',2'-e][1,4]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
129691-05-0 5,8,11,14-Eicosatetraenoic acid, 2,3-dihydroxypropyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
129722-12-9 2(1H)-Quinolinone, 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
129757-76-2 2-Oxepanone, polymer with 1,6-diisocyanatohexane and 2-ethyl-2-(hydroxymethyl)-1,3-propanediol Higher priority based on available information - Human health concern Commercial activity identified To be assessed
1300-94-3 Phenol, 5-methyl-2-pentyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
130169-63-0 Siloxanes and Silicones, di-Me, [(1-oxooctadecyl)oxy]-terminated Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
130209-82-4 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-, 1-methylethyl ester, (5Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1302-27-8 Biotite ((Fe0.4-0.8Mg0.2-0.6)3K(Si3Al)[(OH)0.5-1F0-0.5]2O10) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
130291-58-6 2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, homopolymer, compd. with bromomethane Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
130328-22-2 1,2,3- Propanetricarboxylic acid, 2-hydroxy-, esters with octadecanol,fatty acids,C12-18 and 1,3 propanediol,2,2-bis (hydroxymethyl) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
130353-64-9 Quaternary ammonium compounds, coco alkyl(2,3-dihydroxypropyl)dimethyl, 3-ethers with cellulose 2-hydroxyethyl ether, chlorides Higher priority based on available information - Environmental concern Clarification required TBD
130381-02-1 Protein hydrolyzates, soya, [3-(dodecyldimethylammonio)-2-hydroxypropyl], chlorides Higher priority based on available information - Environmental concern Clarification required TBD
130381-04-3 Protein hydrolyzates, wheat germ, [3-(coco alkyldimethylammonio)-2-hydroxypropyl], chlorides Higher priority based on available information - Environmental concern Clarification required TBD
130381-05-4 Protein hydrolyzates, wheat germ, [3-(dimethyloctadecylammonio)-2-hydroxypropyl], chlorides Higher priority based on available information - Environmental concern Clarification required TBD
130381-06-5 Protein hydrolyzates, wheat germ, [3-(dodecyldimethylammonio)-2-hydroxypropyl], chlorides Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
130381-07-6 Protein hydrolyzates, wheat germ, polymers with vinylpyrrolidone Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
130498-24-7 Limnanthes alba, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
130501-87-0 Stearalkonium Bentonite (Quaternary ammonium compound, Benzyl (hydrogenated C4-C18 alkyl) dimethyl, salts with Montmorillonite clay) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1306-04-3 Chlorapatite (Ca5Cl(PO4)3) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1306-05-4 Fluorapatite (Ca5F(PO4)3) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
13078-36-9 Glycine, N,N,-bis[2-bis(carboxymethyl)amino]ethyl]-, sodium salt (1:3) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
130905-60-1 Hexanedioic acid, mixed esters with decanoic acid, 12-hydroxyoctadecanoic acid, isostearic acid, octanoic acid, 3,3'oxybis[1,2-propanediol] and stearic acid Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
13092-66-5 Phosphoric acid, magnesium salt (2:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
130929-57-6 2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-, (2E)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
130-95-0 Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)- Higher priority based on available information - Human health concern Commercial activity identified To be assessed
130986-04-8 2H-1-Benzopyran, 3,4-dihydro-2,5,7,8-tetramethyl-6-[[methylbis(9-octadecen-1-yloxy)silyl]oxy]-2-(4,8,12-trimethyltridecyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
13103-34-9 Androsta-1,4-dien-3-one, 17-[(1-oxo-10-undecenyl)oxy]-, (17.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
13103-75-8 Benzenamine, N,N-dimethyl-4-[2-(2-pyridinyl)diazenyl]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
131044-77-4 Copper, N-acetyl-L-tyrosine hydroxy-terminated (S)-[2-(acetylamino)-3-(4-hydroxyphenyl)-1-oxopropoxy] Me siloxanes Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
131044-78-5 Copper, hydroxy-terminated Me (S)-[[(5-oxo-2-pyrrolidinyl) carbonyl]oxy] siloxanes 5-oxo-L-proline complexes Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
131216-83-6 Siloxanes and Silicones, 2-(acetylamino)-4-(methylthio)-1-oxobutyoxyMe, hydroxy-terminated Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
131252-83-0 Dodecanedioic acid, diisohexadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
131276-37-4 Hexadecanamide, 9,10,16-trihydroxy-N-[2-hydroxy-3-(tetradecyloxy)propyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
131410-48-5 Gadolinium, [5,8-bis[(carboxy-.kappa.O)methyl]-11-[2-(methylamino)-2-(oxo-.kappa.O)ethyl]-3-(oxo-.kappa.O)-2,5,8,11-tetraazatridecan-13-oato(3-)-.kappa.N5,.kappa.N8,.kappa.N11,.kappa.O13]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
131410-50-9 Calciate(1-), [5,8-bis[(carboxy-.kappa.O)methyl]-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-)-.kappa.N5,.kappa.N8,.kappa.N11,.kappa.O13]-, sodium (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1314-84-7 Zinc phosphide (Zn3P2) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
13149-68-3 D-Gluconic acid, 6-ester with N,N-bis(1-methylethyl)glycine Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
13149-69-4 D-Gluconic acid, 6-[bis[bis(1-methylethyl)amino]acetate] Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1315-04-4 Antimony sulfide (Sb2S5) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
1317-26-6 Aluminum magnesium hydroxide (AlMg2(OH)7), monohydrate Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
1317-57-3 Glauconite ([(Al0-1Fe0-1)1.33Mg0.67]K(Si3.67Al0.33)(OH)2O10) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1318-02-1 Zeolites Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
131812-48-1 1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthalenyl)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
131812-49-2 Naphthalene, 7-(diethoxymethyl)-1,2,3,4-tetrahydro-1,1,2,4,4-pentamethyl- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
131812-51-6 1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-, cis- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
131812-52-7 1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-, trans- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
131812-67-4 1,3-Dioxolane,2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
1319-53-5 Malachite (Cu2(CO3)(OH)2) Higher priority based on available information - Environmental and human health concern Clarification required TBD
131954-48-8 1-Propanaminium, N,N,N-trimethyl-3-[(2-methyl-1-oxo-2-propen-1-yl)amino]-, chloride (1:1), polymer with 1-ethenyl-2-pyrrolidinone Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
1321-57-9 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, mono(1-methylethyl) ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
132207-31-9 Polysiloxanes, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol dihydrogen phosphate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1322-14-1 10-Undecenoic acid, calcium salt (2:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
132259-10-0 Air Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1323-66-6 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, monooctadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
132467-76-6 1-Octadecanaminium, N-[2-hydroxy-3-[3-hydroxy-4-[(3-hydroxypropyl)amino]-2,2-dimethyl-4-oxobutoxy]propyl]-N,N-dimethyl-, chloride Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
132539-06-1 10H-Thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
132539-07-2 1-Piperidinepropanoic acid, 4-(methoxycarbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester, hydrochloride Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
132-69-4 1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-, hydrochloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
132875-61-7 1-Piperidinepropanoic acid, 4-(methoxycarbonyl)-4-[(1-oxopropyl)phenylamino]-, methyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
132-98-9 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenoxyaxetyl)amino]-,potassium salt (1:1), (2S,5R,6R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
133029-32-0 Imidodicarbonimidic diamide, N-(3-aminopropyl)-, homopolymer Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
133040-01-4 2-Thiophenepropanoic acid, .alpha.-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (.alpha.E)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
133098-04-1 Ethane, 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-, (2R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
133099-07-7 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-.alpha., .alpha.-diphenyl-, hydrobromide (1 :1), (3S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
133101-79-8 Elastins, esters with hydroxy-terminated hydroxy Me siloxanes Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
133107-64-9 Insulin (human), 28B-L-lysine-29B-L-proline- Higher priority based on available information - Environmental concern Clarification required TBD
1332-25-8 C.I. Pigment Red 102 Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
133448-16-5 Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol monoisostearate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1335-26-8 Magnesium peroxide Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
1335-36-0 1,2,3-Propanetriol, mono(dihydrogen phosphate), manganese salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1335-56-4 .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, mixt. with iron(2+) carbonate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1336-17-0 2-Propanone, peroxide Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
133652-38-7 173-527-Plasminogen activator (human tissue-type), 173-L-serine-174-L-tyrosine-175-L-glutamine- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
133654-02-1 Decanoic acid, ester with triglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1337-20-8 Chlorophyllins, copper potassium sodium Higher priority based on available information - Environmental and human health concern Clarification required TBD
1337-89-9 1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,6,10,10a-decahydro-1,4a-dimethyl-7-(1-methylethyl)-, (1R,4aR,4bR,10aR)-, ester with 1,2,3-propanetriol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
133814-18-3 Isoquinolinium, 2,2'-[(1,4-dioxo-1,4-butanediyl)bis(oxy-3,1-propanediyl)]bis[1,2,3,4-tetrahydro-6,7,8-trimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-, (1R,1'S,2S,2'R)-rel- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
133814-19-4 Isoquinolinium, 2,2'-[[(4E)-1,8-dioxo-4-octene-1,8-diyl]bis(oxy-3,1-propanediyl)]bis[1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-, (1R,1'R)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
1338929-66-0 Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside 2,6-di-(9Z)-9 octadecenoate (2:1),mono-(9Z)-9-octadecenoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
133934-09-5 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-wheat-oil acyl derivs., inner salts Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
1340-06-3 Ichthyolic acid, sodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
134017-12-2 Octadecanoic acid, 12-[(1- oxoisooctadecyl) oxy]-, isooctadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
13408-62-3 Ferrate(3-), hexakis(cyano-.kappa.C)-, (OC-6-11)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
134112-42-8 1-Propanaminium, N-[2-(dodecyloxy)-2-oxoethyl]-N,N-dimethyl-3-[(1-oxoisooctadecyl)amino]-,chloride Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
13412-64-1 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, monosodium salt, monohydrate, (2S,5R,6R)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
134134-87-5 Proteins, oat Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
13429-07-7 2-Propanol, 1-(2-methoxypropoxy)- Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
134324-28-0 Lactoferrin (cattle clone PM-8/PM-7 protein moiety reduced) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
134375-99-8 Aluminum Zirconium Trichlorohydrex Gly Higher priority based on available information - Environmental and human health concern Clarification required TBD
134523-00-5 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (.beta.R,.delta.R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
134523-03-8 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt (2:1), (.beta.R,.delta.R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
13460-51-0 Boric acid (H3B3O6) Higher priority based on available information - Environmental and human health concern Clarification required TBD
134678-17-4 2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
134737-05-6 Siloxanes and Silicones, di-Me, 3-[3-[(3-coco amidopropyl)dimethylammonio]-2-hydroxypropoxy]propyl group-terminated, acetates (salts) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
134774-45-1 Oxidase, urate (Aspergillus flavus clone 9C/9A reduced) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
135062-02-1 Benzoic acid, 2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
135236-72-5 Butanoic acid, 3-hydroxy-3-methyl-, calcium salt (2:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
135322-32-6 L-Ascorbic acid, compd. with chitosan Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
135326-54-4 Propanol, (tetradecyloxy)-, acetate Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
1353675-54-3 Lindera aggregata aggregata, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1355047-06-1 .alpha.-D-Glucopyranoside, methyl, isooctadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
135507-00-5 Hyaluronic acid, dimethylsilyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
13552-80-2 Undecanoic acid, 1,1',1"-(1,2,3-propanetriyl) ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
13557-75-0 Dodecanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, sodium salt (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
136097-93-3 Fatty acids, beeswax, monoesters with polyglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
136097-96-6 Fatty Acids, C16-22, C>14-alkyl esters, reaction products with polyethylene Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
13614-98-7 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, hydrochloride (1:1), (4S,4aS,5aR,12aS)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
136207-49-3 3,6,9,12,15-Pentaoxaheptatriacontan-1-ol Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
136279-32-8 Interleukin 2 (human), N-L-methionyl- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
136434-34-9 2-Thiophenepropanamine, N-methyl-.gamma.-(1-naphthalenyloxy)-, hydrochloride (1:1), (.gamma.S) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
136470-78-5 2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S,4R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
136504-87-5 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-soya acyl derivs., inner salts Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
136505-01-6 2-Propenenitrile, homopolymer, hydrolyzed, block, reaction products with N,N-dimethyl-1,3-propanediamine Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
136591-59-8 Methanesulfonamide, N-[4-[(1S)-4-(ethylheptylamino)-1-hydroxybutyl]phenyl]-, (2E)-2-butenedioate (2:1) (salt) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
13682-92-3 Aluminum, (glycinato-.kappa.N,.kappa.O)dihydroxy-, (T-4)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
136920-08-6 1-Propanaminium, N-(3-aminopropyl)-2,3-dihydroxy-N,N-dimethyl-, N-cocoacyl derivs., chlorides Higher priority based on available information - Environmental concern Clarification required TBD
137028-15-0 Propanoic acid, 2,2-dimethyl-, isoeicosyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
137044-11-2 1-Propanaminium, 3-[2-(acetylamino)ethoxy]-N,N,N-trimethyl-, chloride Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
13710-19-5 Benzoic acid, 2-[(3-chloro-2-methylphenyl)amino]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
137330-13-3 Tylosin, 4A-O-de(2,6-dideoxy-3-C-methyl-a-L-ribo-hexopyranosyl)-20-deoxo-20-[(3R,5S)-3,5-dimethyl-1-piperidinyl]-, phosphate (1:1)(salt) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
13779-98-1 Plumbane, tetraiodo- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
137862-53-4 L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
137-88-2 Pyridinium, 1-[(4-amino-2-propyl-5-pyrimidinyl)methyl]-2-methyl-, chloride, hydrochloride (1:1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
138068-37-8 Hirudin (Hirudo medicinalis isoform HV1), 1-L-leucine-2-L-threonine-63-desulfo- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
138-14-7 Butanediamide, N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N1-(5-aminopentyl)-N1-hydroxy-, methanesulfonate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
138148-35-3 Butanamide, N,N'-[dithiobis[2,1-ethanediylimino(3-oxo-3,1-propanediyl)]]bis[2,4-dihydroxy-3,3-dimethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
138208-67-0 Decanoic acid, 4-methylpentyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
13832-70-7 Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, octadecyl ester, (3.beta.,20.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
13837-60-0 2H-Pyran, 2-ethynyltetrahydro-2,6,6-trimethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
13838-16-9 Ethane, 2-chloro-1-(difluoromethoxy)-1,1,2-trifluoro- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
138-39-6 Benzenesulfonamide, 4-(aminomethyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
138402-11-6 1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
1384982-80-2 Quaternary Ammonium Compounds, dimethylbis (mixed C12-15-alkyl and cetyl and stearyl), chlorides Higher priority based on available information - Environmental concern Clarification required TBD
138530-95-7 1H-Benzimidazole, 2-[(S)-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
138680-08-7 1-Piperazinecarboxylic acid, 4-methyl-, (5R)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
13870-90-1 Cobinamide, Co-(5'-deoxyadenosin-5'-yl)-, f-(dihydrogen phosphate), inner salt, 3'-ester with (5,6-dimethyl-1-.alpha.-D-ribofuranosyl-1H-benzimidazole-.kappa.N3) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
138786-67-1 1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
13887-98-4 Acetic acid, 2,2'-[oxybis(2,1-ethanediyloxy)]bis- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
138890-62-7 2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (4R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
60662-14-8 Indate(2-)-111In, [N,N-bis[2 [bis(carboxymethyl)amino]ethyl]glycinato(5-)]-, disodium Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
139110-80-8 D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
139247-28-2 Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.',.alpha."-1,2,3-propanetriyltris[.omega.-hydroxy-, benzoate Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
139264-17-8 2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
13945-76-1 Dodecanoic acid, dodecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
139639-23-9 Plasminogen activator, tissue-type Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1396764-55-8 Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, lauryl Me, ethoxylated Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
139755-83-2 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1397-89-3 [1R (1R ,3S ,5R ,6R ,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)]-33-[(3-Amino-3,6-dideoxy-.beta.-D-mannopyranosyl)oxy]-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1398-61-4 Chitin Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1399-80-0 Benzenedimethanaminium, ar-dodecyl-ar,N,N,N,N',N',N'-heptamethyl-, dichloride, mixt. with ar-dodecyl-ar,N,N,N-tetramethylbenzenemethanaminium chloride Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
1401-54-3 Naphtho[1,2-b]furan-2(3H)-one, decahydro-6,9a-dihydroxy-5a-methyl-3,9-bis(methylene)-, (3aS,5aS,6R,9aR,9bS)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
140207-93-8 4-O-Methyl-.alpha.-D-glucurono-.beta.-D-xylan, hydrogen sulfate, sodium salt Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
14028-44-5 Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(1-piperazinyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
1404-90-6 22H-8,11:18,21-Dietheno-23,36-(iminomethano)-13,16:31,35-dimetheno-1H,16H-[1,6,9]oxadiazacyclohexadecino[4,5-m][10,2,16]benzoxadiazacyclotetracosine, vancomycin deriv. Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
1404-93-9 Vancomycin, hydrochloride Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
1405-41-0 Gentamicin, sulfate (salt) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
1405-89-6 Bacitracin Zinc Higher priority based on available information - Environmental concern Clarification required TBD
1405-97-6 Gramicidin Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1406-66-2 Tocopherols Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
140678-14-4 Manganate(6-), [[N,N'-1,2-ethanediylbis[N-[[3-(hydroxy-.kappa.O)-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methyl]glycinato-.kappa.N,.kappa.O]](8-)]-, trisodium trihydrogen, (OC-6-13)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
140-99-8 Butanedioic acid, calcium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
141-02-6 2-Butenedioic acid (2E)-, 1,4-bis(2-ethylhexyl) ester Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
141121-11-1 Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl .beta.-D-glucopyranoside (4:1), benzoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
141250-39-7 Fatty acids, coco, diesters with polyethylene glycol hydrogen citrate, monosodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
141464-42-8 D-Glucopyranose, oligomeric, C8-16-alkyl glycosides Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1415-73-2 9(10H)-Anthracenone, 10-.beta.-D-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-, (10S)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
141-86-6 2,6-Pyridinediamine Higher priority based on available information - Environmental and human health concern Clarification required TBD
141-94-6 5-Pyrimidinamine, 1,3-bis(2-ethylhexyl)hexahydro-5-methyl- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
142104-11-8 2-Butenedioic acid (2E)-, di-C12-15-alkyl esters Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
142164-39-4 Nickel carbonate hydroxide Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
142340-99-6 Propanoic acid, 2,2-dimethyl-, 1,1'-[[[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl] phosphinylidene]bis(oxymethylene)] ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
14246-53-8 Glycine, N-(1-oxooctyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
142-55-2 2-hydroxypropyl laurate Higher priority based on available information - Environmental concern Clarification required TBD
142657-60-1 Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol mono[[(3-coco amidopropyl)dimethylammonio]acetate],chlorides Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
142678-35-1 1H-Benzimidazole, 6-(difluoromethoxy)-2-[(S)-[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
142891-20-1 2-Propenoic acid, 2-chloro-3-[2-chloro-5-(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)phenyl]-, ethyl ester, (2Z)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
14289-32-8 Propanamide, N-(2-methylphenyl)-2-(propylamino)-, (2R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1429320-75-1 Butanedioic acid, 2-sulfo-, 1(or 4)-C10-16-alkyl esters, disodium salts Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
14307-43-8 Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, ammonium salt (1:?) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
143110-73-0 D-Glucose, 2-deoxy-6-O-[2-deoxy-2-[[(3R)-1-oxo-3-[(1-oxododecyl)oxy]tetradecyl]amino]-3-O-[(3R)-1-oxo-3-[(1-oxotetradecyl)oxy]tetradecyl]-4-O-phosphono-.beta.-D-glucopyranosyl]-2-[[(3R)-1-oxo-3-[(1-oxohexadecyl)oxy]tetradecyl]amino]- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
143193-85-5 1H-1,2,4-Triazole-1-ethanol, .alpha.-(2-fluorophenyl)-.alpha.-(4-fluorophenyl)-, mixt. with guazatine acetate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
143201-11-0 6-Heptenoic acid, 7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-, sodium salt (1:1), (3R,5S,6E)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
143388-64-1 1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, monohydrochloride Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1434719-44-4 Protein hydrolyzates, saccharomyces cerevisiae zinc complexes Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1434721-25-1 Protein hydrolyzates, Saccharomyces cerevisiae magnesium complexes Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1434722-94-7 Protein hydrolyzates, Saccharomyces cerevisiae calcium complexes Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1434729-64-2 Protein hydrolyzates, saccharomyces cerevisiae calcium iron magnesium potassium sodium complexes Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
143485-69-2 13-Docosenoic acid, 9-octadecen-1-yl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
143491-57-0 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
143653-53-6 Immunoglobulin G1, anti-(human integrin .alpha.IIb.beta.3) Fab fragment (human-mouse monoclonal c7E3 clone p7E3VHhC.gamma.1 .gamma.1-chain), disulfide with human-mouse monoclonal c7E3 clone p7E3V.kappa.hC.kappa. .kappa.-chain Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
143-67-9 Vincaleukoblastine, sulfate (1:1) (salt) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
143831-71-4 Nuclease, deoxyribo- (human clone 18-1 protein moiety) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
144025-09-2 1H-Imidazole, 1-[2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-, (-)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
144034-80-0 1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
144143-96-4 2-Thiophenepropanoic acid, .alpha.-((2-butyl-1-((4-carboxyphenyl)methyl)-1H-imidazol-5-yl)methylene)-, (.alpha.E)-, methanesulfonate (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
144377-73-1 4,6-Dioxa-14-aza-10-azonia-5-phosphadotriaconta-23,26-dien-1-aminium, 5-[3-[dimethyl[3-[[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]amino]propyl]ammonio]-2-hydroxypropoxy]-2,8-dihydroxy-N,N,10,10-tetramethyl-15-oxo-N-[3-[[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]amino]propyl]-, 5-oxide, chloride (1:3), (23Z,26Z)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
144470-58-6 Octadecanoic acid, 12-hydroxy-, homopolymer, ester with 1,2,3-propanetriol homopolymer Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
144494-65-5 L-Tyrosine, N-(butylsulfonyl)-O-[4-(4-piperidinyl)butyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
144514-51-2 Waxes and waxy substance, derived from Citrus sinensis or Citrus aurantium, Rutaceae Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
144514-54-5 Fatty acids, beeswax, mixed docosyl and 6-hydroxyhexyl esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
14452-57-4 Magnesium peroxide (Mg(O2)) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
144610-93-5 Propanoic acid, 2,2-dimethyl-, tetradecyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
144635-07-4 Glycerides, butter-fat mono-, di- and tri-, oxidized Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
14465-68-0 9,12,15-Octadecatrienoic acid, 1,1',1"-(1,2,3-propanetriyl) ester, (9Z,9'Z,9"Z,12Z,12'Z,12"Z,15Z,15'Z,15"Z)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
144701-48-4 [1,1'-Biphenyl]-2-carboxylic acid, 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
1448790-48-4 Soybean, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
145040-37-5 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
145-13-1 Pregn-5-en-20-one, 3-hydroxy-, (3.beta.)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
145155-23-3 2-166-Interferon .beta.1 (human fibroblast reduced), 17-L-serine- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
145202-66-0 1H-Indole-3-ethanamine,N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-,benzoate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
145269-34-7 Hydrolyzed wheat protein hydroxypropyltriammonium Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
1460304-48-6 Lactylic Esters of fatty acids
Fatty acids, vegetable-oil, 1-carboxyethyl esters
Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1460307-26-9 Lactylic Esters of fatty acids
Fatty acids, tall-oil, 1-carboxyethyl esters
Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1460305-62-7 Monosodium salts of Phosphorylated Mono and Diglycerides
Glycerides, vegetable-oil mono- and di-, mono(dihydrogen phosphates), monosodium salts
Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1460306-77-7 Monosodium salts of Phosphorylated Mono and Diglycerides
Glycerides, animal mono- and di-, mono(dihydrogen phosphates), monosodium salts
Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
14611-52-0 Benzeneethanamine, N,.alpha.-dimethyl-N-2-propyn-1-yl-, hydrochloride (1:1), (.alpha.R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
146-14-5     Riboflavin 5'-​(trihydrogen diphosphate)​, P'→5'-​ester with adenosine Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
146192-98-5 2-Butenedioic acid (2Z)-, monobutyl ester, polymer with ethenyl acetate and 1,7,7-trimethylphenylbicyclo[2.2.1]hept-2-yl 2-propenoate Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
14639-25-9 2-Pyridinecarboxylic acid, chromium(3+) salt (3:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
1463-95-2 Pyridinium, 2-[2-[(5-bromo-2-pyridinyl)amino]ethenyl]-1-ethyl-6-methyl-, iodide (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
146479-72-3 Follicle-stimulating hormone (human .alpha.-subunit reduced), complex with follicle-stimulating hormone (human .beta.-subunit reduced) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
146632-08-8 Siloxanes and Silicones, di-Me, Bu group- and 3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl group-terminated, polymers with 2-[[(heptadecafluorooctyl)sulfonyl]methylamino]ethyl acrylate and iso-Bu methacrylate Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
14663-23-1 2,4-Imidazolidinedione, 1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
147059-72-1 1,8-Naphthyridine-3-carboxylic acid, 7-[(1.alpha.,5.alpha.,6.alpha.)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
147221-93-0 Methanesulfonamide, N-[2-[[4-[3-[(1-methylethyl)amino]-2-pyridinyl]-1-piperazinyl]carbonyl]-1H-indol-5-yl]-, methanesulfonate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
147245-92-9 L-Glutamic acid, polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
147398-77-4 Ethanaminium, N-(carboxymethyl)-N,N-dimethyl-2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]-, inner salt, polymer with methyl 2-methyl-2-propenoate Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
147550-61-6 Copper carbonate hydroxide Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
1476-53-5 Benzamide, N-​[7-​[[3-​O-​(aminocarbonyl)​-​6-​deoxy-​5-​C-​methyl-​4-​O-​methyl-​.alpha.-​L-​lyxo-​hexopyranosyl]​oxy]​-​4-​hydroxy-​8-​methyl-​2-​oxo-​2H-​1-​benzopyran-​3-​yl]​-​4-​hydroxy-​3-​(3-​methyl-​2-​buten-​1-​yl)​-​, sodium salt (1:1) Higher priority based on available information - Environmental concern Clarification required TBD
14769-73-4 Imidazo[2,1-b]thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (6S)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
147732-56-7 L-Lysine, N-(1-oxohexadecyl)glycyl-L-histidyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
147732-57-8 L-Tyrosine, N-[(9Z)-1-oxo-9-octadecenyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
14783-68-7 bis(glycinato-N,O)magnesium Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
14798-03-9 Ammonium Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
148-01-6 Benzamide, 2-methyl-3,5-dinitro- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
14832-91-8 Amethyst (SiO2) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
148506-50-7 Poly[oxy-1,2-ethanediyl(dimethyliminio)-1,3-propanediylimino(1,6-dioxo-1,6-hexanediyl)imino-1,3-propanediyl(dimethyliminio)-1,2-ethanediyl chloride (1:2)] Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
148-79-8 1H-Benzimidazole, 2-(4-thiazolyl)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
148812-63-9 Protein hydrolyzates, wheat, reaction products with palmitoyl chloride Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
149144-85-4 Butanedioic acid, hydroxy-, di-C12-13-branched alkyl esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1492-18-8 L-Glutamic acid, N-[4-[[(2-amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-, calcium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
14932-42-4 Xenon, isotope of mass 133 Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
14982-50-4 Galacturonic acid Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
14984-34-0 D-Glucuronic acid, monosodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
149845-06-7 Butanediamide,N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1- dimethylethyl) amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl) propyl]-2-[(2-quinolinylcarbonyl)amino]-,(2S)-, methanesulfonate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
150378-17-9 D-erythro-Pentonamide, 2,3,5-trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
150399-23-8 L-Glutamic acid, N-[4-[2-(2-amino-4, 7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, sodium salt (1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
150599-70-5 1H-Imidazolium, 1-ethenyl-3-methyl-, methyl sulfate (1:1), polymer with 1-ethenyl-2-pyrrolidinone Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
150824-47-8 1,1-Ethenediamine, N-[(6-chloro-3-pyridinyl)methyl]-N-ethyl-N'-methyl-2-nitro-, (1E)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1508-65-2 Benzeneacetic acid, .alpha.-cyclohexyl-.alpha.-hydroxy-, 4-(diethylamino)-2-butyn-1-yl ester, hydrochloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
151030-83-0 Octadecanoic acid, 12-hydroxy-, ester with 2,2'-[oxybis(methylene)]bis[2-(hydroxymethyl)-1,3-propanediol] Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
151096-09-2 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
151186-19-5 Lactoferrin (human precursor reduced) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
151319-34-5 Acetamide, N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
151661-87-9 Protein hydrolyzates, oat Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
151661-97-1 Siloxanes and Silicones, di-Me, 3-hydroxypropyl group-terminated, ethers with polyethylene glycol monoester with beeswax Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
151-73-5 Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, sodium salt (1:2), (11.beta.,16.beta.)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
151767-02-1 Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
152459-95-5 Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
152751-57-0 2-Propen-1-amine, hydrochloride (1:1), polymer with 2-(chloromethyl)oxirane Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
152887-30-4 Protein hydrolyzates, wheat, [2-hydroxy-3-[3-trimethoxysilyl)propoxy]propyl], hydrolyzed Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
152923-56-3 Immunoglobulin G1, anti-(human interleukin 2 receptor) (human-mouse monoclonal clone 1H4 .gamma.1-chain), disulfide with human-mouse monoclonal clone 1H4 light chain, dimer Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
153065-40-8 Glycerides, Limnanthes alba Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
15307-81-0 Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-, potassium salt (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
153190-98-8 Oxirane, 2-methyl-, polymer with oxirane, monobenzoate, block Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
153259-65-5 Cyclohexanecarboxylic acid, 4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]-, cis- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
*153439-40-8/ 138452-21-8 Benzeneacetic acid, 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-.alpha.,.alpha.-dimethyl-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
153559-49-0 Benzoic acid, 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
153-61-7 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-, (6R,7R)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
154248-97-2 Ceramidase, glucosyl- (human placenta isoenzyme protein moiety) 495-L-histidine- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
154248-98-3 Glycols, 1,2-,C12-16,ethoxylated propoxylated Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
154361-50-9 Cytidine, 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
154-45-0 Benzenemethanol, .alpha.-[1-(methylamino)ethyl]-, (R*,S*)-, sulfate (2:1) (salt) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
15454-75-8 Zinc, bis(5-oxo-L-prolinato-.kappa.N1,.kappa.O2)-, (T-4)- Higher priority based on available information - Environmental and human health concern Clarification required TBD
154598-52-4 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
15475-56-6 L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, sodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
15500-66-0 Piperidinium, 1,1'-[(2.beta.,3.alpha.,5.alpha.,16.beta.,17.beta.)-3,17-bis(acetyloxy)androstane-2,16-diyl]bis[1-methyl-, dibromide Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
155-09-9 Cyclopropanamine, 2-phenyl-, (1R,2S)-rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
155141-29-0 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
155213-67-5 2,7,10,12-Tetraazatridecanoic acid, 4-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4S,6S,9S)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
1553-41-9 5,8,11,14,17-Eicosapentaenoic acid Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
1555-53-9 9-Octadecenoic acid (9Z)-, magnesium salt (2:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
155601-30-2 1H-Pyrazole-1-ethanol,4,5-diamino-,sulfate (1:1) Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
155683-77-5 Oxirane, 2-methyl-, polymer with oxirane, monoisodecyl ether Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
155715-93-8 Gelatins, polymers with keratin hydrolyzates and L-lysine, hydroxy-N,N,N-trimethyl-1 propanaminium chloride-quaternized Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
155715-94-9 Lactoglobulins, reaction products with succinic anhydride mono-C8-16-isoalkyl derivs., sulfonated, sodium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
156028-14-7 1H-Imidazolium, 1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-2-undecyl-, inner salt, sodium salt (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
156042-32-9 L-Serine, N-(1-oxohexadecyl)-, tetradecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
15663-27-1 Platinum, diamminedichloro-, (SP-4-2)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
156679-41-3 N-dodecyl-[3-(4-dimethylamino)benzamido)-propyl]dimethylammonium tosylate Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
156715-43-4 Protein hydrolyzates, soya, [3-(cocoalklydimethylammonio)-2-hydroxypropyl], chlorides Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
156715-50-3 Collagens, pro- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
156798-09-3 Keratins, hydrolyzates, [3-(coco alkyldimethylammonio)-2-hydroxypropyl], chlorides Higher priority based on available information - Environmental concern Clarification required TBD
156798-11-7 Protein hydrolyzates, wheat, [2-hydroxy-3-(trimethylammonio)propyl] chlorides Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
156798-12-8 Olive oil, unsaponifiables Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
15686-51-8 Pyrrolidine, 2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, (2R)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
15687-14-6 Butanamide, N-[2-ethyl-2-(3-methoxyphenyl)butyl]-4-hydroxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
157009-77-3 9,12-Octadecadienoic acid (9Z,12Z)-, dimer, diisoeicosyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
1570-64-5 Phenol, 4-chloro-2-methyl- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
157140-89-1 2,7-Dimethyl-4-oxa-octanitrile Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
157148-07-7 2-Pyrrolidinone, 1-ethenyl-, polymer with 1-triacontene Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
157479-51-1 Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol monoeicosanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
157627-95-7 Poly (oxy-1,2-ethanediyl), ,.alpha.-sulfo-.omega.-hydroxy-,C16-18 and C18-unsatd.alkyl ethers,sodium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
15763-02-7 Butanedioic acid, 2-hydroxy-, 1,4-dioctyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
15792-51-5 Benzenesulfonic acid, 2,5-dichloro-4-[4,5-dihydro-3-methyl-5-oxo-4-[[3-[(phenylamino)sulfonyl]phenyl]azo]-1H-pyrazol-1-yl]-, monosodium salt Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
158112-80-2 Oxiranemethanol,homopolymer,2-hydroxydodecyl ether Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
158483-23-9 Poly(oxy-1,2-ethanediyl),.alpha.,.alpha.',.alpha."-1,2,3-propanetriyltris[.omega.-hydroxy-,2-hydroxypropanoate Higher priority based on available information - Environmental concern Clarification required TBD
158563-45-2 L-Valinamide, L-methionyl-L-prolyl-D-phenylalanyl-L-arginyl-D-tryptophyl-L-phenylalanyl-L-lysyl-L-prolyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
158567-66-9 Propanoic acid, 2,2-dimethyl-, 2-octyldodecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
158570-96-8 Fats and Glyceridic oils, emu, Dromaius novaehollandiae Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
15876-39-8 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one,2',4',5',7'-tetrabromo-3',6'-dihydroxy, aluminum salt (3:2) Higher priority based on available information - Environmental and human health concern Clarification required TBD
158765-79-8 Micrococcus luteus, lysate Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
158966-92-8 Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
15905-81-4 Sulfuric acid, nickel salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
15905-86-9 Nitric acid, uranium salt Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
159317-32-5 Acetic acid, hydroxy-, isooctadecyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
159351-69-6 Rapamycin, 42-O-(2-hydroxyethyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
159666-35-0 2-Propenoic acid, 2-methyl-, polymer with 1, 1-dimethylethyl 2-propenoate and ethyl 2-propenoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
159989-64-7 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
159989-65-8 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-, methanesulfonate (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
160337-95-1 Insulin (human), 21A-glycine-30Ba-L-arginine-30Bb-L-arginine- Higher priority based on available information - Environmental concern Clarification required TBD
16040-38-3 Phosphoric acid, lead salt Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
16051-77-7 D-Glucitol, 1,4:3,6-dianhydro-, 5-nitrate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
16057-43-5 Ethanol,2{2-(octadecyloxy)ethoxy}- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
160965-04-8 Brazil nut, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
161074-67-5 Glutens, hydrolyzates, reaction products with lauroyl chloride, sodiumsalts Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
161074-97-1 D-Glucopyranose, oligomeric, C8-10-alkyl glycosides Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
161308-02-7 Hexanedioic acid, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol, decanoate isooctadecanoate octanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
161756-30-5 Poly(oxy-1,2-ethanediyl), .alpha.-dodecyl-.omega.-hydroxy-,2-hydroxy-1,2,3-propanetricarboxylate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
161814-49-9 Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3S)-tetrahydro-3-furanyl ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
161973-10-0 Magnesium, bis[6-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl-.kappa.O]-1H-benzimidazolato-.kappa.N3]-, (T-4)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
162011-90-7 2(5H)-Furanone, 4-[4-(methylsulfonyl)phenyl]-3-phenyl- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
162030-43-5 Mannopyranuronic acid, 1-O-[hydroxymethyl [[(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)acetyl]oxy]silyl]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
162353-59-5 Quaternary ammonium compounds, (C10-20 and C10-20-unsatd. alkyl) (3-chloro-2-ydroxypropyl) dimethyl, chlorides, reaction products with silk protein hydrolyzates Higher priority based on available information - Environmental concern Clarification required TBD
162353-60-8 Protein hydrolyzates, wheat, reaction products with cocoyl chloride, potassium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
162359-56-0 1,3 Propanediol, 2-amino-2-[2-(4-octylphenyl)ethyl]-, hydrochloride (1 :1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
162888-05-3 Octadecanoic acid, 12-hydroxy-, 16-methylheptadecyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
163545-26-4 1-165-Hematopoietic cell growth factor KL (human clone V19.8:hSCF162), N-L-methionyl-, dimer Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
163661-75-4 Lipids, sunflower Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
16389-88-1 Dolomite (CaMg(CO3)2) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
16391-75-6 29-Nordammara-17(20),24-dien-21-oic acid, 16-(acetyloxy)-3,11-dihydroxy-, (3.alpha.,4.alpha.,8.alpha.,9.beta.,11.alpha.,13.alpha.,14.beta.,16.beta.,17Z)-, compd. with 2,2'-iminobis[ethanol] (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1641-17-4 Methanone, (2-hydroxy-4-methoxyphenyl)(4-methylphenyl)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
164250-88-8 Sunflower oil, oleic acid-high Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
164288-56-6 1-Propanaminium, 3-amino-N-[2-[(2-hydroxyethyl)amino]-2-oxoethyl]-N,N-dimethyl-, N-C12-18 acyl derivs., chlorides Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
16455-61-1 Ferrate(1-), [[.alpha.,.alpha.'-[1,2-ethanediyldi(imino-.kappa.N)]bis[2-(hydroxy-.kappa.O)benzeneacetato-.kappa.O]](4-)]-, sodium (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
16456-36-3 Octanoic acid, tetradecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
164656-23-9 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1649-18-9 1-Butanone, 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
16508-79-5 2-Naphthalenecarboxylic acid, 3-hydroxy-4-(2-phenyldiazenyl)-, barium salt (2:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
16508-80-8 Benzoic acid, 2-(2,4,5,7-tetrabromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)-, aluminum salt (1:?) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
165101-51-9 Becaplermin Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
16561-29-8 Tetradecanoic acid, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
165745-27-7 Carbamic acid, N-butyl-, 3-iodo-2-propyn-1-yl ester, mixt. with N-[1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]-N,N'-bis(hydroxymethyl)urea Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
165800-03-3 Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
16676-29-2 Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, hydrochloride (1:1), (5.alpha.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
16693-53-1 Glycine, N-methyl-N-(1-oxododecyl)-, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
16761-12-9 Heptanoic acid, potassium salt (1:1) Higher priority based on available information - Environmental and human health concern Clarification required TBD
167747-36-6 Fats and Glyceridic oils, mango kernel Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
167817-58-5 D-Glucose, homopolymer, dodecyl ether Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1680-31-5 Carbonic Acid, Dioctyl Ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
16816-67-4 Butanamide, N,N'-[dithiobis[2,1-ethanediylimino(3-oxo-3,1-propanediyl)]]bis[2,4-dihydroxy-3,3-dimethyl-, (2R,2'R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
16824-78-5 Phenol, 2,4,6-trinitro-, calcium salt Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
16830-15-2 Urs-12-en-28-oic acid, 2,3,23-trihydroxy-, O-6-deoxy-.alpha.-L-mannopyranosyl-(1→4)-O-.beta,-D-glucopyranosyl-1→6)-.beta,-D-glucopyranosy ester, (2.alpha.,3.beta.,4.alpha.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
168456-53-9 Poria cocos, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
168677-75-6 Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.'-[[(9Z,12Z)-(2,3-dihydroxypropyl)-9,12-octadecadien-1-yliminio]di-2,1-ethanediyl]bis[.omega.-hydroxy-, chloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
16887-00-6 Chloride Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
16899-10-8 Decanoic acid, 6-hydroxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
169105-05-9 Starch, 2-[N,N-bis(2-carboxyethyl)amino]ethyl ether Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
169107-13-5 Fats and Glyceridic oils, Limnanthes alba seed Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
16941-32-5 Glucagon Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
169590-42-5 Benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
169590-61-8 Protein hydrolyzates, silk, [2-hydroxy-3-(trimethylammonio)propyl], chlorides Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
169590-62-9 Caseins, hydrolyzates, [2-hydroxy-3-(trimethylammonio)propyl], chlorides Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
169590-80-1 Protein hydrolyzates, silk, Et esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
16984-36-4 D-Glucopyranose, 4-O-.alpha.-D-glucopyranosyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
17026-85-6 1-Hexadecanol, 1-(dihydrogen phosphate), potassium salt (1:?) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
170277-31-3 Immunoglobulin G, anti-(human tumor necrosis factor) (human-mouse monoclonal cA2 heavy chain), disulfide with human-mouse monoclonal cA2 light chain, dimer Higher priority based on available information - Environmental concern Clarification required TBD
17121-12-9 1,3,5,7,2,4,6,8-Tetroxatetraphosphocane, 2,4,6,8-tetrahydroxy-,2,4,6,8-tetraoxide,ion(4-) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
171263-26-6 Glycine, N-(1-oxohexadecyl)-L-valylglycyl-L-valyl-L-alanyl-L-prolyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1715-33-9 Pregna-​1,​4-​diene-​3,​20-​dione, 21-​(3-​carboxy-​1-​oxopropoxy)​-​11,​17-​dihydroxy-​, monosodium salt, (11.beta.)​- Higher priority based on available information - Environmental concern Clarification required TBD
171596-29-5 Pyrazino[1', 2' :1,6]pyrido[3, 4-b]indole-1,4-dione,6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
171599-83-0 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
172046-58-1 Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-hydro-.omega.-(tetradecyloxy)-, ester with 2-hydroxy-1,2,3-propanetricarboxylic acid (3:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
172275-79-5 Starch, 1,3-dimethyl-2-oxo-4,5-imidazolidinediyl ether Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
172376-82-8 6,10-Dodecadienal, 3,7,11-trimethyl-, (6Z)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
1724-14-7 erythro-Pentose, 2-deoxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
173010-79-2 Quaternary ammonium compounds, coco alkyl(2,3-dihydroxypropyl)dimethyl, 3-phosphates (esters), chlorides, sodium salts Higher priority based on available information - Environmental concern Clarification required TBD
17375-37-0 Carbonic acid, manganese salt Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
173763-15-0 Aluminum Sesquichlorohydrate Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
173937-91-2 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)- 2-oxoethyl]-2-(4-methoxyphenyl)-, (2R,3R,4S)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
17407-37-3 Butanedioic acid, 1-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl] ester Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1744-22-5 2-Benzothiazolamine, 6-(trifluoromethoxy)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
174722-31-7 Immunoglobulin G1, anti-(human CD20 (antigen)) (human-mouse monoclonal IDEC-C2B8 .gamma.1-chain), disulfide with human-mouse monoclonal IDEC-C2B8 .kappa.-chain, dimer Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
174761-16-1 1H-Imidazolium, 1-ethenyl-3-methyl-, methyl sulfate (1:1), polymer with 1-ethenylhexahydro-2H-azepin-2-one and 1-ethenyl-2-pyrrolidinone Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
17482-42-7 Butanedioic acid, 2-hydroxy-, calcium salt (1:?) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
175357-18-3 L-Phenylalanine, N-(1-oxo-10-undecen-1-yl)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
175893-70-6 Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, diesters with caroboxymethyl wheat protein hydrolyzates Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
175893-71-7 2-Propenamide, N-[3-(dimethylamino)propyl]-2-methyl-, polymer with 1-ethenyl-2-pyrrolidinone, sulfate Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
17618-45-0 Octadecanoic acid, 2-hexyldecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
17619-86-2 Ethanol, 2-amino-, sulfite (salt) Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
17627-10-0 L-Cystine, N,N'-bis(1-oxohexadecyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
17671-27-1 Docosanoic acid, docosyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
17672-22-9 Phenol, 2-amino-6-methyl- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
177080-35-2 Phenol, 4-[(3-hydroxypropyl)amino]-2-nitro- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
177190-98-6 1-Propanaminium, N,N,N-trimrthyl-3-[(1-oxo-3-phenyl-2-propen-1-yl)amino]-,chloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
1778-02-5 Pregn-5-en-20-one, 3-(acetyloxy)-, (3.beta.)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
17879-97-9 Benzenepropanoic acid, 3-amino-.alpha.-ethyl-2,4,6-triiodo-, (R)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
179005-04-0 Siloxanes and Silicones, 3-[4-[[[3-[(2,3-dihydroxypropyl)dimethylammonio]propyl]amino]carbonyl]-2-oxo-1-pyrrolidinyl]propyl Me, di-Me, 3-[3-[[3-(C8-22-acylamino)propyl]dimethylammonio]-2-hydroxypropyl phosphates], chlorides, sodium salts Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
179045-86-4 Immunoglobulin G1, anti-(human interleukin 2 receptor) (human-mouse monoclonal CHI621 .gamma.1-chain), disulfide with human-mouse monoclonal CHI621 light chain, dimer Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
179268-62-3 Isooctahexacontane Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
179268-63-4 Isohexapentacontahectane Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
17941-34-3 Hexadecanoic acid, 9,10,16-trihydroxy-, (9R,10R)-rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
17949-65-4 Zinc, bis(2-pyridinecarboxylato-.kappa.N1,.kappa.O2-, (T-4)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
17955-88-3 Trisiloxane, 1,1,1,3,5,5,5-heptamethyl-3-octyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
179911-08-1 Propanamide, N-ethyl-N-(3-methylphenyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
180254-52-8 Glycerides,sunflower-oil mono-and-di,ethoxylated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
180288-69-1 Immunoglobulin G1, anti-(human p185neu receptor) (human-mouse monoclonal rhuMab HER2 .gamma.1-chain), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer Higher priority based on available information - Environmental concern Clarification required TBD
18089-54-8 Silanol, methyl- Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
182162-80-7 Dodecanoic acid, 2-octyl-, 2-octyldodecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
182298-52-8 Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol monolaurate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
182700-78-3 Siloxanes and Silicones,3-[(3-aminopropyl)amino]propyl Me, di-Me, 3-hydroxypropyl Me, ethoxylated, [(hydroxydimethylsilyl)oxy]-terminated Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
183476-82-6 L-Ascorbic acid, 2,3,5,6-tetrakis(2-hexyldecanoate) Higher priority based on available information - Human health concern Clarification required TBD
18358-13-9 2-Propenoic acid, 2-methyl-, ion(1-) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
185018-43-3 L-Ascorbic acid, 2-[(3.beta.)-cholest-5-en-3-yl hydrogen phosphate], monosodium salt Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
18507-89-6 3-Quinolinecarboxylic acid, 6-(decyloxy)-7-ethoxy-4-hydroxy-, ethyl ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
185243-69-0 1-235-Tumor necrosis factor receptor (human) fusion protein with 236-467-immunoglobulin G1 (human .gamma.1-chain Fc fragment) Higher priority based on available information - Environmental concern Clarification required TBD
185429-83-8 Ethanone, 1-[(1R,2S)-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethyl-2-naphthalenyl]-, rel- Higher priority based on available information - Environmental concern Clarification required TBD
185630-77-7 Fats and Glyceridic oils, Limnanthes alba seed, ethoxylated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
186511-05-7 Sunflower oil, ethoxylated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
1867-66-9  Cyclohexanone, 2-​(2-​chlorophenyl)​-​2-​(methylamino)​-​, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
186826-86-8 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
187175-42-4 Silsesquioxanes, Me, hydroxy-terminated, alginate, compds. with caffeine Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
187339-62-4 1,2,3-Propanetriol, homopolymer, ether with methyl D-glucopyranoside dioctadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
187547-43-9 Fatty Acids, C18-Unsatd., Dimers, Hydrogenated, Esters with Polyglycerol Diisostearate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
187991-39-5 L-ascorbic acid, 6-O-(dihydroxymethylsilyl)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
188039-54-5 Immunoglobulin G1, anti (respiratory syncytial virus protein F) (human-mouse monoclonal MEDI- 493.gamma.1-chain), disulfide with human-mouse monoclonal MEDI-493.kappa.-chain, dimer Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
188062-50-2 2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S,4R)-, sulfate (2:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
188627-80-7 L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-.alpha.-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→6)-disulfide Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
188928-66-7 Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol monoesters with beeswax fatty acids Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
18917-91-4 Aluminum, tris[2-(hydroxy-.kappa.O)propanoato-.kappa.O]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
18917-93-6 Magnesium, bis[2-(hydroxy-.kappa.O)propanoato-.kappa.O]-, (T-4)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
189440-77-5 4,7-Octadienoic acid, methyl ester, (4E)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
190270-74-7 L-Lysine dihydroxymethylsilyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
19035-79-1 1-Hexadecanol, 1-(dihydrogen phosphate), potassium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
190454-07-0 Phosphoric acid, mono- and di-C9-15-alkyl esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
190524-47-1 Inulin, octadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
191114-48-4 2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(1H,7H,9H)-tetrone, 4-ethyloctahydro-11-methoxy-3.alpha.-7,9,11,13,15-hexamethyl-1-[4-[4-(3- pyridinyl)-1H-imidazol-1-yl]butyl]-10-[[3,4,6-trideoxy-3-(dimethylamino)- .beta.-D-xylo-hexopyranosyl]oxy]-, (3.alpha.-S,4R,7R,9R,10R,11R,13R,15R,15aR)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
192230-28-7 Irvingia gabonensis, extract Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
19237-84-4 Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-furanyl-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
19248-94-3 2-Buten-1-ol, 2-methyl-, 1-acetate, (2E)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
192725-17-0 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-.alpha.-(1-methylethyl)-2-oxo-, (.alpha.S)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
1929-30-2 2-Propenoic acid, 3-(4-methoxyphenyl)-, ethyl ester Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
1935-18-8 1-Butanaminium, 4-hydroxy-N,N,N-trimethyl-4-oxo-2-[(1-oxohexadecyl)oxy]-, inner salt Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
193888-44-7 1-Propanaminium, N-(carboxymethyl)-2-hydroxy-N-(2-hydroxyethyl)-N-[2-[(1-oxododecyl)amino]ethyl]-3-(phosphonooxy)-, inner salt, monosodium salt Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
193892-43-2 Poly[oxy(dimethylsilylene)], .alpha.-docosyl-.omega.-(docosyloxy)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
194810-88-3 Amylopectin, hydrogen dodecenylbutanedioate, calcium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1953-02-2 Glycine, N-(2-mercapto-1-oxopropyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
1953-04-4 10H-Benzofuro[3a,3,2-ef][2]benzazepin-10-ol, 1,2,3,4,8a,9-hexahydro-7-methoxy-3-methyl-, hydrobromide (1:1), (8aS,10R,12aS)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
196618-13-0 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
19666-16-1 Benzoic acid, 2-hydroxy-, tridecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1972-08-3 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
1976-28-9 3-Pyridinecarboxylic acid, aluminum salt (3:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
19767-45-4 Ethanesulfonic acid, 2-mercapto-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1977-10-2 Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
19774-82-4 Methanone, (2-butyl-3-benzofuranyl)[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]-, hydrochloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
19794-93-5 1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
197969-51-0 1-Propanaminium, N,N,N-trimethyl-3-[(2-methyl-1-oxo-2-propen-1-yl)amino]-, chloride (1:1), polymer with methyl 2-propenoate and 2-propenoic acid Higher priority based on available information - Environmental concern Clarification required TBD
198404-98-7 Cyclopropanemethanol, 1-methyl-2-[(1,2,2-trimethylbicyclo[3.1.0]hex-3-y)methyl]- Higher priority based on available information - Environmental and human health concern Clarification required TBD
19881-18-6 Benzene, 1-isothiocyanato-4-(4-nitrophenoxy)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
199277-69-5 Octadecanoic acid, 12-(benzoyloxy)-, 2-ethylhexyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2013-12-9 D-Norvaline Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2016-45-7 1-Hexadecanamine, N,N-dimethyl-, hydrochloride (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
202138-50-9 2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide, (2E)-2-butenedioate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
202148-87-6 Acacia concinna, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
2040-10-0 Ethanone, 1-[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
2040-64-4 Tetradecanoic acid, dodecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
204206-44-0 Hexanedioic acid, polymer with 1,2,3-propanetriol, 2-ethylhexanoate octadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
204255-11-8 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1- ethylpropoxy)-, ethyl ester, (3R,4R,5S)-, phosphate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2043-43-8 Propanamide, 2-hydroxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
20537-88-6 Ethanethiol, 2-[(3-aminopropyl)amino]-, 1-(dihydrogen phosphate) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
205537-77-5 Poly[oxy(dimethylsilylene)], .alpha.-hydro-.omega.-hydroxy-, mixt. with dimethicone Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
20559-55-1 Carbamic acid, (5-propoxy-1H-benzimidazol-2-yl)-, methyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
206354-95-2 Isononanoic acid, 1,2,3-propanetriyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
20636-48-0 3,6,9,12-Tetraoxatetradecan-1-ol, 14-(4-nonylphenoxy)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
206555-98-8 5-Heptenoic acid, 7-[(1S,2S,3S,5R)-2-[(1E,3S)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, (5Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2068-78-2 Vincaleukoblastine, 22-oxo-, sulfate (1:1) (salt) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2068-80-6 L-Aspartic acid, magnesium salt (2:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
208054-84-6 1,3-Benzenedicarboxylic acid, polymer with 2,2-dimethyl-1,3-propanediol, hexanedioic acid, 1,6-hexanediol, 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, compd. with 2-amino-2-methyl-1-propanol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
208126-52-7 Resin acids and Rosin acids, mixed esters with dipentaerythritol and 12-hydroxyoctadecanoic acid and stearic acid Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
208126-56-1 Octadecanoic acid, 12-hydroxy-, mixed esters with dipentaerythritoland isostearic acid Higher priority based on available information - Environmental concern Clarification required TBD
208265-92-3 Colony-stimulating factor (human), 3-hydroxypropyl-N-methionyl-, 1-ether with .alpha.-methyl-.omega.-hydroxypoly(oxy-1,2-ethanediyl) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
20858-25-7 3,6,9,12-Tetraoxatetracosanoic acid Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
20858-86-0 D-Gluconic acid, 6-ester with N,N-dimethylglycine Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
20882-75-1 9H-Xanthen-9-one, 1,2,8-trihydroxy-6-methoxy- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
209216-23-9 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]- 6H-purin-6-one,monohydrate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
20938-62-9 .beta.-Alanine, N-[(2R)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl]-, ion(1-) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
209802-43-7 Isooctadecanoic acid, 1-methylheptyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
209810-58-2 Erythropoietin [30-asparagine,32-threonine,87-valine, 88-asparagine,90-threonine] (human) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
21034-17-3 Oxazolium, 3,4-dimethyl-2-[2-(phenylamino)ethenyl]-, iodide Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
21062-37-3 Adenosine, thymidylyl-(3'→5')- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
21109-95-5 Barium sulfide (BaS) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
21127-45-7 3,6,9,12,15-Pentaoxaheptacosanoic acid Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
21187-98-4 Benzenesulfonamide, N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
21245-01-2 Benzoic acid, 4-(dimethylamino)-, 3-methylbutyl ester Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
2124-57-4 1,4-Naphthalenedione,2-[(2E,6E,10E,14E,18E,22E)-3,7,11,15,19,23,27-heptamethly-2,6,10,14,18,22,26-octacosaheptaen-1-yl]-3-mthly- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
21256-18-8 2-Oxazolepropanoic acid, 4,5-diphenyl- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
213127-10-7 2-Propen-1-aminium, N,N-dimethyl-N-2-propenyl-, chloride, polymer with 2-propenoic acid, sodium salt Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
2135-17-3 Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,17,21-trihydroxy-16-methyl-, (6.alpha.,11.beta.,16.alpha.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
213629-14-2 Siloxanes and Silicones, di-Me, Me hydrogen, reaction products with 1,5-hexadiene On Domestic Substances List (DSL) Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
2136-71-2 Ethanol, 2-(hexadecyloxy)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
214047-00-4 L-Serine, N2-(1-oxohexadecyl)-L-lysyl-L-threonyl-L-threonyl-L-lysyl- Higher priority based on available information - Environmental and human health concern Clarification required TBD
215231-33-7 Cyclohexanol, 1-methyl-3-(2-methylpropyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2152-34-3 2-amino-5-phenyl-1,3-oxazol-4-one Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
215322-01-3 Eicosanedioic acid, ester with 1,2,3-propanetriol docosanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
21539-58-2 .beta.-Alanine, N-methyl-N-(1-oxododecyl)-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
21542-96-1 1-Docosanamine, N,N-dimethyl- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
215647-85-1 Interferon .alpha.-2b (human), pegylated Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
21593-23-7 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[(4-pyridinylthio)acetyl]amino]-, (6R,7R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
217969-86-3 2-Methyl-2-propylcyclohexanone Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2180-18-9 Acetic acid, manganese salt Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
2197-63-9 1-Hexadecanol, 1,1'-(hydrogen phosphate) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
219861-08-2 5-​Isobenzofurancarboni​trile, 1-​[3-​(dimethylamino)​propyl]​-​1-​(4-​fluorophenyl)​-​1,​3-​dihydro-​, (1S)​-​, ethanedioate (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
219989-84-1 (1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2 (2-methylthiazol-4-yl)ethenyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
220119-17-5 Avermectin A1a, 25-cyclohexyl-4'-O-de(2,6-dideoxy-3-O-methyl-.alpha.-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-5-(hydroxyimino)-, (5Z)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
220326-00-1 Oxirane, 2-methyl-, polymer with oxirane, diisooctadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
220622-96-8 Poly(oxy-1,2-ethanediyl),.alpha.-(carboxymethyl)-.omega.-hydroxy-, C12-14-alkyl ethers Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
220714-63-6 Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol mono[3-(dimethyloctadecylammonio)-2-hydroxypropyl hydrogen phosphate], inner salts Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
220828-91-1 1-Propanaminium, N-(2-hydroxyethyl)-N,N-dimethyl-3-[(1-oxodocosyl)amino]-, chloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
221227-05-0 L-Arginine, N-(1-oxohexadecyl)glycyl-L-glutaminyl-L-prolyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
22194-22-5 Ethane, 2-chloro-1-(difluoromethoxy)-1,1,2-trifluoro-, (2R)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
22204-24-6 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 1,4,5,6-tetrahydro-1-methyl-2-[(1E)-2-(2-thienyl)ethenyl]pyrimidine (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
222400-35-3 Protein hydrolyzates, wheat, isostearoyl, compds. With 2-amino-2-methyl-1-propanol Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
222400-43-3 Protein hydrolyzates, oat, reaction products with lauroyl chloride, sodium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2224-49-9 Dodecanoic acid, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
22260-51-1 Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'.alpha.)-, monomethanesulfonate (salt) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
22316-47-8 1H-1,5-Benzodiazepine-2,4(3H,5H)-dione, 7-chloro-1-methyl-5-phenyl- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
223266-93-1 .alpha.-D-Galacturono-6-deoxy-.alpha.-L-galacto-.beta.-D-galactan Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
22366-99-0 9,10-Anthracenedione, 1-[(3-aminopropyl)amino]-4-(methylamino)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
223705-57-5 Fatty acids, coco, 2-sulfoethyl esters, ammonium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
223705-79-1 Honey, 2-hydroxy-3-(trimethylammonio) propyl ethers, chlorides Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
223717-75-7 Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside (4:1), tri-(9Z)-9-octadecenoate Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
223747-87-3 Argania spinosa, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
223748-41-2 Sapindus Trifoliatus Fruit Extract Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
223748-90-1 Lentinula edodes, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
223748-92-3 Cyperus esculentus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
223749-33-5 Kigelia africana, ext Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
223749-71-1 Quinoa, Chenopodium quinoa, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
223749-75-5 Ahnfeltia concinna, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
223749-83-5 chlorella vulgaris extract Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
223749-88-0 Enteromorpha compressa, extract Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
223751-71-1 Hypnea musciformis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
223751-74-4 Rhodymenia palmata, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
223751-76-6 Porphyra umbilicalis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
223751-78-8 Sargassum filipendula, ext Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
223751-82-4 Ganoderma lucidum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
224948-78-1 Poly(oxy-1,2-ethanediyl), .alpha.-[2-[methylbis[2-[[(9Z)-1-oxo-9-octadecenyl]amino]ethyl]ammonio]ethyl]-.omega.-hydroxy-, methyl sulfate (salt) Higher priority based on available information - Environmental concern Clarification required TBD
225234-03-7 Fats and Glyceridic oils, sea buckthorn, Hippophae rhamnoides Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
225234-07-1 Fats and Glyceridic oils, Lupinus Alba Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
225234-12-8 Fats and Glyceridic oils, borage seed Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
225234-14-0 Fats and Glyceridic oils, shea butter, unsaponifiable fraction Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
22613-51-0 2-acetoxyethyl stearate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
226700-81-8 Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl]-, C-[(3S)-tetrahydro-3-furanyl] ester, calcium salt (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
226708-41-4 Fatty acids, olive-oil, ethoxylated Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
22694-75-3 Boric acid (H3BO3), triammonium salt Higher priority based on available information - Environmental and human health concern Clarification required TBD
226995-92-2 Poly(oxy-1,2-ethanediyl), .alpha.-[2-[bis(2- aminoethyl)methylammonio]ethyl]-.omega.-hydroxy-, N,N'-di-Limnanthes alba seed-oil acyl derivs., Me sulfates (salts) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
227025-08-3 Oat, hydrolyzed Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
227025-35-6 Protein hydrolyzates, egg shell membrane Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
227200-22-8 L-Ascorbic acid, reaction products with methylsilanetriol and pectin Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
227605-22-3 Lithium magnesium sodium oxide silicate (Li0.03Mg0.39Na0.07O0.15(Si2O5)0.28) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
22766-83-2 Tetradecanoic acid, 2-octyldodecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
22794-26-9 L-Proline, 5-oxo-, dodecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
22801-45-2 9-Octadecenoic acid (9Z)-, 2-octyldodecyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
22916-47-8 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
229975-97-7 2,5,6,10,13-Pentaazatetradecanedioic acid, 3-12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[-4-(2-pyridinyl)phenyl]methyl]-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
23031-32-5 1,3-Benzenediol, 5-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-, sulfate (2:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
23059-38-3 Cyclohexanecarboxylic acid, 1,4-dimethyl-, methyl ester, cis- Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
2307-68-8 Pentanamide, N-(3-chloro-4-methylphenyl)-2-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
23155-02-4 Phosphonic acid, P-[(2R,3S)-3-methyl-2-oxiranyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2315-66-4 3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-[4-(1,1,3,3-tetramethylbutyl)phenoxy]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
23250-42-2 Cyclohexanecarboxylic acid, 1,4-dimethyl-, methyl ester, trans- Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
23277-43-2 Morphinan-3,6,14-triol, 17-(cyclobutylmethyl)-4,5-epoxy-, hydrochloride, (5.alpha.,6.alpha.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
23288-49-5 Phenol, 4,4'-[(1-methylethylidene)bis(thio)]bis[2,6-bis(1,1-dimethylethyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
23312-56-3 4H-​Pyrano[2,​3-​b]​[1,​4]​benzodioxin-​4-​one, decahydro-​4a,​7,​9-​trihydroxy-​2-​methyl-​6,​8-​bis(methylamino)​-​, (2R,​4aR,​5aR,​6S,​7S,​8R,​9S,​9aR,​10aS)​-​, sulfate (1:1) Higher priority based on available information - Environmental concern Clarification required TBD
233603-23-1 Fatty acids, lanolin, 2-octyldodecyl esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
*23444-65-7/ 8001-98-7 1,4-Naphthoquinone, 5,8-dihydroxy-6-(1-hydroxy-4-methyl-3-pentenyl)-, (-)- ) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
234447-17-7 1-Propanone, 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-, hydrochloride, (-)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
235783-76-3 9-Octadecenoic acid, 12-hydroxy-, (9Z,12R)-, homopolymer, ester with triglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2364-67-2 1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-[(1-oxohexadecyl)oxy]-, inner salt, (2R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
2370-64-1 Dodecanoic acid, 17-hydroxy-3,6,9,12,15-pentaoxaheptadec-1-yl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
23736-58-5 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-, compd. with N,N'-bis(phenylmethyl)-1,2-ethanediamine (2:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
2375-03-3 Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, monosodium salt, (6.alpha.,11.beta.)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
2380-86-1 1H-Indol-6-ol Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
23964-57-0 2-Thiophenecarboxylic acid, 4-methyl-3-[[1-oxo-2-(propylamino)propyl]amino]-, methyl ester, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
241148-25-4 Oils, Calophyllum inophyllum Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
2420-29-3 3,6,9,12,15,18-Hexaoxahexatriacontan-1-ol Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
2420-56-6 10,12-Octadecadienoic acid, (10E,12Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
242138-07-4 Immunoglobulin G1, anti-(human immunoglobulin E Fc region) (human-mouse monoclonal E25 clone pSVIE25. gamma.-chain), disulfide with human-mouse monoclonal E25 clone pSVIE25 .kappa.-chain, dimer Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
24292-52-2 2-Propen-1-one, 1-[4-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2-hydroxy-6-methoxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)-, (2E)- Higher priority based on available information - Human health concern Clarification required TBD
24305-27-9 L-Prolinamide, 5-oxo-L-prolyl-L-histidyl- Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
243133-67-7 Poly(oxy-1,2-ethanediyl), .alpha.-(2-hydroxytetradecyl)-.omega.-hydroxy-,.omega. -C16-18-alkyl ethers Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
243137-53-3 Siloxanes and Silicones, di-Me, polymers with mono[(ethenyldimethylsilyl)oxy]-terminated di-Me siloxanes Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
244023-79-8 Carrageen, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
244058-54-6 Pseudopterogorgia elisabethae, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
2451-01-6 Cyclohexanemethanol, 4-hydroxy-.alpha.,.alpha.,4-trimethyl-, monohydrate, cis- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
245443-07-6 L-Glutamic acid, N-(1-oxododecyl)-, mixed (3β)-cholest-5-en-3-yl 2-octyldodecyl esters Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
245443-08-7 L-Glutamic acid, N-(1-oxododecyl)-, mixed (3β)-cholest-5-en-3-yldocosyl 2-octyldodecyl esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
24545-86-6 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dihydroxy-4',5'-dinitro- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
24584-09-6 2,6-Piperazinedione, 4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
246159-33-1 D-Glucopyranose, C16-18-alkyl glycosides Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
246864-39-1 Decanoic acid, 1,2,3-propanetriyl ester, reaction products with polyethylene glycol and 1,2,3-propanetriyl trioctanoate Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
246865-89-4 Fats and Glyceridic oils, coriander seed Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
24729-96-2 L-threo-.alpha.-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, 2-(dihydrogen phosphate) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
247588-54-1 Fats and Glyceridic oils, Pongamia glabra Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
248596-59-0 Siloxanes and Silicones, di-Me, 3-[[(9Z,12R)-12-hydroxy-1-oxo-9- octadecenyl]oxy]propyl group-terminated Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
24871-34-9 3,6,9,12,15,18,21,24,27,30-Decaoxaoctatetracont-39-en-1-ol, (39Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2487-40-3 6H-Purin-6-one, 1,2,3,9-tetrahydro-2-thioxo- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
24905-87-1 Ethanol, 2-[(4-amino-3-nitrophenyl)amino]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
2490-97-3 L-Glutamine, N2-acetyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
24936-74-1 Poly[imino-1,6-hexanediylimino(1,12-dioxo-1,12-dodecanediyl)] Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2495-84-3 L-Ascorbic acid, 6-(9Z)-9-octadecenoate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
24967-93-9 Chondroitin, 4-(hydrogen sulfate) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
24967-94-0 Dermatan, hydrogen sulfate (ester) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
25014-12-4 2-Propenamide, 2-methyl-, homopolymer Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
25104-18-1 L-Lysine, homopolymer Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
25126-32-3 3-10-Caerulein, 5-L-methionine- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
25136-75-8 2-Propen-1-aminium, N,N-dimethyl-N-2-propen-1-yl-, chloride (1:1), polymer with 2-propenamide and 2-propenoic acid Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
25167-62-8 Docosahexaenoic acid Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
25212-15-1 1,3-Pentadiene, homopolymer Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
25248-42-4 Poly[oxy(1-oxo-1,6-hexanediyl)] Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
25249-06-3 D-Galacturonic acid, homopolymer Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
25316-40-9 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
25339-99-5 .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, monododecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
25378-27-2 Eicosapentaenoic acid Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
25395-66-8 L-Ascorbic acid, monooctadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
2540-56-9 9,11-Octadecadienoic acid, (9Z,11E)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
25482-78-4 Peroxymonosulfuric acid, potassium salt Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
25497-28-3 Ethane, difluoro- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
25513-46-6 L-Glutamic acid, homopolymer Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
25568-84-7 1,3-Cyclopentadiene, homopolymer Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
25637-91-6 Dodecanoic acid, diester with 5-hydroxy-6-methyl-3,4-pyridinedimethanol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2565-36-8 Ethanol, 2,2'-[methylenebis(oxy)]bis- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
2568-33-4 1,3-Butanediol, 3-methyl- Higher priority based on available information - Human health concern Clarification required TBD
25709-83-5 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one,2',4',5'-tribromo-3',6'-dihydroxy- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
25709-84-6 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one,2',4',7'-tribromo-3',6'-dihydroxy- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
25852-45-3 Poly (oxy-1, 2-ethanediyl), .alpha.-phosphono-.omega.-(dodecyloxy)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
25905-73-1 9-Octadecenoic acid, 2-hydroxyethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
25999-20-6 Benzoic acid, 6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-ethyl-5-[(2R,5R,6S)-5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]tetrahydro-3-methyl-2-furanyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methyl-, monosodium salt Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
26085-09-6 9,12-Octadecadienoic acid, dimer Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
26086-33-9 Hexanoic acid, 2-ethyl-, 1,1'-[2-ethyl-2-[[(2-ethyl-1-oxohexyl)oxy]methyl]-1,3-propanediyl] ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
26100-51-6 Propanoic acid, 2-hydroxy-, homopolymer Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
26124-25-4 Propanoic acid, ethenyl ester, polymer with ethenyl acetate and 1-ethenyl-2-pyrrolidinone Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
261-31-4 9H-Thioxanthene Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2615-15-8 3,6,9,12,15-Pentaoxaheptadecane-1,17-diol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
26159-34-2 2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, sodium salt (1:1), (.alpha.S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
261713-82-0 Poly(oxy-1,2-ethanediyl), .alpha.-(2-hydroxypropyl)-.omega.-[1-methyl-2-[1-methyl-2-[(1-oxododecyl)oxy]ethoxy]ethoxy]- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
26264-02-8 3,6,9,12-Tetraoxatetradecan-1-ol, 14-(nonylphenoxy)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
26317-27-1 Cuprate(3-), [(7S,8S)-3-carboxy-5-(carboxymethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphine-7-propanoato(5-)-.kappa.N21,.kappa.N22,.kappa.N23,.kappa.N24]-, trihydrogen, (SP-4-2)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
2638-43-9 3,6,9,12,15,18,21-Heptaoxatricosan-1-ol, 23-[4-(1,1,3,3-tetramethylbutyl)phenoxy]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
26402-22-2 Decanoic acid, monoester with 1,2,3-propanetriol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
26402-26-6 Octanoic acid, monoester with 1,2,3-propanetriol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
26446-38-8 .alpha.-D-Glucopyranoside,.beta.-D-fructofuranosyl,monohexadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
26499-65-0 Plaster of Paris (Ca(SO4).1/ 2H2O) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
26538-44-3 1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-, (3S,7R)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
26545-51-7 Benzamide, N,N-diethylmethyl- Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
26566-61-0 Galactose Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
26636-40-8 Poly(oxy-1,2-ethanediyl), .alpha.-docosyl-.omega.-hydroxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
26658-83-3 2-Propenoic acid, 2-methyl-, butyl ester, polymer with 2-(dimethylamino)ethyl 2-methyl-2-propenoate Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
26675-46-7 Ethane, 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
26699-71-8 Hexanedioic acid, monoester with 1,2,3-propanetriol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
26780-50-7 1,4-Dioxane-2,5-dione, 3,6-dimethyl-, polymer with 1,4-dioxane-2,5-dione Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
26787-65-5 Octacosanoic acid, 2-hydroxyethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
26793-35-1 2-Propenoic acid, polymer with N,N-dimethyl-2-propenamide Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
26826-30-2 Ethanol, 2-[2-[2-(tetradecyloxy)ethoxy]ethoxy]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
*26874-89-5/ 53906-28-8/ 28651-01-6 .beta.-D-Glucopyranose,homopolymer Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
26915-12-8 Benzenamine, ar-methyl- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
26920-62-7 1-Docosanaminium, N-(carboxymethyl)-N,N-dimethyl-, inner salt Higher priority based on available information - Environmental concern Clarification required TBD
26942-95-0 Isooctadecanoic acid, 1,1',1"-(1,2,3-propanetriyl) ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2709-56-0 1-Piperazineethanol, 4-[3-[2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
27164-46-1 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[2-(1H-tetrazol-1-yl)acetyl]amino]-, sodium salt (1:1), (6R,7R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
27177-03-3 3,6,9,12,15,18-Hexaoxaeicosan-1-ol, 20-(nonylphenoxy)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
27177-07-7 3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(octylphenoxy)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
27214-38-6 Tetradecanoic acid, monoester with 1,2,3-propanetriol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
27216-37-1 .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, diacetate hexakis(2-methylpropanoate) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
27233-34-7 Poly(oxy-​1,​2-​ethanediyl)​, .alpha.-​sulfo-.omega.-​[(9Z)​-​9-​octadecen-​1-​yloxy]​-​, sodium salt (1:1) Higher priority based on available information - Environmental and human health concern Clarification required TBD
27299-12-3 D-Glucitol, 1,4-anhydro- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
27306-90-7 Poly (oxy-1,2-ethanediyl), .alpha.-(carboxymethyl)-.omega.-(dodecyloxy)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
27321-72-8 Stearic Acid, Monoester with Triglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
2748-88-1 Pyridinium, 4-​methyl-​1-​tetradecyl-​, chloride (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
27522-09-4 Boric acid (H3BO3), ammonium salt (1:?) Higher priority based on available information - Environmental and human health concern Clarification required TBD
27636-82-4 2,4-Imidazolidinedione, (hydroxymethyl)-5,5-dimethyl- Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
27640-89-7 13-Docosenoic acid, (13Z)-13-docosen-1-yl ester, (13Z)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
27707-45-5 .alpha. -D-Glucopyranose, homopolymer Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
27836-64-2 D-Glucopyranoside, dodecyl Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
27836-65-3 D-Glucopyranoside, octadecyl Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
27841-04-9 Heptanoic acid, 1,1'-(2,2-dimethyl-1,3-propanediyl) ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
27841-06-1 Decanoic acid, 1,1'-(2,2-dimethyl-1,3-propanediyl) ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2784-94-3 Ethanol, 2,2'-[[4-(methylamino)-3-nitrophenyl]imino]bis- Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
27871-49-4 Propanoic acid, 2-hydroxy-, methyl ester, (2S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
27876-94-4 2,4,6,8,10,12,14-Hexadecaheptaenedioic acid, 2,6,11,15-tetramethyl-, (2E,4E,6E,8E,10E,12E,14E)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
27923-63-3 .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, trioctadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
28088-63-3 Benzenesulfonic acid, dimethyl-, calcium salt (2:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
28212-44-4 Poly(oxy-1,2-ethanediyl),.alpha.-(carboxymethyl)-.omega.-(4-nonylphenoxy)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
282527-44-0 Hexanedioic acid, polymer with 1,2,3-propanetriol and 2,2,4-trimethyl-1,3-pentanediol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
28261-54-3 Pyrrolidinone Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
28302-36-5 Cuprate(3-), [(7S,8S)-3-carboxy-5-(carboxymethyl)-13-ethenyl-18-ethyl-17-formyl-7,8-dihydro-2,8,12-trimethyl-21H,23H-porphine-7-propanoato(5-)-.kappa.N21,.kappa.N22,.kappa.N23,.kappa.N24]-, sodium (1:3), (SP-4-2)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
28305-25-1 Propanoic acid, 2-hydroxy-, calcium salt (2:1), (2S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2835-98-5 Phenol, 2-amino-5-methyl- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
2835-99-6 Phenol, 4-amino-3-methyl- Higher priority based on available information - Environmental and human health concern Clarification required TBD
28371-16-6 9(10H)-Anthracenone, 10-.beta.-D-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-, (10R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
28395-03-1 Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
28474-90-0 L-Ascorbic acid, dihexadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
28523-86-6 Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
28602-69-9 Diphosphoric acid, ammonium manganese(2+) salt (2:2:3) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
28633-45-6 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron(3+) salt (1:?) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
287115-59-7 2,4,6-Octatriene, 2,6-dimethyl-, hydrogenated, acid-hydrated Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
287115-61-1 3-Penten-2-one, 4-methyl-, self-condensation products Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
28721-07-5 5H-Dibenz[b,f] azepine-5-carboxamide, 10,11-dihydro-10-oxo- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
288094-77-9 1-Propene, 2-methyl-, homopolymer, hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
28829-38-1 Poly[imino[(1S)-1-(2-carboxyethyl)-2-oxo-1,2-ethanediyl] sodium salt (1:1)] Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
28855-27-8 Benzenemethanaminium, ar-dodecyl-ar,N,N,N-tetramethyl-, chloride Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
28874-51-3 L-Proline, 5-oxo-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
288839-50-9 1-Octadecanaminium, N,N-dimethyl-N-octyl-, methyl sulfate (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
29059-24-3 Tetradecanoic acid, monoester with 1,2-propanediol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
29116-98-1 Sorbitan, di-(9Z)-9-octadecenoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
29193-02-0 L-Proline, 5-oxo-, manganese salt (1:?) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2919-66-6 Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-16-methylene- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
293-51-6 Cyclotetrasiloxane Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
29354-98-1 Hexadecanol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2937-54-4 Ethanesulfonothioic acid, 2-amino- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
29383-26-4 Octadecanoic acid, hydroxyl-, 2-ethylhexyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
2944-65-2 Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, iron(2+) salt (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
29454-16-8 Butanedioic acid, 2-sulfo-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
29457-07-6 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-carboxy-3-thienylacetyl]amino]-3,3-dimethyl-7-oxo-, disodium salt, (2S,5R,6R)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
29894-35-7 9-Octadecenoic acid, 12-hydroxy-, (9Z,12R)-, polymer with 1,2,3-propanetriol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
299184-75-1 Oils, Argania spinosa Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
29923-31-7 L-Glutamic acid, N-(1-oxododecyl)-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
299-39-8 7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine, dodecahydro-, (7S,7aR,14S,14aS)-, sulfate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
299-42-3 Benzenemethanol, .alpha.-[(1S)-1-(methylamino)ethyl]-, (.alpha.R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
3.1.1.73 4-hydroxy-3-methoxycinnamoyl-sugar hydrolase Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
3.2.1.6 3-(1→3;1→4)-.beta.-D-glucan 3(4)-glucanohydrolase Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
3.2.1.7 1.-beta.-D-fructan fructanohydrolase Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
3.2.1.133 1, 4-.alpha.-D glucan alpha-maltohydrolase Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
3.4.11 Aminopeptidase Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
3.4.21 Serine endopetidase Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
3.4.22.3 Ficin Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
302-27-2 Aconitane-3,8,13,14,15-pentol, 20-ethyl-1,6,16-trimethoxy-4-(methoxymethyl)-, 8-acetate 14-benzoate, (1.alpha.,3.alpha.,6.alpha.,14.alpha.,15.alpha.,16.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
30233-64-8 Docosanoic acid, monoester with 1,2,3-propanetriol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
302-96-5 1'H-Androstano[3,2-c]pyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
30364-51-3 Glycine, N-methyl-N-(1-oxotetradecyl)-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
303-98-0 2,5-Cyclohexadiene-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaen-1-yl]-5,6-dimethoxy-3-methyl- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
304-55-2 Butanedioic acid, 2,3-dimercapto-, (2R,3S)-rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
30484-77-6 Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propenyl]-, dihydrochloride Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3055-93-4 Ethanol, 2-[2-(dodecyloxy)ethoxy]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3055-94-5 Ethanol, 2-[2-[2-(dodecyloxy)ethoxy]ethoxy]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3055-97-8 3,6,9,12,15,18,21-Heptaoxatritriacontan-1-ol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3055-98-9 3,6,9,12,15,18,21,24-Octaoxahexatriacontan-1-ol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3055-99-0 3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3056-17-5 Thymidine, 2',3'-didehydro-3'-deoxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
305812-16-2 Poly(oxy-1,2-ethanediyl), .alpha. , .alpha'. , .alpha".-1,2,3-propanetriyltris [.omega.-methoxy- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
30599-15-6 1,3-Propanediol, 2,2-bis(hydroxymethyl)-, polymer with oxirane Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
30652-11-0 4(1H)-Pyridinone, 3-hydroxy-1,2-dimethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
30657-38-6 L-Proline, 5-oxo-, compd. with L-lysine (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
306769-73-3 1-Dodecanaminium, N,N-dimethyl-N-[3-[(2-methyl-1-oxo-2-propenyl)amino]propyl]-, chloride, polymer with N-[3-(dimethylamino)propyl]-2-methyl-2-propenamide and 1-ethenyl-2-pyrrolidinone Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3069-40-7 Silane, trimethoxyoctyl- Higher priority based on available information - Environmental and human health concern Clarification required TBD
306-94-5 Naphthalene, 1,1,2,2,3,3,4,4,4a,5,5,6,6,7,7,8,8,8a-octadecafluorodecahydro- Higher priority based on available information - Environmental concern Clarification required TBD
308061-47-4 Alkanes, C12-16 Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
308063-77-6 Caseins, reaction products with diethylenetriamine Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
308066-66-2 Oligosaccharides, fructose-contg. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
308067-11-0 Glycerides, C8-10 mono-, di- and tri-, ethoxylated Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
308067-58-5 IMMUNE GLOBULIN G Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
308068-01-1 Jojoba oil, isomerizes Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
308068-34-0 Glycerides, C16-18 mono-, ethoxylated Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
308068-38-4 Glycerides, mono-, acetates Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
308068-42-0 Glycerides, mixed mono- and di-, esters with diacetyltartaric acid Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
308068-94-2 Imidazolium compounds, 2-C12-14-alkyl-1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-, inner salts Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
308068-97-5 Onium compounds, isoquinolinium, C12-18-alkyl, bromides Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
308069-41-2 Phospholipids, soya Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
308074-11-5 Protein hydrolyzates, compds. with (Z)-N-[3-(dimethylamino)propyl]-9-octadecenamide Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
30909-51-4 Decanoic acid, 2-[4-[3-[2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]-1-piperazinyl]ethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
31229-74-0 Hexadecanoic acid, diester with 5-hydroxy-6-methyl-3,4-pyridinedimethanol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
31230-04-3 Silanediol, 1-methyl-1-phenyl-,homopolymer Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
31282-04-9 D-Streptamine, O-6-amino-6-deoxy-L-glycero-D-galacto-heptopyranosylidene-(1→2-3)-O-.beta.-D-talopyranosyl-(1→5)-2-deoxy-N3-methyl- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
3130-87-8 Asparagine Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
313258-61-6 Fat and Glyceridic oils, wheat germ Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
31478-84-9 Heptadecanoic acid, 16-methyl-, 1-methylethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
31511-30-5 4H-1-Benzopyran-4-one, 3-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, tris(2-hydroxyethyl) ether Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
31512-74-0 Poly[oxy-1,2-ethanediyl(dimethyliminio)-1,2-ethanediyl(dimethyliminio)-1,2-ethanediyl chloride (1:2)] Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
316-42-7 2H-Benzo[a]quinolizine, 3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-isoquinolinyl]methyl]-, hydrochloride (1:2), (2S,3R,11bS)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
3164-34-9 Butanedioic acid, 2,3-dihydroxy- [R-(R*,R*)]-, calcium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
31677-93-7 1-Propanone, 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-, hydrochloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
31692-79-2 Poly[oxy(dimethylsilylene)], .alpha.-hydro-.omega.-hydroxy- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
317-34-0 1H-Purine-2,6-dione, 3,9-dihydro-1,3-dimethyl-, compd. with 1,2-ethanediamine (2:1) Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
31799-91-4 Hyaluronic acid, potassium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
31846-06-7 Cyclohexanol, 3-(1,1-dimethylethyl)-, 1-acetate Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
3184-65-4 Phenol, 4-chloro-2-(phenylmethyl)-, sodium salt (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
31961-83-8 Metaphosphate (P10O3010-) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
32028-95-8 Poly(silylene) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
32093-35-9 Imidazo[2,1-b]thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (6S)-, phosphate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
3211-76-5 Butanoic acid, 2-amino-4-(methylseleno)-,(2S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
32128-65-7 Poly(oxy-1,2-ethanediyl), .alpha.-(2-octyldodecyl)-.omega.-hydroxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
321735-39-1 Siloxanes and Silicones, di-Me, 3-hydroxypropyl group- and 3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl group-terminated, polymers with iso-Bu methacrylate Higher priority based on available information - Human health concern Clarification required TBD
321735-42-6 Siloxanes and Silicones, di-Me, 3-hydroxypropyl group- and 3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl group-terminated,polymers with iso-Bu methacrylate and 2,2,2-trifluoroethyl methacrylate Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
32221-81-1 Glutamic acid, monosodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
32310-26-2 Androstene Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
32440-50-9 2-Pyrrolidinone, 1-ethenyl-, polymer with 1-hexadecene Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3251-56-7 Phenol, 2-methoxy-4-nitro- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
32780-64-6 Benzamide, 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, hydrochloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
32839-18-2 Docosahexaenoic acid, (Z,Z,Z,Z,Z,Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
32839-30-8 Eicosapentaenoic acid, (Z,Z,Z,Z,Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
329925-33-9 Oxacyclopentadec-10-en-2-one, 13-methyl- Higher priority based on available information - Environmental concern Clarification required TBD
33005-95-7 2-Thiopheneacetic acid, 5-benzoyl-.alpha.-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3305-68-8 9-Octadecen-1-ol, phosphate (3:1), (9Z,9'Z,9"Z)- Higher priority based on available information - Environmental concern Clarification required TBD
33069-62-4 Benzenepropanoic acid, .beta.-(benzoylamino)-.alpha.-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (.alpha.R,.beta.S)- Higher priority based on available information - Environmental concern Clarification required TBD
33089-61-1 Methanimidamide, N'-(2,4-dimethylphenyl)-N-[[(2,4-dimethylphenyl)imino]methyl]-N-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
330-95-0 Urea, N, N'-Bis(4-nitrophenyl) -, compd. with 4,6-dimethyl-2(1H)-pyrimidinone(1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
33124-69-5 threo-2,3-Hexodiulosonic acid, .gamma.-lactone Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
33171-05-0 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxyphenyl)-, (1E,6E)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
*22608-11-3/33171-16-3 1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-, (1E,6E)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
331731-18-1 Adalimumab Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
332348-12-6 1-25-Oncostrain M (human precursor) fusion protein with CTLA-A (antigen)(human) fusion protein with immuglobulin G1 (human heavy chain fragment), bimol.(146146')-disulfide Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
33239-19-9 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dihydroxy-4',5'-diiodo-, sodium salt (1:2) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
33286-22-5 1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, hydrochloride (1:1), (2S,3S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
33386-08-2 8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
33564-30-6 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-, monosodium salt, (6R,7S)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
33735-91-0 6H-Purin-6-one, 2-amino-1,7-dihydro-, hydrochloride Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
337376-15-5 Icodextrin Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3374-30-9 Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl(phenylmethyl)amino]phenyl](5-hydroxy-2,4-disulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-, inner salt, calcium salt (2:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
3385-03-3 Pregna-1,4-diene-3,20-dione, 6-fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6.alpha.,11.beta.,16.alpha.)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
3386-18-3 3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
338-98-7 Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
33907-46-9 Octadecanoic acid, hydroxy-, 2-hydroxyethyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
33907-47-0 Octadecanoic acid, hydroxy-, monoester with 1,2-propanediol Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
33940-98-6 9-Octadecenoic acid (9Z)-, monoester with triglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
33954-26-6 Benzoic acid, 3-(acetylamino)-5-[[(2-hydroxyethyl)amino]carbonyl]-2,4,6-triiodo-, monosodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3397-16-8 L-Glutamic acid, N-(1-oxooctadecyl)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
34031-32-8 Gold, [1-(thio-.kappa.S)-.beta.-D-glucopyranose 2,3,4,6-tetraacetato](triethylphosphine)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
34183-22-7 1-Propanone, 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-, hydrochloride Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
34364-24-4 Benzoic acid, isooctadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
34368-04-2 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
34381-68-5 Butanamide, N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]-, hydrochloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
344 (INS) Lecithin Citrate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
34406-66-1 Dodecanoic acid, monoester with decaglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
34424-97-0 Octadecanoic acid, diester with hexaglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
34452-51-2 Acetic acid, 2-mercapto-, potassium salt (1:1) Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
34464-38-5 Isodecane Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
34466-20-1 Ribose Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
34513-50-3 1-Dodecanol, octyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
345648-01-3 1-Propanaminium N- (3-aminopropyl) -2,3-dihydroxy-N,N-dimethyl-,N-limnanthes alba seed-oil acyl derivs., chlorides Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
34580-13-7 10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
34580-14-8 10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (2E)-2-butenedioate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
347174-92-9 Macrocystis pyrifera extract Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
34769-44-3 1,3(2H,9bH)-Dibenzofurandione, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-, sodium salt (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
348120-87-6 Hexanoic acid, 3,5,5-trimethyl-, hexadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
348120-88-7 Hexanoic acid, 3,5,5 -trimethyl-, octadecyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
34965-01-0 Pyrrolidine, 1-[2-(dodecyloxy)ethyl]-, hydrochloride Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
34973-08-5 Luteinizing hormone-releasing factor (swine), acetate (salt) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
350708-35-9 Aspartic acid, compd. with .alpha.-methylbenzeneethanamine (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
350708-40-6 D-Glucaric acid, compd. with (.alpha.S)-.alpha.-methylbenzeneethanamine(1:2) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
35121-78-9 Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
35189-28-7 18,19-Dinorpregn-4-en-20-yn-3-one, 17-(acetyloxy)-13-ethyl-, 3-oxime, (17.alpha.)- Higher priority based on available information - Environmental concern Clarification required TBD
3520-90-9 3,6,9,12,15,18,21-Heptaoxatricosan-1-ol, 23-(4-octylphenoxy)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
3521-62-8 Erythromycin, 2'-propanoate, dodecyl sulfate (salt) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
3521-84-4 D-Glucitol, 1-deoxy-1-(methylamino)-, 3,3'-[(1,6-dioxo-1,6-hexanediyl)diimino]bis[2,4,6-triiodobenzoate] (2:1) (salt) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
3522-50-7 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron(3+) salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
35230-14-9 Propanoic acid, 2-hydroxy-, octadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
35305-74-9 L-Glutamine, N-acetyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
35474-99-8 5,8,11,14-Eicosatetraenoic acid, 2,3-dihydroxypropyl ester, (5Z,8Z,11Z,14Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
35554-44-0 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-(2-propen-1-yloxy)ethyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
35602-69-8 Cholest-5-en-3-ol (3.beta.)-, 3-octadecanoate Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
356065-50-4 Fats and Glyceridic oils, Brazil nut Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
3564-09-8 2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-[2-(2,4,5-trimethylphenyl)diazenyl]-, sodium salt (1:2) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
35700-23-3 Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, (5Z,9.alpha.,11.alpha.,13E,15S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
357-07-3 Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-methyl-, hydrochloride, (5.alpha.)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
357-08-4 Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, hydrochloride, (5.alpha.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
35711-34-3 1H-Pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
3578-72-1 Docosanoic acid, calcium salt (2:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
35944-74-2 1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, methyl ester, monohydrochloride Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3599-32-4 1H-Benz[e]indolium, 2-[7-[1,3-dihydro-1,1-dimethyl-3-(4-sulfobutyl)-2H-benz[e]indol-2-ylidene]-1,3,5-heptatrien-1-yl]-1,1-dimethyl-3-(4-sulfobutyl)-, inner salt, sodium salt (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
36062-04-1 3,5-Heptanedione, 1,7-bis(4-hydroxy-3-methoxyphenyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
361459-38-3 Glycerides, mixed decanoyl and octanoyl mono-, di- and tri-, ethoxylated Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
362-74-3 Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
36284-86-3 Octadecanamide, N-(2-hydroxy-1,1-dimethylethyl)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
36393-20-1 Zincate(2-), bis[L-aspartato(2-)-.kappa.N,.kappa.O1]-, dihydrogen, (T-4)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
364782-34-3 1-Naphthalenemethanamine, .alpha.-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-, hydrochloride, (1:1) (.apha.R) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
36521-89-8 Sorbitan, dioctadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
36655-86-4 D-Glucuronic acid, homopolymer Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
36703-88-5 Inosine, compd. with 1-(dimethylamino)-2-propanol 4-(acetylamino)benzoate (1:3:3) Higher priority based on available information - Environmental concern Clarification required TBD
36791-04-5 1H-1,2,4-Triazole-3-carboxamide, 1-.beta.-D-ribofuranosyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3687-18-1 1-Propanesulfonic acid, 3-amino- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
368869-33-4 Fatty acids, C18-unsatd., dimers, hydrogenated, diesters with triglycerol triisostearate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3697-42-5 2,4,11,13-Tetraazatetradecanediimidamide, N,N"-bis(4-chlorophenyl)-3,12-diimino-, hydrochloride (1:2) Higher priority based on available information - Environmental concern Assessed in Screening Assessment Report (SAR) TBD
37025-55-1 1-Carbaoxytocin, 1-butanoic acid-2-(O-methyl-L-tyrosine)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
37203-87-5 Formaldehyde, mixt. with methylphenol Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
3721-26-4 Cyclopropanamine, 2-phenyl-, (1R,2S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
37220-90-9 Silicic acid, lithium magnesium salt Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
37222-66-5 Potassium peroxymonosulfate sulfate (K5(HSO5)2(HSO4)(SO4)) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
37259-53-3 Lyase, hyaluronate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
37266-93-6 .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, dodecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
37270-89-6 Heparin, calcium salt Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
372-75-8 L-Ornithine, N5-(aminocarbonyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
37286-92-3 Benzenesulfonic acid, ethenyl-, homopolymer, calcium salt Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
37288-34-9 Hyaluronoglucuronidase Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
37288-39-4 Glucosidase, sucrose .alpha.- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
37309-58-3 Decene, homopolymer Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
37316-87-3 Blood-coagulation factor Ixa Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
37318-79-9 Sorbitan, (9Z)-9-octadecenoate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
37321-09-8 D-Streptamine, O-4-amino-4-deoxy-.alpha.-D-glucopyranosyl-(1→8)-O-(8R)-2-amino-2,3,7-trideoxy-7-(methylamino)-D-glycero-.alpha.-D-allo-octodialdo-1,5:8,4-dipyranosyl-(1→4)-2-deoxy- Higher priority based on available information - Environmental concern Clarification required TBD
37326-33-3 Hyaluronoglucosaminidase Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
37349-34-1 1,2,3-Propanetriol, homopolymer, monooctadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
37361-00-5 .beta.-D-Glucan, (1→6)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
3737-09-5 2-Pyridineacetamide, .alpha.-[2-[bis(1-methylethyl)amino]ethyl]-.alpha.-phenyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3778-73-2 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3792-50-5 L-Aspartic acid, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
3801-06-7 Pregna-1,4-diene-3,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-6-methyl-, (6.alpha.,11.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
38079-62-8 L-Glutamic acid, N-(1-oxooxtadecyl)-, sodium salt (1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
381718-28-1 Fats and Glyceridic oils, Rubus idaeus Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
38194-50-2 1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
382-67-2 Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-, (11.beta.,16.alpha.)- Higher priority based on available information - Environmental concern Clarification required TBD
383419-34-9 Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside (4:1), benzoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3847-29-8 Erythromycin, 4-O-.beta.-D-galactopyranosyl-D-gluconate (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
38480-64-7 1-Dodecanesulfonic acid, ion(1-) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
38517-23-6 L-Glutamic acid, N-(1-oxooctadecyl)-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
38517-37-2 L-Glutamic acid, N-(1-oxotetradecyl)-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
38577-97-8 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dihydroxy-4',5'-diiodo- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
38621-51-1 Octadecanoic acid, 12-hydroxy-, monoester with 1,2-propanediol Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
38754-83-5 Glutamic acid, N-(1-oxotetradecyl)-, monosodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
38866-20-5 Morpholinium, 4-[3-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthracenyl)amino]propyl]-4-methyl-, methyl sulfate (1:1) Higher priority based on available information - Environmental and human health concern Clarification required TBD
38886-21-4 Phenol, 2-methoxynitro- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
38916-34-6 Somatostatin (sheep) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
38975-03-0 3,6,9,12,15-Pentaoxaheptacosanoic acid, sodium salt Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
39012-86-7 1,3(2H,9bH)-Dibenzofurandione, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-, sodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
3902-71-4 7H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
39034-24-7 3,6,9,12-Tetraoxahexacosan-1-ol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
3910-88-1 2-Butanone, 4-(octahydro-5,5,8a-trimethylspiro[naphthalene-2(1H),2'-oxiran]-1-yl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
39175-72-9 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ester with 1,2,3-propanetriol monooctadecanoate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
391900-47-3 Leontopodium alpinum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
39300-95-3 .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, hexadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
39322-04-8 Chromium potassium oxide Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
39346-84-4 Starch, dihydrogen phosphate, 2-hydroxypropyl ether Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
3936-02-5 Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-[(3- sulfobenzoyl)oxy]-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
39404-33-6 Dextrates Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
39409-82-0 Carbonic acid, magnesium salt (1:1), mixt. with magnesium hydroxide (Mg(OH)2), hydrate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
39456-59-2 Phosphoric acid, mixt. with sodium fluoride (NaF) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
3976-75-8 3,4-Thiophenediol, tetrahydro-, (3R,4S)-rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
39831-55-5 D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1→6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1→4)]-N1-[(2S)-4-amino-2-hydroxy-1-oxybutyl]-2-deoxy-, sulfate (1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
4.1.1.5 (S)-2-hydroxy-2-methyl-3-oxobutanoate carboxy-lyase Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
40031-31-0 2-Butanone, 1,3,4-trihydroxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
40160-92-7 Poly(oxy-1,2-ethanediyl), .alpha.-(3-pentadecylphenyl)-.omega.-hydroxy- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
40188-41-8 Octanenitrile, 3,7-dimethyl- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
40391-99-9 Phosphonic acid, P,P'-(3-amino-1-hydroxypropylidene) bis- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
40445-72-5 Cholest-5-en-3-ol (3.beta.)-, 12-hydroxyoctadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
404-86-4 6-Nonenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (6E)- Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
40665-92-7 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E,3S)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, (5Z)-rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
4070-80-8 2-Butenedioic acid (2E)-, monooctadecyl ester, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
40738-57-6 2-Propenoic acid, ethenylidene ester, homopolymer Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
40754-59-4 Butanedioic acid, 2-sulfo-, 4-[2-[2-[2-(dodecyloxy)ethoxy]ethoxy]ethyl] ester, sodium salt (1:2) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
40958-31-4 Somatostatin (sheep reduced) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
41080-66-4 Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.',.alpha."-1,2,3-propanetriyltris[.omega.-[(1-oxooctadecyl)oxy]- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
41389-11-1 Phenol, 3-methyl-2-(2-propenyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
41389-12-2 Phenol, 5-methyl-2-(2-propenyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
41395-89-5 Isononanoic acid, isodecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
41575-94-4 Platinum, diammine[1,1-cyclobutanedi(carboxylato-.kappa.O)(2-)]-, (SP-4-2)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
41621-49-2 2(1H)-Pyridinone, 6-cyclohexyl-1-hydroxy-4-methyl-, compd. with 2-aminoethanol (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
41669-40-3 Tetradecanoic acid, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
41672-81-5 L-Proline, 1-(1-oxohexadecyl)-4-[(1-oxohexadecyl)oxy]-, (4R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
41760-23-0 L-Cystine, N,N'-bis(1-oxooctyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
41859-67-0 Propanoic acid, 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
41927-88-2 Sodium iodide (Na123I) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
42116-76-7 Carbamothioic acid, N-[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]-, O-methyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
42131-25-9 Isononanoic acid, isononyl ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
42175-36-0 Propanoic acid, 2-hydroxy-, (9Z)-9-octadecenyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
42231-41-4 Octanoic acid, tridecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
42232-29-1 Hexadecanoic acid, dodecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
42408-82-2 Morphinan-3,14-diol, 17-(cyclobutylmethyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
42461-84-7 D-​Glucitol, 1-​deoxy-​1-​(methylamino)​-​, 2-​[[2-​methyl-​3-​(trifluoromethyl)​phenyl]​amino]​-​3-​pyridinecarboxylate (1:1) Higher priority based on available information - Environmental concern Clarification required TBD
42553-65-1 .beta.-D-Glucopyranose, 6-O-.beta.-D-glucopyranosyl-, 1,1'-[(2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethyl-2,4,6,8,10,12,14-hexadecaheptaenedioate] Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
426262-08-0 Protein hydrolyzates, sour orange (Citrus aurantium dulcis), reaction products with ascorbic acid Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
427-51-0 3'H-Cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione, 17-(acetyloxy)-6-chloro-1,2-dihydro-, (1.beta.,2.beta.)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
42766-91-6 Poly (oxy-1, 2-ethanediyl), .alpha.-[(3b, 5a)-cholestan-3-yl]-.omega.-hydroxy- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
42822-86-6 2-hydroxy-.alpha.,.alpha.,4-trimethylcyclohexanemethanol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
4291-63-8 Adenosine, 2-chloro-2'-deoxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
42924-53-8 2-Butanone, 4-(6-methoxy-2-naphthalenyl)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
4316-73-8 Glycine, N-methyl-, sodium salt (1:1) Higher priority based on available information - Human health concern Clarification required TBD
4386-03-2  Butanoic acid, 4-​[(2-​carboxyethyl)​amino]​ Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
43200-80-2 1-Piperazinecarboxylic acid, 4-methyl-, 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
43218-56-0 Acetamide, 2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
43229-80-7 Formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, rel-, (2E)-2-butenedioate (2:1) (salt) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
4342-03-4 1H-Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazen-1-yl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
4372-02-5 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 4',5'-dibromo-3',6'-dihydroxy-, sodium salt (1:2) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
437-38-7 Propanamide, N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
4403-12-7 Ethanol, 2-[2-[2-(tridecyloxy)ethoxy]ethoxy]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
4419-92-5 Benzoic acid, 2-hydroxy-, compd. with N-ethylethanamine (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
442 (INS) Ammonium salt of phosphorylated glyceride Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
4450-94-6 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ammonium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
4478-97-1 3,6,9,12,15-Pentaoxahentriacontan-1-ol Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
448944-47-6 L-Tryptophanamide, N-acetyl-L-norleucyl-L-alanyl-L-histidyl-D-phenylalanyl-L-arginyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
4492-73-3 1H-Thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS,4S,6aR)-, compd. with N-(2,5-dioxo-4-imidazolidinyl)urea (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
44987-75-9 2,4-Hexadienoic acid, 1-methylethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
45267-19-4 Tetradecanamide, N-[3-(dimethylamino)propyl]- Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
4536-30-5 Ethanol, 2-(dodecyloxy)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
4560-68-3 1,2,3-Propanetricarboxylic acid, 2-hydroxy-,1,2,3-trihexadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
4583-26-0 1-Oxaspiro[4, 5]decan-2-one, 8-(1-methylethyl)-, cis- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
458-88-8 Piperidine, 2-propyl-, (2S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
4618-23-9 Benzoic acid, 2,3,4,5-tetrachloro-6-(2,4,5,7-tetrabromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)-, disodium salt Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
464-92-6 Urs-12-en-28-oic acid, 2,3,23-trihydroxy-, (2.alpha.,3.beta.,4.alpha.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
4697-14-7 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[2-carboxy-2-(3-thienyl)acetyl]amino]-3,3-dimethyl-7-oxo-, sodium salt(1:2), (2S,5R,6R)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
4706-78-9 Sulfuric acid, monododecyl ester, potassium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
472-11-7 Spirost-5-ene-1,3-diol, (1.beta.,3.beta.,25R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
472b (INS) Lactylated Mono- and Diglycerides Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
473 (INS) Sucrose esters of fatty acids Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
474-62-4 Ergost-5-en-3-ol, (3.beta.,24R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
475 (INS) Polyglycerol Esters of Fatty Acids Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
477 (INS) Propylene Glycol Mono Fatty Acid Esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
477 (INS) Propylene Glycol Monoesters and Diesters of fat-forming fatty acids Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
477-32-7 Butanoic acid, 2-methyl-, (9R,10R)-10-(acetyloxy)-9,10-dihydro-8,8-dimethyl-2-oxo-2H,8H-benzo[1,2-b:3,4-b']dipyran-9-yl ester, (2R) - Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
47931-85-1 Calcitonin (salmon) Higher priority based on available information - Environmental concern Clarification required TBD
480995-77-5 2-Propenoic acid, 2-methyl-,polymer with butyl 2-propenoate, hexadecyleicosyl 2-methyl-2-propenoate and methyl 2-methyl-2-propenoate Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
481-06-1 Naphtho[1,2-b]furan-2,8(3H,4H)-dione, 3a,5,5a,9b-tetrahydro-3,5a,9-trimethyl-, (3S,3aS,5aS,9bS)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
4827-59-2 Olean-12-en-29-oic acid, 11-oxo-3-[(1-oxooctadecyl)oxy]-, (3.beta.,20.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
483-18-1 2H-Benzo[a]quinolizine, 3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-isoquinolinyl]methyl]-, (2S,3R,11bS)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
484-33-3 1,3-Propanedione, 1-(4-methoxy-5-benzofuranyl)-3-phenyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
4861-19-2 Urea, phosphate (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
487-26-3 4H-1-Benzopyran-4-one, 2,3-dihydro-2-phenyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
488-43-7 1-amino-1-deoxy-D-glucitol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
490-83-5 L-threo-2,3-Hexodiulosonic acid, .gamma.-lactone Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
491-58-7 9(10H)-Anthracenone, 1,8-dihydroxy-3-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
4934-42-3 .alpha.-D-Glucopyranuronic acid, monosodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
49553-76-6 9-Octadecenoic acid (9Z)-, monoester with oxybis[propanediol] Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
49562-28-9 Propanoic acid, 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-, 1-methylethyl ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
4956-37-0 Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 17-heptanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
495-69-2 Glycine, N-benzoyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
49625-21-0 Butanoic acid, 4-[[4-[[[(4-methoxy-2-nitrophenyl)amino]carbonyl]amino]benzoyl]amino]-2-oxo- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
49697-38-3 Androsta-1,4-dien-3-one, 11-hydroxy-16,17-dimethyl-17-(1-oxopropyl)-, (11.beta.,16.alpha.,17.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
497227-50-6 Digoxin Immune Fab (Ovine) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
497-30-3 1H-Imidazole-4-ethanaminium, .alpha.-carboxy-2,3-dihydro-N,N,N-trimethyl-2-thioxo-, inner salt, (.alpha.S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
49745-95-1 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
497-76-7 .beta.-D-Glucopyranoside, 4-hydroxyphenyl Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
4991-65-5 1,3-Benzoxathiol-2-one, 6-hydroxy- Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
5.3.1.9 D-glucose-6-phosphate aldose-ketose-isomerase Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
500-38-9 1,2-Benzenediol, 4,4'-(2,3-dimethyl-1,4-butanediyl)bis- Higher priority based on available information - Environmental and human health concern Clarification required TBD
500-92-5 Imidodicarbonimidic diamide, N-(4-chlorophenyl)-N'-(1-methylethyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
501-30-4 4H-Pyran-4-one, 5-hydroxy-2-(hydroxymethyl)- Higher priority based on available information - Environmental and human health concern Clarification required TBD
50-47-5 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
50545-60-3 Phenol, methyl-, tetrabromo deriv. Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
505-73-7 Acetic acid, 2,2'-dithiobis- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
506-03-6 1,2-Propanediol, 3-(hexadecyloxy)-, (2S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
50610-28-1 Ethanol, 2-[(4-amino-2-chloro-5-nitrophenyl)amino]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
50622-20-3 L-Glutamic acid, N-(1-oxododecyl)-, sodium salt (1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
50638-95-4 Benzene, [2-[(3-methyl-2-buten-1-yl)oxy]ethyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
50643-20-4 Poly (oxy-1,2-ethanediyl), .alpha.-hexadecyl-.omega.-hydroxy-,phosphate, Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
50679-08-8 1-Piperidinebutanol, .alpha.-[4-(1,1-dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
507454-10-6 formaldehyde cross-linked hyaluronan Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
50800-85-6 Indium chloride (111InCl3) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
508-02-1 Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)- Higher priority based on available information - Environmental concern Clarification required TBD
50813-16-6 Metaphosphoric acid, sodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
50982-74-6 Ethanol, 2-(4-amino-3-nitrophenoxy)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
50994-40-6 1,4-Benzenediamine, sulfate (1:?) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
51022-69-6 Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-16,17-[cyclopentylidenebis(oxy)]-9-fluoro-11-hydroxy-, (11.beta.,16.alpha.)- Higher priority based on available information - Environmental concern Clarification required TBD
51023-21-3 1H-Imidazolol, ethyldihydro[(9Z)-9-octadecen-1-yl]- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
51033-30-8 Decanoic acid, monoester with triglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
51115-67-4 Butanamide, N,2,3-trimethyl-2-(1-methylethyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
51-15-0 Pyridinium, 2-[(hydroxyimino)methyl]-1-methyl-, chloride Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
51158-08-8 Poly (oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-,ether with 1,2,3- propanetriol monooctadecanoate (2:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5117-19-1 3,6,9,12,15,18,21-heptaoxatricosane-1,23-diol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
51192-09-7 Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with 1,2,3-propanetriol mono-(9Z)-9-octadecenoate (2:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
5119-24-4 Galactopyranuronic acid, compd. with allantoin (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
512-42-5 Sulfuric acid, monomethyl ester, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
51260-59-4 Hexadecanol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
513-10-0 Ethanaminium, 2-[(diethoxyphosphinyl)thio]-N,N,N-trimethyl-, iodide Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
51311-89-8 Antimony iodide Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
51322-75-9 2,1,3-Benzothiadiazol-4-amine, 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
51333-22-3 Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, (11.beta.,16.alpha.)- Higher priority based on available information - Environmental concern Clarification required TBD
51365-71-0 1,2-Benzenedicarboxamide, N,N'-dioctadecyl- Higher priority based on available information - Environmental concern Clarification required TBD
51395-96-1 Mannan Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
51-40-1 1,2-Benzenediol, 4-[(1R)-2-amino-1-hydroxyethyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) Higher priority based on available information - Environmental concern Clarification required TBD
514-36-3 Pregn-4-ene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
51513-58-7 6,10-Dodecadienal, 3,7,11-trimethyl-,(6E)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
51-55-8 Benzeneacetic acid, .alpha.-(hydroxymethyl)- (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5168-89-8 3,6,9,12,15,18-Hexaoxaoctacosan-1-ol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
51742-87-1 4-Quinolinemethanol, .alpha.-(2R)-2-piperidinyl-2,8-bis(trifluoromethyl)-, (.alpha.S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5175-83-7 Phenol, 2,4,6-tribromo-, bismuth(3+) salt (3:1) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
51781-21-6 2(1H)-Quinolinone, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
517-88-4 1,4-Naphthalenedione, 5,8-dihydroxy-2-[(1S)-1-hydroxy-4-methyl-3-penten-1-yl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
51810-70-9 Zinc phosphide Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
518-28-5 Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R,5aR,8aR,9R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
518-40-1 Benzoic acid, 2-(6-hydroxy-4,5-diiodo-3-oxo-3H-xanthen-9-yl)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
51852-65-4 Poly(oxy-1,2-ethanediyl), .alpha.-[2-hydroxy-3-[(1-oxooctadecyl)oxy]propyl]-.omega.-hydroxy- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
51898-34-1 3-Pyridinecarboxylic acid, (2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-yl ester, rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
51938-44-4 Sorbitan, octadecanoate (2:3) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
51952-41-1  Luteinizing hormone-​releasing factor (swine)​, hydrochloride (1:?) Higher priority based on available information - Environmental concern Clarification required TBD
52-01-7 Pregn-​4-​ene-​21-​carboxylic acid, 7-​(acetylthio)​-​17-​hydroxy-​3-​oxo-​, .gamma.-​lactone, (7.alpha.,​17.alpha.)​- Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
520-18-3 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
520-26-3 4H-1-Benzopyran-4-one,7-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-,(S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
52108-64-2 Chitin, 6-(carboxymethyl) ether Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
52128-35-5 2,4-Quinazolinediamine, 5-methyl-6-[[(3,4,5-trimethoxyphenyl)amino]methyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
521-78-8 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N,.beta.-trimethyl-, (2Z)-2-butenedioate (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
52205-73-9 Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 3-[N,N-bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate), sodium salt (1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
52232-67-4 L-Phenylalanine, L-seryl-L-valyl-L-seryl-L-a-glutamyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylglycyl-L-lysyl-L-histidyl-L-leucyl-L-asparaginyl-L-seryl-L-methionyl-L-a-glutamyl-L-arginyl-L-valyl-L-a-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-a-aspartyl-L-valyl-L-histidyl-L-asparaginyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
522-40-7 Phenol, 4,4'-[(1E)-1,2-diethyl-1,2-ethenediyl]bis-, 1,1'-bis(dihydrogen phosphate) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
52-24-4 Aziridine, 1,1',1"-phosphinothioylidynetris- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
522-48-5 1H-Imidazole, 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-, hydrochloride (1:1) Higher priority based on available information - Environmental concern Clarification required TBD
522-51-0 Quinolinium, 1,1'-(1,10-decanediyl)bis[4-amino-2-methyl-, dichloride Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
52263-83-9 9H-Carbazole-2-acetic acid, 6-chloro-.alpha.-methyl-, (.alpha.R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
52304-36-6 .beta.-Alanine, N-acetyl-N-butyl-, ethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
52315-75-0 L-Lysine, N6-(1-oxododecyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
52467-63-7 1-Hexadecanaminium, N,N-dihexadecyl-N-methyl-, chloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
52468-60-7 Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propenyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
52557-98-9 Bicyclo[2.2.1]heptane-2-carboxylic acid, 3,3-dimethyl- Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
52558-73-3 Glycine, N-methyl-N-(1-oxotetradecyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
525-82-6 4H-1-Benzopyran-4-one, 2-phenyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
52609-21-9 Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.'-[(2S)-1,5-dioxo-2-[(1-oxododecyl)amino]-1,5-pentanediyl]bis[.omega.-(octadecyloxy)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
52645-53-1 Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, (3-phenoxyphenyl)methyl ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
52725-64-1 Tetradecanamide, N,N-bis(2-hydroxyethyl)-, mixt. with N,N-bis(2-hydroxyethyl)dodecanamide Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5274-65-7 Ethanol, 2-[2-[(9Z)-9-octadecenyloxy]ethoxy]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
52793-97-2 Benzenaminium, N,N,N-trimethyl-4-[(4,7,7-trimethyl-3-oxobicyclo[2.2.1]hept-2-ylidene)methyl]-, methyl sulphate (1:1) Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
52845-07-5 Isoeicosane Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
53026-67-8 Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside (4:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
530-43-8 Hexadecanoic acid, (2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl ester Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
5306-85-4 D-Glucitol, 1,4:3,6-dianhydro-2,5-di-O-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
53082-57-8 2-Butenoic acid, 2-methyl-, propyl ester, (2Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
53123-88-9 Rapamycin Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
53-16-7 Estra-1,3,5(10)-trien-17-one, 3-hydroxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
53171-04-3 1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-3-[(1-oxododecyl)oxy]-, chloride Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
532-11-6 3H-1,2-Dithiole-3-thione, 5-(4-methoxyphenyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
53-21-4 8-Azabicyclo[3.2.1]octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, hydrochloride (1:1), (1R,2R,3S,5S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
53230-10-7 4-Quinolinemethanol, .alpha.-(2R)-2-piperidinyl-2,8-bis(trifluoromethyl)-, (.alpha.S)-rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
53238-80-5 .beta.-d-Glucan, (1→3), (1→6) - Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
5323-95-5 9-Octadecenoic acid, 12-hydroxy-, sodium salt (1:1), (9Z,12R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
53240-01-0 D-Glucose, homopolymer, decyl ether Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
532-40-1 Thiazolium, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-[2-(phosphonooxy)ethyl]-, chloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
53251-94-8 Morpholinium, 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]-, bromide Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
533-50-6 2-Butanone, 1,3,4-trihydroxy-, (3S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
533910-00-8 Decanedioc acid, mixed esters with isostearic acid and 2,2'-[oxybis(methylene)]bis[2-ethyl-1,3-propanediol] Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
533928-79-9 Hexanoic acid,2-ethyl-,triester with 1,2,3,4-butanetetrol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5340-95-4 D-Glucopyranose, 6-O-.alpha.-D-galactopyranosyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
53-43-0 Androst-5-en-17-one, 3-hydroxy-, (3.beta.)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
5343-92-0 1,2-Pentanediol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5353-26-4 3,6,9,12-Tetraoxatriacont-21-en-1-ol, (Z)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
*81859-24-7/53568-66-4 Cellulose, 2-hydroxyethyl 2-[2-hydroxy-3-(trimethylammonio)propoxy]ethyl 2-hydroxy-3-(trimethylammonio)propyl ether, chloride On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
53609-72-6 Poly[oxy(methyl-1,2-ethanediyl)], .alpha.,.alpha.'-1,4- butanediylbis[.omega.-hydroxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
536993-92-7 Spirulina maxima, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
53716-49-7 9H-Carbazole-2-acetic acid, 6-chloro-.alpha.-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
53772-83-1 1-Piperazineethanol, 4-[(3Z)-3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
538-02-3 Cyclopentaneethanamine, N,.alpha.-dimethyl-, hydrochloride Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
53850-34-3 Proteins, thaumatins Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
53882-12-5 Acetic acid, 2,2'-[(2-chloro-5-cyano-1,3-phenylene)diimino]bis[2-oxo- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
53885-35-1 Thieno[3,2-c]pyridine, 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydro-, hydrochloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
54-35-3  4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)-, compd. with 2-(diethylamino)ethyl 4-aminobenzoate (1:1) Higher priority based on available information - Environmental concern Clarification required TBD
54024-22-5 18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17.alpha.)- Higher priority based on available information - Environmental concern Clarification required TBD
541-15-1 1-Butanaminium, 2,4-dihydroxy-N,N,N-trimethyl-4-oxo-, inner salt, (2R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
541-35-5 Butanamide Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
54182-58-0 Aluminum, hexadeca-.mu.-hydroxytetracosahydroxy[.mu.8-[[1,3,4,6-tetra-O-sulfo-.beta.-D-fructofuranosyl .alpha.-D-glucopyranoside tetrakis(sulfato-.kappa.O')](8-)]]hexadeca- Higher priority based on available information - Environmental and human health concern Clarification required TBD
5422-34-4 Propanamide, 2-hydroxy-N-(2-hydroxyethyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
54301-26-7 Glycine, N-(1-oxo-10-undecenyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
54392-28-8 Sorbitan, triisooctadecanoate, poly(oxy-1,2-ethanediyl) derivs. Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
54422-45-6 9-Octadecenamide, N-[2-hydroxy-1-(hydroxymethyl)heptadecyl]-, (9Z)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
544-62-7 1,2-Propanediol, 3-(octadecyloxy)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
54482-09-6 Hexadecanamide, 2-hydroxy-N-[2-hydroxy-1-(hydroxymethyl) heptadecyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
54527-84-3 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl 5-[2-[methyl(phenylmethyl)amino]ethyl] ester, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
54549-25-6 D-Glucopyranoside, decyl Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
54549-26-7 D-Glucopyranoside, tetradecyl Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
54549-27-8 D-​Glucopyranoside, hexadecyl Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
*54578-91-5/ 54018-18-7 2-Butenedioic acid (2Z)-, polymer with methoxyethene, butyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
54590-52-2 Benzenesulfonic acid, 4-dodecyl-, compd. with 1-amino-2-propanol (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
546-46-3 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, zinc salt (2:3) Higher priority based on available information - Environmental and human health concern Clarification required TBD
54684-78-5 Octadecanoic acid, 12-[(1-oxooctadecyl)oxy]-, octadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
54-71-7 2(3H)​-​Furanone, 3-​ethyldihydro-​4-​[(1-​methyl-​1H-​imidazol-​5-​yl)​methyl]​-​, hydrochloride (1:1)​, (3S,​4R)​- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
548-73-2 2H-Benzimidazol-2-one, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
54910-89-3 Benzenepropanamine, N-methyl-.gamma.-[4-(trifluoromethyl)phenoxy]- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
54965-21-8 Carbamic acid, N-[6-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
54965-24-1 Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
549-66-6 Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, monopentanoate (salt) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
55-03-8 L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt (1:1) Higher priority based on available information - Environmental concern Clarification required TBD
55028-72-3 5-​Heptenoic acid, 7-​[(1R,​2R,​3R,​5S)​-​2-​[(1E,​3R)​-​4-​(3-​chlorophenoxy)​-​3-​hydroxy-​1-​buten-​1-​yl]​-​3,​5-​dihydroxycyclopentyl​]​-​, sodium salt (1:1)​, (5Z)​-​rel- Higher priority based on available information - Environmental concern Clarification required TBD
55079-83-9 2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (2E,4E,6E,8E)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
551-11-1 Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
55134-13-9 Salinomycin, 4-methyl-, (4S)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
55172-29-7 Thallium chloride (201TlCl) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
552-12-5 D-Galactopyranuronic acid Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
55268-74-1 4H-Pyrazino[2,1-a]isoquinolin-4-one, 2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
552-94-3 Benzoic acid, 2-hydroxy-, 2-carboxyphenyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
55297-96-6 Acetic acid, [[2-(diethylamino)ethyl]thio]-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester, [3aS-(3a.alpha.,4.beta.,5.alpha.,6.alpha.,8.beta.,9.alpha.,9a.beta.,10S*)]-, (E)-2-butenedioate (1:1) (salt) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
55306-04-2 Olean-12-en-28-oic acid, 2,3,19,23-tetrahydroxy-, .beta.-D-glucopyranosyl ester, (2.alpha.,3.beta.,4.beta.,19.alpha.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
553-54-8 Benzoic acid, lithium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5543-57-7 2H-1-Benzopyran-2-one, 4-hydroxy-3-[(1S)-3-oxo-1-phenylbutyl]- Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
554-57-4 Acetamide, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
55-48-1 Benzeneacetic acid, .alpha.-(hydroxymethyl)- (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, sulfate (2:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
555-44-2 Hexadecanoic acid, 1,1',1"-(1,2,3-propanetriyl) ester Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
555-45-3 Tetradecanoic acid, 1,1',1"-(1,2,3-propanetriyl) ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
55584-26-4 2,4-Hexadienoic acid, 1-methylethyl ester, (2E,4E)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
556-38-7 Pentanoic acid, zinc salt (2:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
557-61-9 1-Octacosanol Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
5579-66-8 3,6,9,12,15,18,21,24,27-Nonaoxanonacosane-1,29-diol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
55837-20-2 4(3H)-Quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-, rel- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
55840-13-6 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ester with 1,2,3-propanetriol monooctadecanoate Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
55852-15-8 Propanoic acid, 2-hydroxy-, compd. with N-[3-(dimethylamino)propyl]-16-methylheptadecanamide (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
55852-84-1 Bacitracin, methylenebis[2-hydroxybenzoate] (salt) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
5588-33-0 10H-Phenothiazine, 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylsulfinyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
55901-20-7 Proline, 5-oxo-, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
55940-73-3 Benzoic acid, 2-hydroxy-, oxybis(methyl-2,1-ethanediyl) ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
56038-13-2 .alpha.-D-Galactopyranoside, 1,6-dichloro-1,6-dideoxy-.beta.-D-fructofuranosyl 4-chloro-4-deoxy- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
56090-54-1 Triglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5611-51-8 Pregna-1,4-diene-3,20-dione, 21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11.beta.,16.alpha.)- Higher priority based on available information - Environmental concern Clarification required TBD
56124-62-0 Pentanoic acid, 2-[(2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-.alpha.-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
56180-94-0 D-Glucose, O-4,6-dideoxy-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-.alpha.-D-glucopyranosyl-(1→4)-O-.alpha.-D-glucopyranosyl-(1→4)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
56211-40-6 3-Pyridinesulfonamide, N-[[(1-methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
56235-92-8 Butanedioic acid, hydroxy-, bis(2-ethylhexyl) ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
56272-24-3 Histidine, hydrochloride Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
56275-01-5 Silicic acid, trimethylsilyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
56296-78-7 Benzenepropanamine, N-methyl-.gamma.-[4-(trifluoromethyl)phenoxy]-, hydrochloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
56343-01-2 Benzoic acid, 2-hydroxy-5-sulfo-, sodium salt (1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
563-72-4 Ethanedioic acid, calcium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
56390-09-1 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
56519-72-3 Decanoic acid, 1,3-propanediyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
56554-41-7 9,12,15-Octadecatrienoic acid, 2,3-dihydroxypropyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
56639-51-1 Aluminum, hydroxybis(tetradecanoato-.kappa.O)- Higher priority based on available information - Environmental and human health concern Clarification required TBD
56767-76-1 [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-.alpha.-methyl-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
56827-95-3 1-Hexadecanol, phosphate (3:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
5697-02-9 1-Naphthalenol, 2-methyl-, 1-acetate Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
56992-68-8 Poly(oxy-1,2-ethanediyl), .alpha.-benzoyl-.omega.-(dodecyloxy)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
57022-38-5 Propanamide, 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]-, hydrochloride (1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5703-94-6 3,6,9,12-Tetraoxadocosan-1-ol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
57041-67-5 Ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
57072-40-9 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, chromium(3+) salt (1:?) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
5714-73-8 Glycine, N-benzoyl-, compd. with 1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
57248-88-1 Phosphonic acid, P,P'-(3-amino-1-hydroxypropylidene)bis-, sodium salt (1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5725-96-2 Methanamine, N-hydroxy-N-methyl- Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
57271-36-0 Benzene, ethenyl-, polymer with butene and ethene Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
57-42-1 4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5743-17-9 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-, monobenzoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
57452-98-9 4H-Pyrazino[2,1-a]isoquinolin-4-one, 2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-, (11bR)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
57524-53-5 Ethanol, 2-[(4-methoxy-2-nitrophenyl)amino]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
57524-89-7 Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-[(1-oxopentyl)oxy]-, (11.beta.)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
57568-20-4 Propanoic acid, 2-​hydroxy-​, 2-​octyldodecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
57569-76-3 Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.',.alpha."-1,2,3-propanetriyltris[.omega.-(acetyloxy)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
57606-04-9 2(3H)-Furanone, 4-ethyldihydro-3-hydroxy-4-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
57-63-6 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17.alpha.)- Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
576-37-4 Glucuronic acid Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
576-55-6 Phenol, 2,3,4,5-tetrabromo-6-methyl- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
57762-37-5 4-Thiazolidinecarboxylic acid, compd. with L-lysine (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
57773-65-6 1-9-Luteinizing hormone-releasing factor (swine), 6-D-tryptophan-9-(N-ethyl-L-prolinamide)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
57808-66-9 2H-Benzimidazol-2-one, 5-chloro-1-[1-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-4-piperidinyl]-1,3-dihydro- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
57817-89-7 Kaur-16-en-18-oic acid, 13-[(2-O-.beta.-D-glucopyranosyl-.beta.-D-glucopyranosyl)oxy]-, .beta.-D-glucopyranosyl ester, (4.alpha.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
57-83-0 Pregn-4-ene-3,20-dione Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
57834-33-0 Benzoic acid,4-[[(methylphenylamino)methylene]amino]-,ethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
57834-50-1 Benzoic acid, 4-[[[[4-(ethoxycarbony)phenyl]amino]methylene]amino]-,ethyl ester Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
57-85-2 Androst-4-en-3-one, 17-(1-oxopropoxy)-, (17.beta.)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
57852-57-0 5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, hydrochloride (1:1), (7S,9S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5786-21-0 5H-Dibenzo[b,e][1,4]diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
57934-97-1 2-Cyclohexene-1-carboxylic acid, 2-ethyl-6,6-dimethyl-,ethyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
57963-76-5 4a(2H)-Naphthalenol, octahydro-4,4,8a-trimethyl-,trans- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
57963-77-6 cis-1,1,10-Trimethyl-9-decahydronaphthol Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
57982-77-1 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
58001-44-8 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, (2R,3Z,5R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
58-05-9 L-Glutamic acid, N-[4-[[(2-amino-5-formyl-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5819-47-6 5-Pyrrolidinecarboxylic acid, 2-oxo-, magnesium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
58-28-6 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N-methyl-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
58306-30-2 Carbamic acid, N,N'-[[2-[(2-methoxyacetyl)amino]-4-(phenylthio)phenyl]carbonimidoyl]bis-, C,C'-dimethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5836-69-1 Phosphinic amide, P,P-dibutyl-N,N-dipropyl- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
58-46-8 2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-, (3R,11bR)-rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
58543-16-1 Kaur-16-en-18-oic acid, 13-[(O-.beta.-glucopyranosyl-(1→2)-O-[.beta.-D-glucopyranosyl-(1→3)]-.beta.-D-glucopyranosyl)oxy]-,.beta.-D-glucopyranosyl ester, (4.alpha.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
58579-51-4 Imidazo[2,1-b]quinazolin-2(3H)-one, 6,7-dichloro-1,5-dihydro-,hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5858-61-7 2,7-Naphthalenedisulfonic acid, 3-[[4-(acetylamino)phenyl]azo]-4-hydroxy-, disodium salt Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
585-86-4 D-Glucitol, 4-O-.beta.-D-galactopyranosyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5863-51-4 Benzenemethanaminium, N-[4-[(2-chlorophenyl)[4-[ethyl[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylene]-3-methyl-2,5-cyclohexadien-1-ylidene]-N-ethyl-3-sulfo-, inner salt, sodium salt (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
58748-27-9 Fatty acids, C8-10, propylene esters Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
58786-99-5 Morphinan-3,14-diol, 17-(cyclobutylmethyl)-, (2S,3S)-2,3-dihydroxybutanedioate (1:1) (salt) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
58846-77-8 .beta.-D-Glucopyranoside, decyl Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
58855-36-0 Ethanol, 2,2'-iminobis-, compd. with .alpha.-sulfo-.omega.-(dodecyloxy)poly(oxy-1,2-ethanediyl) (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
589-68-4 Tetradecanoic acid, 2,3-dihydroxypropyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
59-05-2 L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5905-52-2 Propanoic acid, 2-hydroxy-, iron(2+) salt (2:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
59056-93-8 Ethanone, 1-[(2R,3S)-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl]-, rel- Higher priority based on available information - Environmental concern Clarification required TBD
59070-56-3 Poly(oxy-1,2-ethanediyl), .alpha.,.alpha'.,.alpha."-1,2,3-propanetriyltris[.omega.-hydroxy-, monododecanoate Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
59219-71-5 Hexanoic acid, 3,5,5-trimethyl-, 3,5,5-trimethylhexyl ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
59231-35-5 Hexanoic acid, 3,5,5-trimethyl-, isodecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
59272-74-1 Spiro[7H-benzo[de]quinoline-7,1'-cyclohexane]-4',6-diol, 1,2,3,8,9,9a-hexahydro-5-methoxy-1-methyl-, (1'.alpha.,4'.beta.,9aR)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
5936-28-7 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-[(5R)-5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-, hydrochloride, (3S)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
59-42-7 Benzenemethanol, 3-hydroxy-.alpha.-[(methylamino)methyl]-, (.alpha.R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
594-45-6 Ethanesulfonic acid Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
59-46-1 Benzoic acid, 4-amino-, 2-(diethylamino)ethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
59467-70-8 4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5949-16-6 Cinchonan-9-ol, (9S)-, sulfate (2:1) (salt) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5949-44-0 Androst-4-en-3-one, 17-[(1-oxoundecyl)oxy]-, (17.beta.)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
59-52-9 1-Propanol, 2,3-dimercapto- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
59587-08-5 1,3-Dioxolo[4,5-g]quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo-, sodium salt (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
59599-53-0 Benzoic acid, 2-hydroxy-, 2-(2-hydroxy-1-methylethoxy)-1-methylethyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
59599-58-5 Benzenesulfonic acid, 4-tridecyl-, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
59599-61-0 Octenoic acid, (5-hydroxy-6-methyl-3,4-pyridinediyl)bis(methylene) ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
596-51-0 Pyrrolidinium, 3-[(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethyl-, bromide (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
5967-73-7 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl-, hydrochloride, (6R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
59708-52-0 4-Piperidinecarboxylic acid, 4-[(1-oxopropyl)phenylamino]-1-(2-phenylethyl)-, methyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
59729-32-7 5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-, hydrobromide (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
59729-33-8 5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
59792-81-3 Aluminum, tris(5-oxo-L-prolinato-.kappa.N1,.kappa.O2)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
59804-37-4 2H-Thieno[2,3-e]-1,2-thiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
59820-63-2 2-[3-(methylamino)-4-nitrophenoxy]ethanol Higher priority based on available information - Environmental and human health concern Clarification required TBD
5985-99-9 Piperidine, 2-propyl-, (2R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
5987-82-6 Benzoic acid, 4-amino-3-butoxy-, 2-(diethylamino)ethyl ester, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
59-92-7 L-Tyrosine, 3-hydroxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
59970-10-4 3,6,9,12-Tetraoxatriacontan-1-ol Higher priority based on available information - Environmental concern Clarification required TBD
60031-93-8 Cyclohexanemethanol, 4-ethenyl-a,a,4-trimethyl-3-(1-methylethenyl)-,1-acetate,(1R,3S,4S)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
60063-90-3 Ammonium Carrageenan Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
60106-89-0 2-Propanol, 1-[(1-methylethyl)amino]-3-(2-propylphenoxy)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
60-13-9 Benzeneethanamine, .alpha.-methyl-, sulfate (2:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
60142-96-3 Cyclohexaneacetic acid, 1-(aminomethyl)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
60166-93-0 1,3-Benzenedicarboxamide, N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxy-1-oxopropyl]amino]-2,4,6-triiodo- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
60270-33-9 Docosanamide, N-[3-(dimethylamino)propyl]- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
6027-43-6 1-Propanone, 3-(3,4-dihydroxyphenyl)-1-(3-.beta.-D-glucopyranosyl-2,4,6- trihydroxyphenyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
60-31-1 Ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl-, chloride (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
603-50-9 Phenol, 4,4'-(2-pyridinylmethylene) bis-, 1,1'-diacetate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
603-85-0 Phenol, 2-amino-3-nitro- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
60323-79-7 Starch, polymer with 2-propenoic acid, graft, sodium salt Higher priority based on available information - Environmental concern Clarification required TBD
60-41-3 Strychnidin-10-one, sulfate (2:1) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
604-68-2 .alpha.-D-Glucopyranose, 1,2,3,4,6-pentaacetate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
6054-98-4 Benzoic acid, 3,3'-(1,2-diazenediyl)bis[6-hydroxy-, sodium salt (1:2) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
606-06-4 2,5-Cyclohexadiene-1,4-dione, 2-[(2E)-3,7-dimethyl-2,6-octadienyl]-5,6-dimethoxy-3-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
60650-88-6 Sericin A Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
60684-33-5 2,5-Cyclohexadiene-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaen-1-yl)-5,6-dimethoxy-3-methyl- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
60752-63-8 L-Methionine, N-(2-thienylcarbonyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
60778-99-6 Sulfuric acid, aluminum magnesium salt (1:?:?) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
60908-77-2 Isohexadecane Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
60-92-4 Adenosine, cyclic 3',5'-(hydrogen phosphate) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
611-75-6 Benzenemethanamine, 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl-, monohydrochloride Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
61177-45-5 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, potassium salt (1:1), (2R,3Z,5R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
613-03-6 1,2,4-Benzenetriol, 1,2,4-triacetate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
61364-37-2 Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (14bR)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
6145-69-3 1,2-Propanediol, 3-(hexadecyloxy)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
61477-96-1 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
6159-41-7 10-Undecenoic acid, potassium salt (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
616204-22-9 L-Argininamide, N-acetyl-L-.alpha.-glutamyl-L-.alpha.-glutamyl-L-methionyl-L-glutaminyl-L-arginyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
61661-06-1 1,2-Benzenediol, 4-[2-[[(1S)-3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
61692-77-1 2-Butenoic acid, 2-methyl-, 2-methylbutyl ester, (2Z)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
61693-08-1 Heptadecane, 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16-hexadecamethyl- Higher priority based on available information - Environmental concern Clarification required TBD
61702-44-1 1,4-Benzenediamine, 2-chloro-, sulfate (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
617-05-0 Benzoic acid, 4-hydroxy-3-methoxy-, ethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
61718-82-9 1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (1E)-, (2Z)-2-butenedioate (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
61757-59-3 Poly(oxy-1,2-ethanediyl),.alpha.-(carboxymethyl)-.omega.-(tridecyloxy)-,sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
61788-55-4 Flavonoids, lemon oil Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
61789-08-0 Glycerides, soya mono-, hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
61789-25-1 Corn oil, ethoxylated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
61789-88-6 Fatty acids, olive-oil, sodium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
61789-89-7 Fatty acids, palm kernel-oil, sodium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
61790-62-3 Fatty acids, coco, reaction products with N1,N1-dimethyl-1,3-propanediamine Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
61790-79-2 Fatty acids, palm-oil, sodium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
6182-11-2 Octadecanoic acid, 1,1'-(1-methyl-1,2-ethanediyl) ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
61849-14-7 Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, monosodium salt, (5Z,9.alpha.,11.alpha.,13E,15S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
61869-08-7 Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S,4R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
61886-59-7 Benzenesulfonic acid, tridecyl-, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
620-64-4 Eicosanoic acid, 1,2,3-propanetriyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
620-67-7 Heptanoic acid, 1,1',1"-(1,2,3-propanetriyl) ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
62125-22-8 Isooctadecanoic acid, 1,1'-[2,2-bis[[(1-oxoisooctadecyl)oxy]methyl]-1,3-propanediyl] ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
62152-14-1 1-Propanesulfonic acid, 2-methyl-2-[(1-oxo-2-propen-1-yl)amino]-, ammonium salt (1:1), homopolymer Higher priority based on available information - Environmental and human health concern Clarification required TBD
6217-54-5 4,7,10,13,16,19-Docosahexaenoic acid, (4Z,7Z,10Z,13Z,16Z,19Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
6219-67-6 1,3-Benzenediamine, 4-methoxy-, sulfate (1:?) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
6219-69-8 1,3-Benzenediamine, 4-ethoxy-, sulfate Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
62288-83-9 Vasopressin, 1-(3-mercaptopropanoic acid)-8-D-arginine-, monoacetate(salt) Higher priority based on available information - Environmental concern Clarification required TBD
62406-73-9 6,10-Dioxaspiro[4,5]decane,8,8-dimethyl-7-(-1-methylethyl)- Higher priority based on available information - Environmental and human health concern Clarification required TBD
62-52-2 Magnesium, [aspartato(2-)]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
6261-30-9 Cyclopentanol, 2-cyclopentylidene- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
62625-14-3 Phenol, 2-amino-6-chloro-4-nitro-, hydrochloride (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
6273-99-0 Mercury, [.mu.-[orthoborato(2-)-.kappa.O:.kappa.O']]diphenyldi- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
6297-03-6 Octadecane, 1,1'-oxybis Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
629-82-3 Octane, 1,1'-oxybis- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
6304-31-0 Pyridine, 2-butyl-4-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
63074-08-8 Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
63084-98-0 Phenol, 4-amino-, sulfate (2:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
63089-86-1 Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with D-glucitol (6:1), tetra-(9Z)-9-octadecenoate Higher priority based on available information - Environmental concern Clarification required TBD
630-93-3 2,​4-​Imidazolidinedione, 5,​5-​diphenyl-​, sodium salt (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
631-89-0 Retinol, 15-[(9Z,12Z)-9,12-octadecadienoate] Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
635-38-1 Hexadecanoic acid, [3-hydroxy-2-methyl-5-[[(1-oxohexadecyl)oxy]methyl]-4-pyridinyl]methyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
635-39-2 6H-Purin-6-one, 2-amino-1,9-dihydro-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
6358-53-8 2-Naphthalenol, 1-[2-(2,5-dimethoxyphenyl)diazenyl]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
63590-64-7 Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
63612-50-0 2,4-Imidazolidinedione, 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]- Higher priority based on available information - Environmental concern Clarification required TBD
63659-18-7 2-Propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
63663-21-8 Pentanediamide, N1,N5-dibutyl-2-[(1-oxododecyl)amino]-, (2S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
6371-76-2 2-Naphthalenecarboxylic acid, 3-hydroxy-4-(2-phenyldiazenyl)-, calcium salt (2:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
6371-96-6 Butanamide, 2-[2-(4-methoxy-2-nitrophenyl)diazenyl]-N-(2-methylphenyl)-3-oxo- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
637-32-1 Imidodicarbonimidic diamide, N-(4-chlorophenyl)-N'-(1-methylethyl)-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
638-94-8 Pregna-1,4-diene-3,20-dione, 11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11.beta.,16.alpha.)- Higher priority based on available information - Environmental concern Clarification required TBD
63-89-8 3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxohexadecyl)oxy]-, inner salt, 4-oxide, (7R)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
64019-93-8 Propanoic acid, 2,2-dimethyl-, 4-[1-hydroxy-2-(methylamino)ethyl]-1,2-phenylene ester, hydrochloride Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
64024-15-3 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, hydrochloride (1:1), (2R,6R,11R)-rel- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
64053-00-5 Decanoic acid, 2-[4-[(3Z)-3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]-1-piperazinyl]ethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
642072-46-6 Ethanol, 2,2'-iminobis-,compd. with .alpha.-sulfo-.omega.-(tetradecyloxy) poly ( oxy-1,2-ethanediyl) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
64211-45-6 Ethanone, 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-, O-[(2,4-dichlorophenyl)methyl]oxime, (1Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
64221-86-9 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-, (5R,6S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
64228-81-5 Isoquinolinium, 2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, dibenzenesulfonate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
64248-79-9 Isooctadecanoic acid, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
64294-91-3 C.I. Pigment Yellow 43 Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
64366-24-1 Carrageenan, potassium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
644-62-2 Benzoic acid, 2-[(2,6-dichloro-3-methylphenyl)amino]- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
645-05-6 1,3,5-Triazine-2,4,6-triamine, N2,N2,N4,N4,N6,N6-hexamethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
64519-44-4 L-Proline, 5-oxo-, (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
64519-82-0 D-arabino-Hexitol, 6-O-.alpha.-D-glucopyranosyl-, (2.xi.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
64544-07-6 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-8-oxo-, 1-(acetyloxy)ethyl ester, (6R,7R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
646996-25-0 Glycine, N-(2-aminoethyl)-N-[2-(carboxymethoxy)ethyl]-, N-wheat germ-oil acyl derivs., disodium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
64-73-3 2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, monohydrochloride, (4S,4aS,5aS,6S,12aS)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
64855-91-0 Proline, 5-oxo-, compd. with L-arginine (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
64924-67-0 4(3H)-Quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-, monohydrobromide, rel- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
6493-05-6 1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
6505-30-2 Benzenemethanaminium, N-[4-[[4-(diethylamino)phenyl][4-[ethyl[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylene]-3-methyl-2,5-cyclohexadien-1-ylidene]-N-ethyl-3-sulfo-, inner salt, sodium salt (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
65072-04-0 Alkaloids, Veratrum Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
65-19-0 Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, hydrochloride (1:1), (16.alpha.,17.alpha.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
65-22-5 4-Pyridinecarboxaldehyde, 3-hydroxy-5-(hydroxymethyl)-2-methyl-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
65235-31-6 Phenol, 4-[(2-hydroxyethyl)amino]-3-nitro- Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
65271-80-9 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
65-28-1 Phenol, 3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]-, methanesulfonate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
6533-00-2 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17.alpha.)-(+-)- Higher priority based on available information - Environmental concern Clarification required TBD
65389-08-4 Indium-111In, tris(8-quinolinolato-.kappa.N1,.kappa.O8)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
65405-96-1 Nickel, [.mu.-[carbonato(2-)-.kappa.O:.kappa.O']]dihydroxydi- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
65473-14-5 1-Naphthalenemethanamine, N-methyl-N-[(2E)-3-phenyl-2-propen-1-yl]-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
6548-12-5 Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, inner salt, barium salt (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
6556-12-3 D-Glucuronic acid Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
65710-07-8 D-Streptamine, O-4-amino-4-deoxy-.alpha.-D-glucopyranosyl-(1→8)-O-(8R)-2-amino-2,3,7-trideoxy-7- (methylamino)-D-glycero-.alpha.-D-allo-octodialdo-1,5:8,4-dipyranosyl-(1→4)-2-deoxy-, sulphate (salt) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
65-71-4 2,4(1H,3H)-Pyrimidinedione, 5-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
65807-02-5 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-, 2-(aminocarbonyl)hydrazide Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
65-82-7 L-Methionine, N-acetyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
65896-16-4 1H-Imidazol-2-amine, N-(2-bromo-6-fluorophenyl)-4,5-dihydro- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
65899-73-2 1H-Imidazole, 1-[2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
6600-40-4 L-Norvaline Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
660-27-5 Acetic acid, 2,2-dichloro-, compd. with N-(1-methylethyl)-2-propanamine (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
66085-59-4 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-(2-methoxyethyl) 5-(1-methylethyl) ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
66095-81-6 Ethanol, 2-[(2-methoxy-4-nitrophenyl)amino]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
66104-22-1 Ergoline, 8-[(methylthio)methyl]-6-propyl-, (8.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
66104-23-2 Ergoline, 8-[(methylthio)methyl]-6-propyl-, (8.beta.)-, monomethanesulfonate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
66108-95-0 1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
66161-62-4 Glycine, N-(2-hydroxyethyl)-N-[2-[(1-oxododecyl)amino]ethyl]-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
66170-10-3 L-Ascorbic acid, 2-(dihydrogen phosphate), sodium salt (1:3) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
66357-35-5 1,1-Ethenediamine, N'-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N-methyl-2-nitro- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
66357-59-3 1,1-Ethenediamine, N'-[2-[[[5-[(dimethylamino)methyl]-2 furanyl]methyl]thio]ethyl]-N-methyl-2-nitro-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
66376-36-1 Phosphonic acid, P,P'-(4-amino-1-hydroxybutylidene)bis- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
66-40-0 Ethanaminium, N,N,N-triethyl- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
6640-03-5 1-Tetradecanol, 1-(hydrogen phosphate) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
66469-15-6 Isooctadecanoic acid, potassium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
66575-29-9 1H-Naphtho[2,1-b]pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-, [3R-(3-.alpha.,4a-.beta.,5-.beta.,6-.beta.,6a-.alpha.,10-.alpha.,10a-.beta.,10b-.alpha.)]- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
66671-82-7 1,4-Benzenediamine, 2-methoxy-, sulfate (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
66711-21-5 1,4-Benzenediamine, 2,6-dichloro-N1-(4,5-dihydro-1H-imidazol-2-yl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
667-84-5 Butamide, N-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
66794-58-9 Sorbitan, monoisooctadecanoate, poly(oxy-1,2-ethanediyl) derivatives Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
66849-33-0 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide, (2S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
66852-54-8 Pregna-1,4-diene-3,20-dione, 21-chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (6.alpha.,11.beta.,16.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
669066-11-9 Celosia argentea cristata, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
67254-72-2 Fatty acids, castor-oil, esters with polyglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
67254-73-3 Glycerides, mixed mono- and di- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
67392-87-4 Spiro[17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthrene-17,2'(5'H)-furan]-3,5'(2H)-dione, 1,3',4',6,7,8,9,10,11,12,13,14,15,16,20,21-hexadecahydro-10,13-dimethyl-, (2'S,6R,7R,8R,9S,10R,13S,14S,15S,16S)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
676-46-0 Butanedioic acid, 2-hydroxy-, sodium salt (1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
67762-83-8 Siloxanes and Silicones, di-Me, Me stearyl Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
67783-98-6 Formaldehyde, polymer with 4,4'-(1-methylethylidene)bis[phenol] and 2-methylphenol Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
67784-87-6 Glycerides, palm-oil mono- and di-, hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
67784-88-7 Glycerides, palm-oil mono- and di-, hydrogenated, ethoxylated Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
67801-20-1 4-Penten-2-ol,3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
67846-16-6 1-Propanaminium, N-ethyl-N,N-dimethyl-3-[(1-oxooctadecyl)amino]-, ethyl sulfate (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
67874-65-1 Propanoic acid, 3-mercapto-, 2,3-dihydroxypropyl ester Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
*67914-69-6/ 85058-43-1 1-Piperazinecarboxylic acid, 4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, ethyl ester, rel- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
67915-31-5 Piperazine, 1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-(1-methylethyl)-, rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
67938-21-0 Isooctadecanoic acid, diester with oxybis[propanediol] Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
679809-58-6 Enoxaparin sodium Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
68003-13-4 Boric acid (H3BO3), compd. with 1-amino-2-propanol (1:1) Higher priority based on available information - Environmental and human health concern Clarification required TBD
*68004-11-5/ 26855-44-7 Octadecanoic acid, monoester with tetraglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
68015-98-5 1,3-Benzenediamine, 4-ethoxy-, sulfate (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
68-05-3 Ethanaminium, N,N,N-triethyl-, iodide (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
68127-22-0 D-Proline, 5-oxo-, (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
68130-12-1 Boric acid, 2-aminoethyl ester Higher priority based on available information - Environmental and human health concern Clarification required TBD
68130-24-5 Decanoic acid, ester with 2,2'-[oxybis(methylene)]bis[2-(hydroxymethyl)-1,3-propanediol] octanoate pentanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
68130-52-9 Decanoic acid, mixed esters with hexanoic acid, octanoic acid and trimethylolpropane Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
68155-26-0 Amides, vegetable-oil, N,N-bis(hydroxyethyl) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68187-29-1 L-Glutamic acid, N-coco acyl derivs., compds. with triethanolamine (1:1) Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
68187-30-4 L-Glutamic acid, N-coco acyl derivatives, disodium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68187-32-6 L-Glutamic acid, N-coco acyl derivs., monosodium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68239-79-2 Phenol, 3-(ethylamino)-4-methyl-, sulfate (2:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
68239-83-8 Nitro-1,4-benzenediamine sulfate (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
68239-84-9 Phenol, 3-(diethylamino)-, sulfate (2:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
68333-16-4 Lactobacillus acidophilus Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68373-14-8 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-, 4,4-dioxide, (2S,5R)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
68391-32-2 2-Naphthalenaminium, 8-[2-(4-amino-3-nitrophenyl)diazenyl]-7-hydroxy-N,N,N-trimethyl-, chloride (1:1) Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
68401-82-1 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-, sodium salt (1:1), (6R,7R)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
68413-33-2 Quaternary ammonium compounds, bis(2-hydroxy-C>10-alkyl)dimethyl, chlorides Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
68424-38-4 Fatty acids, C16-18, sodium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68440-49-3 Peanut Oil, ethoxylated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68459-67-6 Castor oil, ester with glycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68475-42-3 Imidazo[2,1-b]quinazolin-2(3H)-one, 6,7-dichloro-1,5-dihydro- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
68475-50-3 Aluminum, tris[5-amino-4-hydroxy-3-(phenylazo)-2,7-naphthalenedisulfonato(2-)]di- Higher priority based on available information - Environmental and human health concern Clarification required TBD
68476-25-5 Feldspar-group minerals Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
*68479-64-1/ 79702-63-9 Butanedioic acid, 2-sulfo-, mono[2-[[(9Z)-1-oxo-9-octadecen-1-yl]amino]ethyl] ester, sodium salt (1:2) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
68506-86-5 5-Hexenoic acid, 4-amino- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
68552-95-4 Fatty acids, vegetable-oil, ethoxylated Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
*68553-03-7/ 66105-29-1 Glycerides, coco mono-, ethoxylated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68554-53-0 Siloxanes and Silicones, di-Me, (octadecyloxy)-terminated Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
685-73-4 D-Galacturonic acid Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68580-63-2 Octacosanol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68606-18-8 Glycerides, mixed coco, decanoyl and octanoyl Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68606-81-5 Currant, Ribes nigrum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68607-24-9 Quaternary ammonium compounds, C20-22-alkyltrimethyl, chlorides Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
90506-41-5 Phosphoric acid, mono C12-14 alkyl esters, potassium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
68650-43-1 Chicory, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68693-11-8 Acetamide, 2-[(diphenylmethyl)sulfinyl]- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
68783-34-6 Coconut oil, potassium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68797-65-9 1-Propanaminium, N-ethyl-N,N-dimethyl-3-[(1-oxodocosyl)amino]-, ethyl sulfate (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
688013-96-9 L-Tyrosine, N-[(2S)-3-carboxy-2-hydroxy-1-oxopropyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68813-55-8 2-​Naphthalenecarboxyli​c acid, 4,​4'-​methylenebis[3-​hydroxy-​, compd. with 3-​[(1E)​-​2-​(1,​4,​5,​6-​tetrahydro-​1-​methyl-​2-​pyrimidinyl)​ethenyl]​phenol (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
68814-13-1 1-Hexadecanol, phosphate Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
68844-77-9 1H-Benzimidazol-2-amine, 1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
68877-55-4 Propanoic acid, 3-[2-(2-heptyl-4,5-dihydro-1.eta.-imidazol-1-yl)ethoxy]-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
68880-55-7 Spiramycin, hexanedioate (1:1) (salt) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
68889-49-6 9-Octadecenoic acid (9Z)-, 1,2,3-propanetriyl ester, polymer with .alpha.-hydro-.omega.-hydroxypoly(oxy-1,2-ethanediyl) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
68890-92-6 Poly(oxy-1,2-ethanediyl), .alpha.-(3-carboxy-1-oxosulfopropyl)-.omega.-hydroxy-, ethers with lanolin alcs., disodium salts Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
68908-98-5 Poly(oxy-1,2-ethanediyl), .alpha.-(C12-13-alkyl)-.omega.-carboxymethoxy-, sodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
68910-56-5 Quaternary ammonium compounds, di-C12-15-alkyldimethyl, chlorides Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
68915-25-3 Keratins, lauroyl Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
68919-21-1 Keratins, octanoyl Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
68920-03-6 Glycerides, C16-18 and C18-unsatd., deodorizer distillates Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68929-04-4 1H-Imidazolium, 1-[2-(2-carboxyethoxy)ethyl]-1-(2-carboxyethyl)-4,5-dihydro-2-undecyl-, hydroxide, sodium salt (1:1:2) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
6893-02-3 L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
68935-40-0 1H-Indene-2-propanoic acid, 2,3-dihydro-1-oxo-5,6-bis(phenylmethoxy)-2-propyl- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
68936-89-0 1,2,3-Propanetriol, homopolymer, (9Z,12R)-12-hydroxy-9-octadecenoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
68938-15-8 Fatty acids, coco, hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68938-32-9 Fatty acids, wheat germ-oil Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68951-62-2 Octadecanoic acid, reaction products with 2-amino-2-methyl-1-propanol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
68953-11-7 Amides, mink-oil, N-[3-(dimethylamino)propyl] Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68953-55-9 Fats and Glyceridic oils, vegetable, esters with polyglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68953-59-3 Ethanaminium, 2-amino-N-(2-aminoethyl)-N-(2-hydroxyethyl)-N-methyl-, N,N'-bis(hydrogenated tallow acyl) derivs., Me sulfates (salts) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
68953-68-4 Aluminum, chloro propylene glycol complexes Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
68956-08-1 Fatty acids, C6-12, triesters with trimethylolpropane Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
6899-04-3 Glutamine Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68990-51-2 Fatty acids, vegetable oil, esters with sterols mixed with vegetable-oil glycerides Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
68990-74-9 Dandelion, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
69049-74-7 4H-Pyrano[3,2-g]quinoline-2,8-dicarboxylic acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-, sodium salt (1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
69071-70-1 Fats and Glyceridic oils, apricot kernel, ethoxylated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
6916-74-1 Docosanoic acid, 2,3-dihydroxypropyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
69247-83-2 Hexanoic acid, 2-ethyl-, isooctadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
6949-98-0 Hexadecanoic acid, 9,10,16-trihydroxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
69-52-3 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-, sodium salt (1:1), (2S,5R,6R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
69537-38-8 1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-3-[(1-oxodocosyl)oxy]-, chloride (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
6966-09-2 Cyclohexanone, 2-(1-piperidinylmethyl)-, hydrochloride (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
69712-56-7 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, (6R,7S)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
70-00-8 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
70084-87-6 Glutens, enzyme-modified Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
70131-69-0 Silsesquioxanes, Ph Higher priority based on available information - Human health concern Commercial activity identified To be assessed
701-54-2 Cyclohexanecarboxylic acid, 4-(aminomethyl)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
70214-77-6 2-Nonanol,6,8-dimethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
70359-46-5 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
70609-66-4 Ethanesulfonic acid, 2-[(1-oxododecyl)amino]-, sodium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
706808-37-9 [29-tyrosine,104-glutamic acid] CTLA-4 (antigen) (human extracellular domain-containing fragment) fusion protein with immunoglobulin G1(human monoclonal Fc domain-containing fragment), bimol. (120120')-disulfide Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
70729-68-9 Heptanoic acid, 1,1'-[oxybis(2,1-ethanediyloxy-2,1-ethanediyl)] ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
70729-87-2 Isooctadecanoic acid, compd. with N,N-dimethyl-1-dodecanamine (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
7085-55-4 4H-1-Benzopyran-4-one, 2-[3,4-bis(2-hydroxyethoxy)phenyl]-3-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-5-hydroxy-7-(2-hydroxyethoxy)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
70913-86-9 Alkanes C18-70 Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
70914-02-2 Glycerides, C14-18 and C16-18-unsatd. mono- and di-, ethoxylated Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
7091-57-8 8-Quinolinol, benzoate (salt) Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
70969-43-6 Fatty acids, palm kernel-oil, potassium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
70983-91-4 Glutens, corn, hydrolyzed, sodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
71032-90-1 1,2-Propanediol, 3-[3-hydroxy-2-(9-octadecen-1-yloxy)propoxy]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
71060-72-5 Quaternary ammonium compounds, tri-C14-18-alkylmethyl, chlorides Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
71109-09-6 1-Naphthaleneacetic acid, 4-cyclohexyl-.alpha.-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
71125-38-7 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
71138-97-1 Cellulose, 2-hydroxypropyl methyl ether, acetate hydrogen butanedioate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
71185-87-0 Octadecanoic acid, triester with hexaglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
71195-58-9 Propanamide, N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
71277-79-7 .alpha.-D-Glucopyranosiduronic acid, (3.beta.,20.beta.)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-.beta.-D-glucopyranuronosyl-, sodium salt (1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
71320-77-9 Benzamide, 4-chloro-N-[2-(4-morpholinyl)ethyl]- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
71329-50-5 Guar gum, 2-hydroxypropyl 2-hydroxy-3-(trimethylammonio)propyl ether, chloride Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
71368-20-2 L-Glutamic acid, N-(1-oxotetradecyl)-, sodium salt (1:?) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
71463-34-8 1H-Imidazolium, 1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-2-undecyl-, hydrogen sulfate (salt), monosodium salt Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
7147-34-4 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-tris(2-ethylhexyl)ester Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
71486-22-1 Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-[(2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2.beta.,3.beta.,4.beta.,5.alpha.,12R,19.alpha.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
71566-49-9 Isononaoic acid,2-ethylhexyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
71735-79-0 13-Oxabicyclo[10.1.0]trideca-4,8-diene, trimethyl- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
71-78-3 2-Piperidinemethanol, .alpha.,.alpha.-diphenyl-, hydrochloride Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
71812-38-9 Sorbitan, isooctadecanoate (2:3) Higher priority based on available information - Environmental concern Clarification required TBD
71-81-8 Benzenepropanaminium, .gamma.-(aminocarbonyl)-N-methyl-N,N-bis(1-methylethyl)-.gamma.-phenyl-, iodide Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
71850-81-2 1-Propanaminium, N-(carboxymethyl)-3-[[(9Z,12R)-12-hydroxy-1-oxo-9-octadecen-1-yl]amino]-N,N-dimethyl-, inner salt Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
7187-62-4 Quinolinium, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
71957-08-9 Cobalt, bis(D-gluconato-.kappa.O1,.kappa.O2)-,(T-4)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
719-59-5 Methanone, (2-amino-5-chlorophenyl)phenyl- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
71976-00-6 3,6,9,12,15,18,21,24,27,30-Decaoxaoctatetracont-39-en-1-ol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
7211-53-2 Docosanoic acid, potassium salt (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
721-50-6 Propanamide, N-(2-methylphenyl)-2-(propylamino)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
72175-39-4 Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside, octadecanoate (8:2:3) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
72230-86-5 Terpenes and Terpenoids, cedarwood-oil, Texan, hydroxy, acetates Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
72255-09-5 Poly[oxy(methyl-1,2-ethanediyl)],.alpha.-hydro-.omega.-hydroxy-,ether with butanediol (2:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
7230-93-5 Dodecanoic acid, aluminum salt (3:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
7232-21-5 Benzamide, 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
72480-62-7 Oils, ginseng Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
72484-69-6 Oxirane, methyl-, polymer with oxirane, mono(2-decyltetradecyl) ether Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
72509-76-3 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-ethyl 5-methyl ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
72559-06-9 Spiro[9,4-(epoxypentadeca[1,11,13]trienimino)-2H-furo[2',3':7,8]naphth[1,2-d]imidazole-2,4'-piperidine]-5,10,26(3H,9H)-trione, 16-(acetyloxy)-6,18,20-trihydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1'-(2-methylpropyl)-, (9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
72576-78-4 Octanoic acid, isooctadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
72576-80-8 Hexadecanoic acid, isooctadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
72576-81-9 Tetradecanoic acid, isooctadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
72956-09-3 2-Propanol, 1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
72957-37-0 N2-(N-glycyl-L-histidyl)-L-lysine monoacetate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
*72968-47-9/ 84012-31-7 Passionflower, Passiflora incarnate, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
73020-09-4 Oat gum Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
73231-34-2 Acetamide, 2,2-dichloro-N-[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-[4-(methylsulfonyl)phenyl]ethyl]- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
73296-86-3 Isooctadecanoic acid, ester with oxybis[propanediol] Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
*73296-98-7/ 84082-59-7 Mate, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
73-31-4 Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]- Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
73334-07-3 1,3-Benzenedicarboxamide, N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N1-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
73384-59-5 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, (6R,7R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
73590-58-6 1H-Benzimidazole, 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
7360-38-5 Hexanoic acid, 2-ethyl-, 1,1',1"-(1,2,3-propanetriyl) ester Higher priority based on available information - Human health concern Commercial activity identified To be assessed
7361-61-7 4H-1,3-Thiazin-2-amine, N-(2,6-dimethylphenyl)-5,6-dihydro- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
73771-04-7 Pregna-1,4-diene-3,20-dione, 17-[(ethoxycarbonyl)oxy]-11-hydroxy-21-(1-oxopropoxy)-, (11.beta.)- Higher priority based on available information - Environmental concern Clarification required TBD
73772-45-9 1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[(1-oxodecyl)amino]-, inner salt Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
73772-46-0 1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[(1-oxooctyl)amino]-, inner salt Higher priority based on available information - Environmental concern Clarification required TBD
7400-08-0 2-Propenoic acid, 3-(4-hydroxpheyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
74103-07-4 1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
7413-34-5 L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, sodium salt (1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
7414-83-7 Phosphonic acid, P,P'-(1-hydroxyethylidene)bis-, sodium salt (1:2) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
74191-85-8 Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](2,3-dihydro-1,4-benzodioxin-2-yl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
742087-55-4 Steroids, soya hydroxy, 12-hydroxyoctadecanoates Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
74315-67-6 Amylopectin, 2-hydroxypropyl ether Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
7440-56-4 Germanium Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
7446-27-7 Phosphoric acid, lead(2+) salt (2:3) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
74464-83-8 2-Pyridineacetamide, .alpha.-[2-[bis(1-methylethyl)amino]ethyl]-.alpha.-phenyl-, (.alpha.R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
74504-65-7 1,2,3-Propanetriol, homopolymer, decanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
74563-64-7 1,2,3-Hexadecanetriol, 3,7,11,15-tetramethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
74578-69-1 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, sodium salt (1:2), (6R,7R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
7460-12-0 Benzenemethanol, .alpha.-​[(1S)​-​1-​(methylamino)​ethyl]​-​, (.alpha.S)​-​, sulfate (2:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
74610-55-2 Tylosin, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
74811-65-7 Croscarmellose sodium Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
748142-30-5 Octadecanoic acid, 12-hydroxy-, homopolymer, ester with 1,1'-[oxybis[2,2-bis(hydroxymethyl)-3,1-propanediyl]] didocosanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
7492-32-2 Benzenepropanaminium, .gamma.-(aminocarbonyl)-N-methyl-N,N-bis(1-methylethyl)-.gamma.-phenyl- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
7492-68-4 Carbonic acid, copper salt Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
75018-70-1 Ethanesulfonic acid, 2-[[[[(3.alpha.,5.beta.,7.alpha.,12.alpha.,20S)-3,7,12-trihydroxy-20-methylpregnan-21-yl]seleno-75Se]acetyl]amino]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
75248-76-9 2-Butenoic acid, polymer with ethenyl acetate and ethenyl 4-(1,1-dimethylethyl)benzoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
752-56-7 Riboflavin, 2',3',4',5'-tetrabutanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
75330-75-5 Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
7541-59-5 1,2,3,4-Butanetetrol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
7542-37-2 D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1→3)-O-.beta.-D-ribofuranosyl-(1→5)-O-[2-amino-2-deoxy-.alpha.-D-glucopyranosyl-(1→4)]-2-deoxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
7554-65-6 1H-Pyrazole, 4-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
75607-67-9 9H-Purin-6-amine, 2-fluoro-9-(5-O-phosphono-.beta.-D-arabinofuranosyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
756819-45-1 Siloxanes and Silicones, di-Me, mono[3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl] group-terminated, polymers with Bu methacrylate, 2-ethylhexyl acrylate and Me methacrylate Higher priority based on available information - Human health concern A Notice or Order has been published indicating that the Significant New Activity (SNAc) provisions of the Canadian Environmental Protection Act, 1999 apply to this substance Removed from R-ICL
75706-12-6 4-Isoxazolecarboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
75760-37-1 2-Propenoic acid, 2-methyl-, polymer with ethyl 2-propenoate and .alpha.-(2-methyl-1-oxo-2-propenyl)-.omega.-(octadecyloxy)poly(oxy-1,2-ethanediyl) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
75911-79-4 Bicyclo[3.2.1]octan-8-ol, 1,5-dimethyl-, 8-acetate Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
76009-37-5 9-Octadecenoic acid (9Z)-, diester with hexaglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
762-26-5 4,8-Decadienal, 5,9-dimethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
76-25-5 Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11.beta.,16.alpha.)- Higher priority based on available information - Environmental concern Clarification required TBD
76-38-0 Ethane, 2,2-dichloro-1,1-difluoro-1-methoxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
76414-35-2 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-trioctyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
76420-72-9 L-Proline, N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl- Higher priority based on available information - Environmental concern Clarification required TBD
76-42-6 Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5.alpha.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
7651-99-2 Phosphonic acid, P,P',P",P"-[1,2-ethanediylbis[nitrilobis(methylene)]]tetrakis-, sodium salt (1:5) Higher priority based on available information - Environmental concern Clarification required TBD
76547-98-3 L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
76584-70-8 Pentanoic acid, 2-propyl-, sodium salt (2:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
7659-95-2 2,6-Pyridinedicarboxylic acid, 4-[2-[(2S)-2-carboxy-5-(.beta.-D-glucopyranosyloxy)-2,3-dihydro-6-hydroxy-1H-indol-1-yl]ethenyl]-2,3-dihydro-, (2S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
7675-83-4 L-Aspartic acid, compd. with L-arginine (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
7681-78-9 Cyclohexanaminium, 4,4'-methylenebis[N,N,N-trimethyl-, diiodide Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
7681-93-8 6,11,28-Trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 22-[(3-amino-3,6-dideoxy-b-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-, (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
76932-56-4 Luteinizing hormone-releasing factor (swine), 6-[3-(2-naphthalenyl)-D-alanine]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
76963-41-2 1,1-Ethenediamine, N'-[2-[[[2-[(dimethylamino)methyl]-4-thiazolyl]methyl]thio]ethyl]-N-methyl-2-nitro- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
7704-67-8 Erythromycin, thiocyanate (salt) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
7704-71-4 2-Butenedioic acid (2E)-, magnesium salt (1:?) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
7704-72-5 2-Butenedioic acid (2E)-, potassium salt (1:?) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
7704-73-6 2-Butenedioic acid (2E)-, sodium salt (1:?) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
770691-21-9 Gadolinium, [rel-10-[(2R,3S)-2-(hydroxy-κO)-3-hydroxy-1-(hydroxymethyl) propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)- .kappa.N1,.kappa.N4,.kappa.N7,.kappa.N10,.kappa.O1,.kappa.O4,.kappa.O7]-, (SA-8-1425362'5')- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
7718-51-6 2-Butenedioic acid (2E)-, calcium salt (1:?) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
7732-97-0 Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, diheptanoate Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
7757-81-5 2,4-Hexadienoic acid, sodium salt (1:1), (2E,4E)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
7757-87-1 Phosphoric acid, magnesium salt (2:3) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
7757-96-2 2,5-Furandione, dihydro-3-(1-octenyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
7773-03-7 Sulfurous acid, potassium salt (1:1) Higher priority based on available information - Environmental and human health concern Clarification required TBD
7776-28-5 myo-Inositol, hexakis(dihydrogen phosphate), calcium salt (1:6) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
7783-84-8 Phosphinic acid, iron(3+) salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
77851-07-1 2-cyclohexene-1-carboxylic acid, 2,3,6,6-tetramethyl-, ethyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
78822-40-9 L-​threo-​.alpha.-​D-​galacto-​Octopyranoside, methyl 7-​chloro-​6,​7,​8-​trideoxy-​6-​[[[(2S,​4R)​-​4-​ethyl-​2-​piperidinyl]​carbonyl]​amino]​-​1-​thio-​, hydrochloride (1:1) Higher priority based on available information - Environmental concern Clarification required TBD
77883-43-3 Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](2,3-dihydro-1,4-benzodioxin-2-yl)-, methanesulfonate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
7789-46-0 Iron bromide (FeBr2) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
7790-44-5 Stibine, triiodo- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
77923-28-5 Cyclododecane, (2-methoxyethoxy)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
77940-93-3 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester, (4S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
78103-84-1 1-Naphthalenecarbonitrile, 1,2,3,4-tetrahydro-4,4-dimethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
78110-38-0 Propanoic acid, 2-​[[(Z)​-​[1-​(2-​amino-​4-​thiazolyl)​-​2-​[[(2S,​3S)​-​2-​methyl-​4-​oxo-​1-​sulfo-​3-​azetidinyl]​amino]​-​2-​oxoethylidene]​amino]​oxy]​-​2-​methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
78246-49-8 Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride (1:1), (3S,4R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
78336-31-9 Poly(oxy-1,2-ethanediyl), .alpha.-(12-hydroxydodecyl)-.omega.-[(12-hydroxydodecyl)oxy]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
78415-72-2 [3,4'-Bipyridine]-5-carbonitrile, 1,6-dihydro-2-methyl-6-oxo- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
78418-01-6 2-hydroxy-5-(1-oxooctyl)-benzoic acid Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
78509-74-7 1-(hexadecyloxy)octadecan-2-ol) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
78616-98-5 Dodecanoic acid, 2-aminoethyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
78628-80-5 1-Naphthalenemethanamine, N-[(2E)-6,6-dimethyl-2-hepten-4-yn-1-yl]-N-methyl-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
78755-81-4 4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
78809-92-4 Chitosan, N-(3-carboxy-1-oxopropyl) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
79120-33-5 Litharge (PbO) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
79-17-4 Hydrazinecarboximidamide Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
79350-37-1 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-, (6R,7R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
79416-55-0 Docosanoic acid, 1,1'-(1,2-ethanediyl) ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
79449-98-2 4-Piperidinecarboxylic acid, 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-, (3R,4S)-rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
79458-68-7 Lysine, compd. with S-(carboxymethyl)-L-cysteine (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
79516-68-0 4-Piperidinecarboxylic acid, 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-, (3S,4R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
79547-78-7 4-Piperidinecarboxylic acid, 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-, hydrochloride (1:1), (3S,4R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
79548-73-5 L-threo-.alpha.-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-4-ethyl-2-piperidinyl]carbonyl]amino]-1-thio- Higher priority based on available information - Environmental concern Clarification required TBD
79559-97-0 1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride (1:1), (1S,4S)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
79617-96-2 1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1S,4S)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
79665-93-3 9-Octadecenoic acid (9Z)-, monoester with decaglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
797-63-7 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17.alpha.)- Higher priority based on available information - Environmental concern Clarification required TBD
79777-30-3 Octadecanoic acid, monoester with decaglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
79794-75-5 1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-, ethyl ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
79811-24-8 L-Glutamic acid, N-(1-oxooctadecyl)-, sodium salt (1:?) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
79902-63-9  Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
8000-26-8 Oils, pine needle Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8001-27-2 Hirudin Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8005-33-2 C.I. Natural Black 1 Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8007-48-5 Oils, sweet bay Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8007-56-5 Aqua regia Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
8013-00-1 Terpinene Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
80154-34-3 Benzaldehyde, 4-(.beta.-D-allopyranosyloxy)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
8015-61-0 Aloin Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
8016-24-8 Oils, hemp seed Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8016-55-5 Rhubarb, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8026-99-1 Oils, lime, sweet Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8027-43-8 Oils, birch bud Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8027-93-8 Carbonic acid, dipotassium salt, sulfurized Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8028-45-3 Glycerides, oxidized Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
80370-57-6 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-[[(2-furanylcarbonyl)thio]methyl]-8-oxo-, (6R,7R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
80435-42-3 Iron alloy, base, Fe 63-74,Cr 12.0-15.0,Ni 12.0-15.0,W 1.50-3.00,Mn 0-1.00,Si 0.30-0.80,C 0.35-0.50,Mo 0.20-0.50,P 0-0.045,S 0-0.030 (UNS S66009) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
80455-45-4 Cellulose, hexadecyl 2-hydroxyethyl ether Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
80474-14-2 Androsta-1,4-diene-17-carbothioic acid, 6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-, S-(fluoromethyl) ester, (6.alpha.,11.beta.,16.alpha.,17.alpha.)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
8049-47-6 Pancreatin Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8049-84-1 C.I. Natural Green 3 Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8049-97-6 Melanins Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8050-05-3 Milk Preparations, Yogurt Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8050-30-4 Wood rosin, ester with 1,2,3-propanetriol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8054-39-5 Onion, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8057-54-3 Thymus gland, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
8057-61-2 Kidney, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
808-48-0 Pregn-4-ene-3,20-dione, 21-(2,2-dimethyl-1-oxopropoxy)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
80892-32-6 2-Propenoic acid, 2-methyl-, polymer with diethylbenzene (pharmaceutical grade) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
81025-04-9 D-Glucitol, 4-O-.beta.-D-galactopyranosyl-, hydrate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
81103-11-9 Erythromycin, 6-O-methyl- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
81131-70-6 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-.beta.,.delta.,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, sodium salt (1:1), (.beta.R,.delta.R,1S,2S,6S,8S,8aR)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
81403-80-7 2-Furancarboxamide, N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
81409-90-7 Ergoline-8-carboxamide, N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-, (8.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
81752-33-2 Isooctadecanoic acid, monoester with oxybis[propanediol] Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
81782-89-0 6,8-Nonadien-3-one, 2,4,4,7-tetramethyl Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
81783-01-9 6,8-Nonadien-3-one,2,4,4,7-tetramethyl-,oxime Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
81818-54-4 1,4-Naphthalenedione, 2-methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
81897-25-8 Isooctadecanoic acid, 2-ethylhexyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
81907-73-5 3-Cyclopentene-1-acetic acid, 2,2,3-trimethyl-, ethyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
82009-34-5 2-Heptenoic acid, 7-[[(2R)-2-amino-2-carboxyethyl]thio]-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-, (2Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
820212-37-1 Siloxanes and Silicones,di-Me, hexacosyl Me Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
82030-87-3 Somatotropin (human), N-L-methionyl- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
82048-29-1 1-Piperidinyloxy, 4-[(3-carboxy-1-oxopropyl)amino]-2,2,6,6-tetramethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
820-66-6 1-Octadecanaminium, N-(carboxymethyl)-N,N-dimethyl-, inner salt Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
82097-50-5 Benzenesulfonamide, 2-(2-chloroethoxy)-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
82204-94-2 L-Glutamic acid, N-(1-oxododecyl)-, 1,5-bis(2-octyldodecyl) ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
82248-59-7 Benzenepropanamine, N-methyl-.gamma.(2-methylphenoxy)-, hydrochloride (1:1), (.gamma.R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
82249-33-0 Hexanedioic acid, 3-(2,3-dihydroxypropyloxy)-2-hydroxypropyl diester, esters from reaction with a mixture of octanoic, decanoic, isooctadecanoic, octadecanoic and 12-hydroxyoctadecanoic acids Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
82410-32-0 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
82419-36-1 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
82586-55-8 3-Isoquinolinecarboxylic acid, 2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-, hydrochloride (1:1), (3S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
82640-04-8 Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
827306-88-7 L-Lysinamide, N2-acetyl-L-lysylglycyl-L-histidyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
82752-99-6 3H-1,2,4-Triazol-3-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochloride Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
827596-80-5 Octadecanoic acid, 12-hydroxy-, polymer with oxirane, triblock Higher priority based on available information - Environmental and human health concern Clarification required TBD
82980-39-0 Glycerides, wheat germ-oil Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
83016-76-6 2-Propanol, 1-amino-, compd. with .alfa.-sulfo-.omega.-(dodecyloxy) poly (oxy-1, 2-ethanediyl) (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
83120-95-0 2-Propenoic acid, 2-methyl-, dodecyl ester, polymer with 1-ethenyl-2-pyrrolidinone and 2-propenoic acid Higher priority based on available information - Human health concern Commercial activity identified To be assessed
83150-76-9 L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide Higher priority based on available information - Environmental concern Clarification required TBD
832-01-9 2-Propenoic acid, 3-(4-methoxyphenyl)-, methyl ester Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
83271-10-7 Dextrin, hexadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
83-43-2 Pregna-​1,​4-​diene-​3,​20-​dione, 11,​17,​21-​trihydroxy-​6-​methyl-​, (6.alpha.,​11.beta.)​- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
83-46-5 stigmast-5-en-3-ol, (3-.beta.)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
83-48-7 Stigmasta-5,22-dien-3-ol, (3.beta.,22E)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
83512-85-0 Chitosan, N-(carboxymethyl) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
83615-24-1 Cholest-5-en-3-ol (3.beta.)-, 3-isooctadecanoate Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
83-67-0 1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
83684-11-1 Phosphonic acid, mono(3-methyloxiranyl) ester, (2R-cis)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
83-73-8 8-Quinolinol, 5,7-diiodo- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
83763-47-7 Ethanol, 2-[(3-amino-4-methoxyphenyl)amino]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
83763-48-8 Ethanol, 2-[(3-amino-4-methoxyphenyl)amino]-, sulfate (1:1) Higher priority based on available information - Environmental and human health concern Clarification required TBD
83826-43-1 Tetradecanoic acid, octyldodecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
83881-52-1 Acetic acid, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, hydrochloride (1:2) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
83898-65-1 2H-Benzimidazol-2-one, 5-chloro-1-[1-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-4-piperidinyl]-1,3-dihydro-, (2Z)-2-butenedioate (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
83905-01-5 1-Oxa-6-azacyclopentadecan-15-one, 13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]-, (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
83919-23-7 Pregna-1,4-diene-3,20-dione, 9,21-dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methyl-, (11.beta.,16.alpha.)- Higher priority based on available information - Environmental concern Clarification required TBD
84012-19-1 Eggplant, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84012-22-6 Hieracium pilosella, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84012-36-2 Polygonum bistorta, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84012-38-4 Ruscus aculeatus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84-02-6 10H-Phenothiazine, 2-chloro-10-[3-(4-methyl-1-piperazinyl)propyl]-, (2Z)-2-butenedioate (1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
84041-77-0 Ethanol, 2,2'-[(2-nitro-1,4-phenylene)diimino]bis- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
84057-84-1 1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
84069-44-3 Chitosan, 2-hydroxypropyl ether Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
84082-55-3 Lupine, L. albus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84082-60-0 Matricaria recutita, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84082-61-1 Melissa officinalis extract Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84082-63-3 Menyanthes trifoliata, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84082-68-8 Myristica fragrans, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84366-81-4 Riboflavin 5'-(trihydrogen diphosphate), P'→5'-ester with adenosine, disodium salt Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
84449-90-1 Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
84563-62-2 Chitosan, hexanedioate (salt) Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
84603-54-3 Calluna vulgaris, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84603-61-2 Hawthorn, Crataegus oxyacantha, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84603-73-6 Laurus nobilis, ext Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84604-04-6 Polygonum aviculare, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84604-07-9 Prunus serotina, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84604-12-6 Rose, Rosa centifolia, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84604-13-7 Rose, Rosa gallica, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84604-15-9 Sabal serrulatum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84604-16-0 Saccharomyces cerevisiae, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84604-17-1 Saffron, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84604-20-6 Silybum marianum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84605-10-7 13-Docosenoic acid, isooctadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
84605-12-9 13-Docosenoic acid, 13-docosenyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
84608-82-2 2-hydroxy-3-(oleoyloxy) propyl 5-oxo-L-prolinate Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
84625-28-5 Ash (Fraxinus), F. excelsior, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84625-36-5 Euphrasia officinalis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84625-39-8 Fennel ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84625-42-3 Galium aparine, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
*84625-48-9/ 84929-75-9 Rhamnus frangula, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84625-61-6 3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
84642-57-9 Cyclopentanone, 2-[(3,3,5-trimethylcyclohexyl)acetyl]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
84643-53-8 1-Hexadecanaminium, 2-hydroxy-N-(2-hydroxyethyl)-N,N-dimethyl-, chloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
84649-82-1 Aloe ferox, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84649-87-6 Arctium majus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84649-90-1 Asparagus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84649-91-2 Avens, Geum urbanum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84649-93-4 Barosma Betulina, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84649-96-7 Boldo, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84649-98-9 Cinnamomum zeylanicum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84649-99-0 Cocoa, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84650-07-7 Galega officinalis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84650-11-3 Geranium robertianum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84650-12-4 Ginseng, Panax pseudoginseng, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84650-13-5 Guaiacum officinale, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84650-18-0 Nepeta hederacea, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84650-41-9 Pterocarpus santalinus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84650-55-5 Rhamnus purshiana, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84681-71-0 Rape oil, hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84695-94-3 Alchemilla vulgaris, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84695-96-5 Ammi visnaga, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84696-01-5 Cola Nitida, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84696-12-8 Eleutherococcus senticosus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84696-13-9 Fucus vesiculosus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84696-20-8 Horehound, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84696-27-5 Nymphaea alba, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84696-40-2 Pepper (Piper), P. methysticum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84696-50-4 Solanum dulcamara, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
*84696-51-5/ 90064-01-0 Spearmint, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84750-06-1 Octadecanoic acid, monoester with 1,2,3-propanetriol, mixt. with .alpha.-(1-oxooctadecyl)-.omega.-hydroxypoly(oxy-1,2-ethanediyl) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
84753-08-2 1, 3-bis (2-ethylhexyl) cyclohexane Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
84775-42-8 Anise, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84775-50-8 Coriander, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84775-51-9 Cumin, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84775-54-2 Cypripedium calceolus pubescens, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84775-57-5 Filipendula ulmaria, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84775-63-3 Indigofera tinctoria, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84775-71-3 Ocimum basilicum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84775-83-7 Sage, Salvia sclarea, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84775-94-0 Radish, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84775-95-1 Rhatany, Krameria triandra, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84775-96-2 Roselle, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84776-25-0 Cetraria islandica, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84776-26-1 Cimicifuga racemosa, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84776-30-7 Combretum micranthum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84776-64-7 Jasmine, Jasminum grandiflorum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
847-84-7 3-Hexanone, 6-(dimethylamino)-4,4-diphenyl-, hydrochloride Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
84787-64-4 Anacyclus pyrethrum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84787-66-6 Condurango, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84787-71-3 Sanguisorba officinalis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84837-08-1 Aloe, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84878-33-1 Isononanoic acid, hexadecyl ester Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
84878-34-2 Isononanoic acid, octadecyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
84878-61-5 2H-Pyran-2-acetic acid, 6-[(1R)-1-[(2S,5R,7S,8R,9S)-2-[(2S,2'R,3'S,5R,5'R)-3'-[(2,6-dideoxy-3,4-di-O-methyl-.beta.-L-arabino-hexopyranosyl)oxy]octahydro-2-methyl-5'-[(2S,3S,5R,6S)-tetrahydro-6-hydroxy-3,5,6-trimethyl-2H-pyran-2-yl][2,2'-bifuran]-5-yl]-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]dec-7-yl]ethyl]tetrahydro-2-hydroxy-4,5-dimethoxy-3-methyl-, ammonium salt (1:1), (2R,3S,4S,5R,6S)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
84929-28-2 Guarana, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84929-30-6 Lawsonia inermis alba, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84929-34-0 Myrica cerifera, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84929-35-1 Nepeta cataria, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84929-42-0 Pine, Pinus maritima, ext Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84929-46-4 Ptychopetalum olacoides, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84929-54-4 Viburnum prunifolium, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84929-57-7 Allspice, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84929-68-0 Morinda citrifolia, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84929-76-0 Rubus idaeus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84929-78-2 Strawberry, Fragaria vesca, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84961-45-5 Ceratonia siliqua, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84961-57-9 Pomegranate, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84961-62-6 Tamarind, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84961-64-8 Tanacetum vulgare, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
84988-87-4 Glycerides, Vegetable Oil Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85005-44-3 Glycerides, lanolin Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85066-57-5 Poly(oxy-1,2-ethanediyl), .alpha.-(1-oxooctadecyl)-.omega.-(octadecyloxy)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
85085-21-8 Astragalus gummifer, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85085-23-0 Beeswax, saponified Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85085-31-0 Eriodictyon glutinosum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85085-34-3 Fir, Abies balsamea, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85085-46-7 Lycium barbarum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85085-48-9 Melaleuca alternifolia, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85085-51-4 Nelumbo nucifera, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85085-54-7 Cyperus rotundus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85116-63-8 Aloysia triphylla, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85116-74-1 Cerebrosides Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85116-75-2 Hemlock (poison), ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85117-06-2 Goldenrod, Solidago virgaurea, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85117-13-1 Quince, Cydonia oblonga, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85186-76-1 Fatty acids, C14-18 and C18-unsatd., branched and linear, 2-ethylhexyl esters Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85187-05-9 Senna, Cassia angustifolia, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85-19-8 Methanone, (5-chloro-2-hydroxyphenyl)phenyl- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
85251-63-4 Apple, Malus sylvestris,ext Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85251-64-5 Barley, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85251-65-6 Beech, Fagus sylvatica, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85252-25-1 Benzoic acid, 2-hydroxy-, isodecyl ester Higher priority based on available information - Environmental concern Clarification required TBD
85264-33-1 1H-Pyrazole-1-methanol, 3,5-dimethyl- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
85305-88-0 Ceramide, 1-O-.beta.-D-galactopyranosyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
85392-03-6 5-Decenoic acid Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
85392-04-7 6-Decenoic acid Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
85392-05-8 5-Decenoic acid, 1-butyl-5-carboxypentyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
85392-06-9 6-Decenoic acid, 1-butyl-5-carboxypentyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
853947-59-8 Decanoic acid, reaction products with 1,3-butanediol and octanoic acid Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
85441-61-8 3-Isoquinolinecarboxylic acid, 2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-, (3S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
85480-28-0 Hexanedioic acid, isodecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
85480-47-3 Acorus calamus, ext., hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
855310-95-1 Octadecanoic acid, 12-hydroxy-homopolymer, ester with 2,2-(oxybis(methylene))bis(2-(hydroxymethyl)-1,3-propanedriol)(3:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
85536-07-8 Glycerides, C8-10 mono- and di- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85536-23-8 Amides, rape-oil, N-(hydroxyethyl), ethoxylated On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
85563-48-0 1-Hexadecanaminium, N-(2-hydroxyethyl)-N,N-dimethyl-, phosphate (1:1) (salt) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
85586-07-8 Sulfuric acid, mono-C12-14-alkyl esters, sodium salts Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
85586-30-7 Glycerides, rape-oil mono- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85594-37-2 Grape, ext Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85-61-0 Coenzyme A Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85622-93-1 Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
*85650-52-8/ 61337-67-5 Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
85-70-1 1,2-Benzenedicarboxylic acid, 1-(2-butoxy-2-oxoethyl) 2-butyl ester Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
85711-58-6 Lecithins, hydrolyzed Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85711-76-8 Dodecanoic acid, hydrogenated castor-oil alkyl esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
85721-05-7 1-Piperazineethanol, 4-[(3Z)-3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]-, acetate (ester) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
85721-33-1 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
85765-48-6 Ethanol, 2-[4-[(2-aminoethyl)amino]-3-nitrophenoxy]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
85895-78-9 Propanoic acid, 2-hydroxy-, potassium salt (1:1), (2S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
85940-31-4 Caraway, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85940-33-6 Carlina acaulis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
85940-38-1 Ephedra sinica, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
86050-77-3 D-Glucitol, 1-deoxy-1-(methylamino)-, [N,N-bis[2-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.N]ethyl]glycinato(5-)-.kappa.N,.kappa.O]gadolinate(2-) (2:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
861407-54-7 Octanoic acid, 5,7,7-trimethyl-2-(1,3,3-trimethylbutyl)-,2-[[3-hydroxy-2,2-bis[[[5,7,7-trimethyl-1-oxo-2-(1,3,3-trimethylbutyl)octyl]oxy]methyl]propoxy]methyl]-2-[[[5,7,7-trimethyl-1-oxo-2-(1,3,3-trimethylbutyl)octyl]oxy]methyl]-1,3-propanediyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
86347-15-1 1H-Imidazole, 5-[1-(2,3-dimethylphenyl)ethyl]-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
86362-36-9 3-Pyridinecarboxylic acid, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
86386-73-4 1H-1,2,4-Triazole-1-ethanol, .alpha.-(2,4-difluorophenyl)-.alpha.-(1H-1,2,4-triazol-1-ylmethyl)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
86419-69-4 1,2-Ethanediamine, N1-(5-methoxy-2-nitrophenyl)-, hydrochloride (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
86481-08-5 Poly(oxy-1,2-ethanediyl), .alpha., .alpha'.-(1-methyl-1,2-ethanediyl)bis[.omega.-[[(9Z)-1-oxo-9-octadecenyl]oxy]- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
86541-74-4 1H-1-Benzazepine-1-acetic acid, 3-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, hydrochloride (1:1), (3S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
865-44-1 Iodine chloride (ICl3) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
86601-87-8 13-Docosenoic acid, tetracosyl ester, (13Z)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
866-82-0 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, copper(2+) salt (1:2) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
867301-59-5 Pikea robusta, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
86-75-9 8-Quinolinol, 8-benzoate Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
868047-49-8 Castor oil, hydrogenated, Isostearate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
86827-92-1 3,4-Thiophenediol, tetrahydro- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
86846-21-1 Poly(oxy-1,2-ethanediyl),.alpha.,.alpha'.,.alpha."-1,2,3-propanetriyltris[.omega.-[(1-oxoisooctadecyl)oxy]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
869-06-7 Butanedioic acid,2 hydroxy-,magnesium salt (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
869734-19-0 acids, Cannabis sativa seed-oil, esters with polyethylene glycol ether with glycerol (3:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
87-08-1 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-, (2S,5R,6R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
87-18-3 Benzoic acid, 2-hydroxy-, 4-(1,1-dimethylethyl)phenyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
872131-04-9 Divinyl sulfone cross-linked hyaluronan Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
87226-41-3 Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-, (1R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
87233-61-2 1H-Benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
87333-19-5 Cyclopenta[b]pyrrole-2-carboxylic acid, 1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-, (2S,3aS,6aS)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
87362-54-7 Bicyclo[3.3.1]nonan-1-ol, 5-methyl-, 1-acetate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
87390-32-7 Tetradecanoic acid, monoester with decaglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
875919-10-1 Fatty acids, limnanthes alba seed-oil, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-nonadecafluoro-1-[[(2-octyldodecyl)oxy]methyl]undecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
87679-37-6 1H-Indole-2-carboxylic acid, 1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-, (2S,3aR,7aS)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
877677-19-5 Rumex occidentalis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
87771-40-2 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)(2-hydroxyethyl)amino]-2,4,6-triiodo- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
87806-31-3 Photofrin Porfimer sodium Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
87-99-0 Xylitol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
88040-23-7 Pyrrolidinium, 1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-, inner salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
88103-59-7 13-Docosenoic acid, 2-octyldodecyl ester, (13Z)- Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
88120-12-1 Isooctadecanoic acid, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
88150-42-9 3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
88416-50-6 Phosphonic acid, (dichloromethylene)bis-, disodium salt, tetrahydrate Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
88598-53-2 .alpha.-D-Glucopyranose, 2-deoxy-6-O-[2-deoxy-2-[[(3R)-1-oxo-3-[(1-oxododecyl)oxy]tetradecyl]amino]-3-O-[(3R)-1-oxo-3-[(1-oxotetradecyl)oxy]tetradecyl]-4-O-phosphono-.beta.-D-glucopyranosyl]-2-[[(3R)-3-hydroxy-1-oxotetradecyl]amino]-, 3-[(3R)-3-hydroxytetradecanoate] Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
88768-40-5 6H-Pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid, 9-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]octahydro-10-oxo-, (1S,9S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
88845-49-2 Furcellaran, calcium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
88889-14-9 L-Proline, 4-cyclohexyl-1-[2-[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetyl]-, sodium salt (1:1), (4S)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
89141-50-4 Arsonodithious acid, [4-[(4,6-diamino-1,3,5-triazin-2-yl)amino]phenyl]-, bis(2-aminoethyl) ester, dihydrochloride Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
89365-50-4 1,3-Benzenedimethanol, 4-hydroxy-.alpha.1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
89786-04-9 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, (2S,3S,5R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
89957-43-7 Annatto tree, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89957-45-9 Anthyllis vulneraria, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89957-58-4 Artemisia abrotanum, ext Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89957-81-3 Avens, Geum rivale, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89957-84-6 Barberry, Berberis aristata, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89957-89-1 Beet, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89957-90-4 Beet, red, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89957-98-2 Boswellia carterii, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89958-09-8 Buckwheat, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89958-13-4 Cabbage, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89958-29-2 Carnation, Dianthus caryophyllus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89961-55-7 Poly(oxy-1,2-ethanediyl),.alpha.-(3-carboxy-1-oxosulfopropyl)-.omega.-[(9Z)- 9-octadecen-1-yloxy]-,sodium salt (1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
89997-35-3 Celery, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89997-53-5 Cherry, sour, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89997-65-9 Chrysanthemum parthenium, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89997-82-0 Cola acuminata, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89997-84-2 Collinsonia canadensis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89997-98-8 Crithmum maritimum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
89998-03-8 Cucurbita pepo, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9000-02-6 Amber Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9000-20-8 Kino, eucalyptus Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9000-21-9 Furcellaran Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9000-57-1 Resins, sandarac Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9000-58-2 Resins, scammony Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9001-01-8 Kallikrein Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
9001-12-1 Collagenase Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
9001-28-9 Blood-​coagulation factor IX Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9001-63-2 Lysozyme Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9001-77-8 Phosphatase, acid Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9001-78-9 Phosphatase, alkaline Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
9002-61-3 Gonadotropin, chorionic Higher priority based on available information - Environmental concern Clarification required TBD
9002-64-6 Parathormone Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
9002-70-4 Gonadotropin, pregnant mare serum Higher priority based on available information - Environmental concern Clarification required TBD
90027-90-0 Phoenix Dactylifera (Date) Fruit Extract Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90028-03-8 Dill, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90028-20-9 Echinacea purpurea, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90028-31-2 Epilobium angustifolium, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90028-32-3 Equisetum hyemale, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90028-68-5 Evernia prunastri, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
*9002-96-4/ 30999-06-5 Poly(oxy-1,2-ethanediyl), .alpha.-[4-[[(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-yl]oxy]-1,4-dioxobutyl]-.omega.-hydroxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
90038-01-0 1H-Imidazole, 5-[(2,3-dimethylphenyl)methyl]-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
9003-97-8 Polycarbophil calcium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
9004-30-2 Cellulose, carboxymethyl 2-hydroxyethyl ether Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
90045-23-1 Garcinia cambogia, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90045-46-8 Guava, Psidium guajava pyrifera, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90045-52-6 Hawthorn, Crataegus monogyna extract Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90045-73-1 Hirudo medicinalis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90045-89-9 Iris germanica florentina, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90045-98-0 Jojoba, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90045-99-1 Jujube, Zizyphus jujuba, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90046-08-5 Knautia arvensis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90046-12-1 Laminaria digitata, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9004-59-5

Cellulose, ethyl methyl ether
Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
9004-84-6 Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.-(tridecyloxy)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
90063-39-1 Ledum palustre, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90063-40-4 Lentil, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90063-50-6 Lilac, Syringa vulgaris, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90063-53-9 Linden, Tilia americana, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90063-56-2 Linden, Tilia vulgaris, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90063-58-4 Lithospermum officinale, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90063-83-5 Mandarin orange, tangerine, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90063-86-8 Mango, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90063-92-6 Melia azedarach, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90063-96-0 Mentha aquatica, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90063-97-1 Mentha arvensis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90064-03-2 Mercurialis perennis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90064-11-2 Mulberry, Morus nigra, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90064-35-0 Nymphaea odorata, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9006-52-4 Tannins, albumin complexes Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
9008-02-0 Hemoglobins Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90082-21-6 Opuntia ficus-indica, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90082-36-3 Panicum miliaceum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90082-41-0 Pea, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90082-59-0 Pepper (Piper)​, P. cubeba, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90082-75-0 Pine, Pinus pinaster, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90082-77-2 Pine, Pinus strobus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90082-86-3 Plantain, Plantago ovata, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90082-87-4 Plum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90082-95-4 Polygala senega latifolia, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9008-30-4 Lysophosphatidylcholines Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90083-08-2 Potato, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9009-32-9 1,2,3-Propanetriol, homopolymer, octadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
9009-65-8 Protamines, sulfates Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
90105-89-8 Prickly ash, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90105-92-3 Prunella vulgaris, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90106-13-1 Rauwolfia serpentina, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90106-16-4 Reseda luteola, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90106-20-0 Rhododendron chrysanthum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90106-33-5 Rhus glabra, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90106-41-5 Rumex crispus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90106-48-2 Rye, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9010-66-6 Zeins Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90106-66-4 Scutellaria galericulata, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90106-68-6 Sea buckthorn, Hippophae rhamnoides, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90131-20-7 Sorbus domestica, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90131-25-2 Spinach, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90131-34-3 Stellaria media, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90131-43-4 Tagetes erecta, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90131-48-9 Terminalia chebula, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90131-49-0 Terminalia sericea, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90131-55-8 Teucrium scorodonia, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90131-58-1 Thuya occidentalis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90131-68-3 Tribulus terrestris, ext Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90147-43-6 Withania somnifera, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90147-49-2 Yam, Dioscorea villosa, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90147-58-3 Yucca filamentosa, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90170-45-9 L-Alanine, N-coco acyl derivs., sodium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
90170-86-8 L-Aspartic acid, N-coco acyl derivs., sodium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
9022-75-7 Poly[oxy[hydroxymethyl)-1,2-ethanediyl]], .alpha.-dodecyl-.omega.-hydroxy- Higher priority based on available information - Human health concern Commercial activity identified To be assessed
9024-52-6 Aldolase, fructose diphosphate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9025-35-8 Galactosidase, .alpha.- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90274-24-1 Benzenemethanol, 4-hydroxy-a-[[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]methyl]-, hydrochloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
90283-04-8 1-Dodecanaminium, N-[2-(dodecyloxy)-2-oxoethyl]-N,N-dimethyl-, chloride Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
90320-32-4 Alisma plantago, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90320-42-6 Alpinia officinarum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90357-06-5 Propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
9036-66-2 D-Galacto-L-arabinan Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9036-88-8 D-Mannan Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90387-74-9 Glycine, N-coco acyl derivs., sodium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
90-39-1 7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine, dodecahydro-, (7S,7aR,14S,14aS)- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
9039-53-6 Kinase (enzyme-activating), uro- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
90411-66-8 Hexanoic acid, 2-ethyl-, C12-15-alkyl esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
90411-68-0 Hexanoic acid, 2-ethyl-, C16-18-alkyl esters Higher priority based on available information - Human health concern Commercial activity identified To be assessed
9041-22-9 .beta.-D-Glucan Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9042-08-4 Rennets Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
9042-14-2 Dextran, hydrogen sulfate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9044-05-7 Dextran, carboxymethyl ether Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
9045-23-2 Lactoglobulins, .beta- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9046-38-2 D-Galacturonan Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9048-49-1 HUMAN ALBUMIN Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9050-93-5 .beta.-D-Glucan, (1→3)-, carboxymethyl ether, sodium salt Higher priority based on available information - Human health concern Clarification required TBD
*9051-97-2/ 9050-90-2/ 9052-00-0/ 31667-87-5/ 199665-06-0 .beta.-D-Glucan, (1→3)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90529-57-0 1-Propanaminium, 3-amino-N-ethyl-N,N-dimethyl-, N-soya acyl derivs., Et sulfates Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
9057-02-7 Pullulan (A polysaccharide polymer consisting of .alpha.-1,4-; .alpha.-1,6-glucan units) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
90604-34-5 Alcohols, C20-22 Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
90604-49-2 Sweetsop, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90604-80-1 Zirconium, chloro glycine hydroxy aluminum complexes Higher priority based on available information - Environmental and human health concern Clarification required TBD
9061-82-9 Carrageenan, sodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9062-73-1 Sorbitan, dodecanoate, poly(oxy-1,2-ethanediyl) derivs. Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
9065-63-8 Oxirane, methyl-, polymer with oxirane, butyl ether Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
9074-78-6 .alpha.-D-Glucan Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
9079-02-1 Natto Gum Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90-81-3 Benzenemethanol, .alpha.-[(1R)-1-(methylamino)ethyl]-, (.alpha.S)-rel- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
90817-34-8 2,3-Pyridinediamine, 6-methoxy-N2-methyl- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
90967-66-1 Hexanoic acid, 3,5,5-trimethyl-, isooctadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
90990-01-5 Connective tissue, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
90990-05-9 Fatty acids, avocado-oil, iso-Pr esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
90990-06-0 Fatty acids, avocado-oil, isooctadecyl esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
90990-08-2 Fatty acids, C8-18 Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91031-35-5 Fatty acids, C16-18, esters with propylene glycol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
91031-45-7 Fatty acids, C16-18, 1, 2-ethanediylbis (oxy-2, 1-ethanediyl) esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
91031-63-9 Fatty acids, C16-18, magnesium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91032-11-0 Fatty acids, C12-20, reaction products with triethanolamine,di-Me sulfate-quaternized Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
91052-14-1 Glycerides C16-18 and C-18 unsatd.mono-and di-,acetates Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
91052-16-3 Glycerides, C16-18 and C18-unsatd. mono- and di-, citrates On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
91052-49-2 Glycerides, C12-18 mono- and di- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91052-83-4 Glycerides, sunflower-oil mono- and di-, 2,3-bis(acetyloxy)butanedioates Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91069-37-3 1-Oxaspiro[4.5]decan-2-one, 8-methyl-, cis- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
91069-38-4 1-Oxaspiro[4.5]decan-2-one, 8-methyl-, trans- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
91069-39-5 1-Oxaspiro[4,5]decan-2-one, 8-ethy-,cis- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
91069-40-8 1-Oxaspiro [4,5]decan-2-one,8-ethyl-,trans- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
*91078-95-4/ 8016-14-6 Fats and Glyceridic oils, fish, hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91079-91-3 Protein hydrolyzates, fish Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
911484-90-7 1,3-Benzenedicarboxylic acid, 5-sulfo-, polymer with 1,3-benzenedicarboxylic acid, 1,4-cyclohexanedimethanol and 2,2'-oxybis[ethanol], sodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
91161-71-6 1-Naphthalenemethanamine, N-[(2E)-6,6-dimethyl-2-hepten-4-yn-1-yl]-N-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
91374-20-8 2H-Indol-2-one, 4-[2-(dipropylamino)ethyl]-1,3-dihydro-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
91374-21-9 2H-Indol-2-one, 4-[2-(dipropylamino)ethyl]-1,3-dihydro- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
915223-67-5 Siloxanes and Silicones, di-Me, Me 3,3,4,4,5,5,6,6,6-nonafluorohexyl, Me stearyl Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
91648-56-5 Ethanol, 2-(2-ethoxyethoxy)-, 2"-[(C12-15-branched and linear alkyl)oxy] derivs., hydrogen sulfates, sodium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
91-68-9 Phenol, 3-(diethylamino)- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
91722-22-4 Sugarcane, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91722-67-7 Larrea divaricata, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91723-14-7 Glycerides, sunflower-oil mono- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91744-23-9 Glycerides, C16-18 and C18-unsatd. mono-, di- and tri-, citrates, potassium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91744-28-4 Glycerides, C12-18 di- and tri- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91744-32-0 Glycerides, C8-10 mono-, di- and tri- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91744-36-4 Glycerides, C16-18 mono-, di- and tri-, citrates Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91744-38-6 Glycerides, C16-​18 mono-​, di- and tri-​, hydrogenated, citrates, potassium salts Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91744-48-8 Glycerides, lard mono-, di- and tri-, hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91744-56-8 Glycerides, mixed C8-10 and succinyl Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
91744-68-2 Glycerides, palm-oil mono-, di- and tri-, hydrogenated, citrates Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91745-12-9 Adansonia digitata, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91770-13-7 Hierochloe odorata, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91770-19-3 Loquat, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91770-22-8 Maple, Acer saccharum, ext Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91770-69-3 Spruce, Picea abies, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91771-33-4 Bambusa vulgaris, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91771-60-7 Cryptomeria japonica, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91824-88-3 Isooctadecanoic acid, monoester with tetraglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
91845-22-6 Helichrysum stoechas, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91845-35-1 Ocimum sanctum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
91995-81-2 Fatty acids, C10-20 and C16-18-unsatd., reaction products with triethanolamine,di-Me sulfate-quaternized Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
92045-76-6 Paraffin waxes and Hydrocarbon waxes, microcryst., hydrotreated Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
92045-77-7 Petrolatum (petroleum), hydrotreated Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
92128-82-0 Laminaria,ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
92128-87-5 Lecithins, hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
92134-98-0 2,4-Imidazolidinedione, 5,5-diphenyl-3-[(phosphonooxy)methyl]-, disodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
92-13-7 2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S,4R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
921608-21-1 Castor oil, hydrogenated, 12-hydroxyoctadecanoate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
92201-55-3 Cedrus atlantica, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
92201-88-2 Imidazolium compounds, 2-(C9-19 and C9-19-unsatd. alkyl)-1-[(C10-20 and C10-20-unsatd. amido)ethyl]-4,5-dihydro-1-Me, Me sulfates Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
92202-01-2 Olive oil, reaction products with sorbitol Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
922708-02-9 Eicosanedioc Acid,1,20-bis(23-Dihydroxypropyl)ester,Tridocosanoate Monoisooctadecanoste Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
92276-53-4 Propanesulfonic acid, amino- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
92339-11-2 1,3-Benzenedicarboxamide, 5,5'-[(2-hydroxy-1,3-propanediyl)bis(acetylimino)]bis[N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
92346-80-0 Acanthopanax senticosus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
92348-62-4 Octanoic acid, hydroxy- Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
92456-63-8 Actinidia chinensis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
92456-72-9 Cassava, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
92457-01-7 Gardenia jasminoides, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
92457-12-0 Jojoba, ext., hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
92665-29-7 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1-propen-1-yl)-, (6R,7R)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
92731-30-1 Mucopolysaccharides, heparinoids, duodenum, mucosa Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
92759-13-2 Cinchonan-9-ol, 6'-methoxy-, pentanoate (ester), (8.alpha.,9R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
*92761-26-7/ 90457-82-2 Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 3,3'-(1,4-phenylenedimethylidyne)bis[7,7-dimethyl-2-oxo- Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
92880-86-9 Furcellaran, potassium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
92880-87-0 Furcellaran, sodium salt Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
92952-81-3 Phenol, 4-[(3-hydroxypropyl)amino]-3-nitro- Higher priority based on available information - Environmental and human health concern Clarification required TBD
93106-60-6 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
93107-08-5 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrochloride (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
93164-89-7 Bacopa monnieri, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
93165-11-8 Commiphora mukul, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
93166-05-3 1-Propanaminium, N-(2-aminoethyl)-N-(carboxymethyl)-2-hydroxy-N-(2-hydroxyethyl)-3-(phosphonooxy)-, N-C6-18 acyl derivs., inner salts, disodium salts Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
93221-48-8 2-Propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-, (2S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
93379-54-5 Benzeneacetamide, 4-[(2S)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
93384-25-9 Ledum groenlandicum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
93384-34-0 Phospholipids, spinal cord Higher priority based on available information - Human health concern Identified for future survey TBD
93384-40-8 Sage, salvia hispanica, ext Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
93385-03-6 3,6,9,12-Tetraoxaoctacosan-1-ol, 11-methyl-, acetate Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
93385-12-7 Octadecanoic acid, 12-[(1-oxooctadecyl)oxy]-, isooctadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
93385-13-8 Ethanol, 2-[2-[2-[2-(isohexadecyloxy)propoxy]ethoxy]ethoxy]-, acetate Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
93385-14-9 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-triisohexadecyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
93413-44-6 Cyclohexanol, 1-[(1S)-2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
93413-69-5 Cyclohexanol, 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
93479-97-1 1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
93507-51-8 1-Propanaminium, 3-[(2-hydroxy-1-oxopropyl)amino]-N,N,N-trimethyl-, chloride (1:1) Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
93571-82-5 Fatty acids, C6-24 and C16-18-unsatd., esters with sucrose Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
93572-53-3 Fats and Glyceridic oils, menhaden, hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
93573-19-4 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tris(1-methyl-C11-17-alkyl) esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
936544-53-5 L-Argininamide, N-(1-oxohexadecyl)-L-histidyl-D-phenylalanyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
93685-96-2 Mimosa, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
93803-86-2 Isooctadecanoic acid, octyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
93820-81-6 Hexadecanoic acid, C16-18-alkyl esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
93820-97-4 Octadecanoic acid, C16-18-alkyl esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
93841-25-9 Benzeneethanol, 2,5-diamino-, sulfate (1:1) Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
93957-54-1 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, (3R,5S,6E)-rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
93957-55-2 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, sodium salt (1:1), (3R,5S,6E)-rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
93981-97-6 Hexanoic acid, 2-ethyl-, 1-methyl-1,2-ethanediyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
94089-18-6 Butanamide, 2,​4-​bis(acetyloxy)​-​N-​[3-​(acetyloxy)​propyl]​-​3,​3-​dimethyl-​, (2R)​- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94158-13-1 Ethanol, 2,2'-[(4-amino-3-nitrophenyl)imino]bis-, monohydrochloride Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
94158-14-2 Ethanol, 2-(1,3-benzodioxol-5-ylamino)-, hydrochloride (1:1) Higher priority based on available information - Environmental and human health concern Clarification required TBD
94167-02-9 Fucus serratus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94167-04-1 Linden, Tilia tomentosa, ext Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94167-05-2 Mulberry, Morus alba, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94201-19-1 1-Oxaspiro[4.5]decan-2-one, 8-methyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
94201-62-4 Docosanoic acid, 2-hydroxy-1,3-propanediyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
94218-72-1 Interleukin 2 (human clone pTIL2-21a protein moiety) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
94237-18-0 Butanedioic acid, 2,3-dihydroxy-, ditetradecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
94-24-6 Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
94247-26-4 Tetradecyl isooctadecanoate Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
94247-28-6 Docosanoic acid, isohexadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
94277-32-4 1,2-Hexadecanediol, 1,1'-(hydrogen phosphate), monosodium salt Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
94279-95-5 Prunus africana, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94279-99-9 Scutellaria baicalensis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94333-50-3 1-Cyclohexene-1-carboxylic acid, 2-ethyl-3,6,6-trimethyl-, ethyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
94333-51-4 Cyclohexanecarboxylic acid, 6-ethylidene-2,2,5-trimethyl-, ethyl ester Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
94334-08-4 Hedychium flavum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94334-35-7 Tuberose, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94349-62-9 Aloe barbasensis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94350-04-6 Protein hydrolyzates, flaxseed Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94350-05-7 Protein hydrolyzates, rice bran Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94350-06-8 Protein hydrolyzates, wheat germ Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94400-98-3 Naphth[2,3-b]oxirene, 1a,2,3,4,5,6,7,7a-octahydro-1a,3,3,4,6,6-hexamethyl-, (1aR,4S,7aS)-rel- Higher priority based on available information - Environmental and human health concern Clarification required TBD
94423-19-5 Octadecanoic acid, diester with triglycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
94-43-9 Mercury, (benzoato-O)phenyl- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
94465-74-4 Fomes officinalis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94465-78-8 Mytilus edulis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94465-79-9 Ostrea edulis, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94-51-9 1-Propanol, 3,3'-oxybis-, 1,1'-dibenzoate Higher priority based on available information - Human health concern Commercial activity identified To be assessed
94551-75-4 Protein hydrolyzates, tuna Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94749-08-3 2-Naphthalenecarboxylic acid, 1-hydroxy-, compd. with 4-hydroxy-.alpha.1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
94891-31-3 Quaternary ammonium compounds, di-C16-18-alkyldimethyl, salts with hectorite Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
94891-33-5 Benzenemethanaminium, N,N-dimethyl-N-octadecyl-, chloride, reaction products with hectorite Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
949109-75-5 Sterols, phytosterols Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94944-92-0 Eggs, salmon, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
94945-01-4 Gelidium cargilagineum, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
95009-14-6 Agaricus bisporus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
95058-81-4 Cytidine, 2'-deoxy-2',2'-difluoro- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
95094-00-1 2-Propanol, 1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-, (2S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
95193-70-7 Amines, N-(C8-18 and C18-unsatd. alkyl)trimethylenedi-, reaction products with 2-chloroethanol and sodium chloroacetate Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
95193-83-2 1H-Indene-1,3 (2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts Higher priority based on available information - Environmental and human health concern Clarification required TBD
95233-18-4 1,4-Naphthalenedione, 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
952500-62-8 Ophiopogon japonicus, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
95370-65-3 Proline, 5-oxo-, compd. with N2-coco acyl-L-arginine Et ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
95371-16-7 Sulfonic acids, C14-16-1-alkene, sodium salts Higher priority based on available information - Human health concern No commercial activity identified Removed from R-ICL
95382-33-5 Magnesium, bis[6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl-.kappa.O]-1H-benzimidazolato-.kappa.N3]-, (T-4)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
95576-89-9 1,2-Propanediol, 3-[(4-amino-2-chloro-5-nitrophenyl)amino]- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
95576-92-4 1,2-Propanediol, 3,3'-[(2-chloro-5-nitro-1,4-phenylene)diimino]bis- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
95-84-1 Phenol, 2-amino-4-methyl- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
958873-87-5 Ethanaminium, 2-Amino-N-(2-Aminoethyl)-N-[2-(2-Hydroxyethoxy)Ethyl]-N-Methyl-, N,N'-Di-Limnanthes Alba Seed-Oil Acyl Derivs., Me Sulfates(Salts) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
95912-87-1 Fatty acids, C16-18, C12-18-alkyl esters Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
96036-03-2 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[[(3S,5S)-5-[(dimethylamino)carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-, (4R,5S,6S)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
96055-45-7 2-Propenoic acid, 2-methyl-, polymer with diethenylbenzene, compd. with 3-[(2S)-1-methyl-2-pyrrolidinyl]pyridine Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
96081-39-9 Alkyl(C16-18)polyethyleneglycol tetra decylene glycolether Higher priority based on available information - Environmental and human health concern Commercial activity identified To be assessed
96352-58-8 .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl O-.alpha.-D-galactopyranosyl-(1-6)-, (9Z)-9-octadecenoate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
96499-68-2 Dodecanoic acid, monoester with oxybis[propanediol] Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
96507-89-0 Bifidobacterium longum, lysate Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
96507-91-4 Cardamom, Elettaria cardamomum miniscula, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
96684-40-1 .beta.-Cyclodextrin, compd. with 4-hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide (5:2) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
96690-56-1 Walnut, Juglans nigra, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
96829-58-2 L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
96-83-3 Benzenepropanoic acid, 3-amino-.alpha.-ethyl-2,4,6-triiodo- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
96840-56-1 Phenol, 2-ethoxy-4-[(1-methylethoxy)methyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
96946-41-7 Isoquinolinium, 2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1'R,2R,2'R)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
96946-42-8 Isoquinolinium, 2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-,1R,1'R,2R,2'R)-, benzenesulfonate (1:2) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
97-18-7 Phenol, 2,2'-thiobis[4,6-dichloro- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
97240-79-4 .beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
97281-48-6 Phosphatidylcholines, soya, hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
97281-59-9 Ulva lactuca, ext Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
97298-48-1 2-Butenedioic acid, 1, 4-bis (1-methylheptyl) ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
97338-28-8 Octadecanoic acid, 12-[(1-oxooctadecyl) oxy]-, isohexadecyl ester Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
97358-80-0 Isooctadecanoic acid, mono- and diesters with glycerol Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
97375-39-8 Zirconium, 4,5-dihydro-5-oxo-1-(4-sulfophenyl)-4-[(4-sulfophenyl)azo]-1H-pyrazole-3-carboxylate complexes Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
97468-37-6  5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[2-(4-pyridinylthio)acetyl]amino]-, (6R,7R')-, compd. with N,N'- bis(phenylmethyl)-1,2-ethanediamine (2:1) Higher priority based on available information - Environmental concern Clarification required TBD
97488-92-1 Glycerides, vegetable-oil mono- and di-, hydrogenated Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
97615-94-6 Fish, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
97722-02-6 Glycerides, tall-oil mono-, di-, and tri- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
97766-44-4 Swertia cordata, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
977-79-7 Pregna-4,6-diene-3,20-dione, 6,17-dimethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
97862-59-4 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-C8-18 acyl derivs., inner salts Higher priority based on available information - Environmental and human health concern A Ministerial Condition has been imposed on this substance Removed from R-ICL
97862-76-5 Foots oil (petroleum), carbon-treated Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
97862-89-0 Paraffin waxes (petroleum), carbon-treated Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
97862-97-0 Petrolatum (petroleum), carbon-treated Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
97867-33-9 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, compd. with 2-hydroxypropanoic acid (1:1) Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
97952-68-6 Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, salts with montmorillonite Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
97952-72-2 Salai, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
980-71-2 2-Pyridinepropanamine, .gamma.-(4-bromophenyl)-N,N-dimethyl-, (2Z)-2-butenedioate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
98106-71-9 Mandarin orange, Satsuma, ext. Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
98123-83-2 Pyrazino[2,1-a][2]benzazepin-4(1H)-one, 2-(cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydro- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
98133-47-2 Butanamide, 2,4-bis(acetyloxy)-N-[3-(acetyloxy)propyl]-3,3-dimethyl- Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
98319-26-7 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-(1,1-dimethylethyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)- Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
98530-12-2 Interferon .alpha.2 (human leukocyte clone pM21 protein moiety reduced) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
98530-76-8 Blood-coagulation factor XIVa (human protein moiety) Lower priority in the context of the R-ICL - based on available information no concern was identified No commercial activity identified Removed from R-ICL
98717-15-8 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, hydrochloride (1:1), (2S)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
98-96-4 2-Pyrazinecarboxamide Higher priority based on available information - Environmental concern Commercial activity identified To be assessed
99011-02-6 1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
990-73-8 Propanamide, N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
99-10-5 Benzoic acid, 3,5-dihydroxy- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
99283-10-0 Colony-stimulating factor 2 (human clone pHG25 protein moiety reduced) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
99294-93-6 Imidazo[1,2-.alpha.]pyridine-3-acetamide, N,N,6-trimethyl-2-(4-methylphenyl)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
99300-78-4 Cyclohexanol, 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
99343-90-5 Furan, tetrahydro-2,4-dimethyl-4-phenyl-, (2R,4R)-rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
99343-91-6 Furan, tetrahydro-2,4-dimethyl-4-phenyl-, (2R,4S)-rel- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
99439-28-8 Quartz-​beta (SiO2) Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
99542-23-1 1-Propanaminium, N-ethyl-N,N-dimethyl-3-[[(9Z,12Z)-1-oxo-9,12-octadecadienyl]amino]-, ethyl sulfate Higher priority based on available information - Environmental concern No commercial activity identified Removed from R-ICL
99-57-0 Phenol, 2-amino-4-nitro- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
99610-72-7 Phenol, 2-[(2-hydroxyethyl)amino]-4,6-dinitro- Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
99614-01-4 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-, hydrochloride (1:1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
99614-02-5 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]- Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
99924-37-5 Protein hydrolyzates, reticulin Lower priority in the context of the R-ICL - based on available information no concern was identified Identified for future survey TBD
99948-86-4 2-[(dihydroxymethylsilyl)oxy]propionic acid Higher priority based on available information - Environmental and human health concern No commercial activity identified Removed from R-ICL
ATCC 55456 Vibrio cholerae strain CVD 103-HgR Live Attenuated Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
ATCC 76060 ASPERGILLUS AWAMORI Higher priority based on available information - Human health concern Clarification required TBD
ATCC 76061 ASPERGILLUS AWAMORI Higher priority based on available information - Human health concern Clarification required TBD
ATCC 76061K ASPERGILLUS AWAMORI Higher priority based on available information - Human health concern Clarification required TBD
  HEPATITIS A VIRUS VACCINE INACTIVATED - HM - 175 Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  HEPATITIS B SURFACE ANTIGEN - RIT 4376 (RECOMBINANT) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  VARICELLA VIRUS - OKA STRAIN LIVE ATTENUATED Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  DIPHTHERIA TOXOID Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  TETANUS TOXOID Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  PERTUSSIS TOXOID Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  PERTUSSIS FILAMENTOUS HAEMAGGLUTININ Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  PERTUSSIS PERTACTIN Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  INACTIVATED POLIO VIRUS TYPE1 - MAHONEY STRAIN Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  INACTIVATED POLIO VIRUS TYPE2 - MEF - 1 STRAIN Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  INACTIVATED POLIO VIRUS TYPE3 - SAUKETT STRAIN Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  MEASLES VIRUS VACCINE LIVE ATTENUATED - SCHWARTZ STRAIN Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  MUMPS VIRUS VACCINE LIVE ATTENUATED - RIT4385 STRAIN Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  HAEMOPHILUS INFLUENZAE - TYPE B (HIB) CAPSULAR POLYSACCHARIDE Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  Purified, split, inactivated influenza virus strain A/Singapore/6/1986 (H1N1) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  Purified, split, inactivated influenza virus strain A/Wuhan/359/1995 (H3N2) Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  Purified, split, inactivated influenza virus strain B/Beijing/184/1993 Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  SALMONELLA TYPHI VI VACCINE CAPSULAR POLYSACCHARIDE - TY2 STRAIN Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  MEASLES VIRUS EDMONSTON STRAIN LIVE ATTENUATED Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  MUMPS VIRUS JERYL LYNN STRAIN LIVE ATTENUATED Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  RUBELLA VIRUS WISTAR RA 27/3 STRAIN LIVE ATTENUATED Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
  VARICELLA VIRUS OKA/MERCK STRAIN LIVE ATTENUATED Lower priority in the context of the R-ICL - based on available information no concern was identified Clarification required TBD
1.1.3.4/9001-37-0 .beta.-D-glucose:oxygen 1-oxidoreductase On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1.11.1.6 hydrogen-peroxide:hydrogen-peroxide oxidoreductase On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
100-21-0 1,4-Benzenedicarboxylic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10024-97-2 Nitrogen oxide (N2O) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10025-87-3 Phosphoric trichloride On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10025-91-9 Stibine, trichloro- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10034-85-2 Hydriodic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10034-99-8 Sulfuric acid magnesium salt (1:1), heptahydrate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10043-01-3 Sulfuric acid, aluminum salt (3:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10043-11-5 Boron Nitride (BN) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10043-22-8 Ethanedioic acid, potassium salt (1:?) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10043-52-4 Calcium chloride On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10043-84-2 Phosphinic acid, manganese(2+) salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10049-04-4 Chlorine oxide (ClO2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
100-51-6 Benzenemethanol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10058-23-8 Peroxymonosulfuric acid, monopotassium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10058-44-3 Diphosphoric acid, iron(3+) salt (3:4) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10101-39-0 Silicic acid (H2SiO3), calcium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10101-53-8 Sulfuric acid, chromium(3+) salt (3:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10102-17-7 Thiosulfuric acid (H2S2O3), disodium salt, pentahydrate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10102-71-3 Sulfuric acid, aluminum sodium salt (2:1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
101-20-2 Urea, N-(4-chlorophenyl)-N'-(3,4-dichlorophenyl)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10124-31-9 Phosphoric acid, ammonium salt (1:?) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10124-36-4 Sulfuric acid, cadmium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10124-55-7 Sulfuric acid, manganese salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10141-00-1 Sulfuric acid, chromium(3+) potassium salt (2:1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
101-86-0 Octanal, 2-(phenylmethylene)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10193-36-9 Silicic acid (H4SiO4) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
102-71-6 Ethanol, 2,2',2"-nitrilotris- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
102-76-1 1,2,3-Propanetriol, triacetate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10279-63-7 Sulfuric acid, chromium potassium salt (1:?:?) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
102972-64-5 2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, polymer with 1-ethenylhexahydro-2H-azepin-2-one and 1-ethenyl-2-pyrrolidinone On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10326-41-7 Propanoic acid, 2-hydroxy-, (2R)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10361-03-2 Metaphosphoric acid (HPO3), sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10361-29-2 Carbonic acid, ammonium salt (1:?) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10361-37-2 Barium chloride (BaCl2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10361-65-6 Phosphoric acid, ammonium salt (1:3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
104037-85-6 Benzoic acid, 2-[[3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl]amino]-, methyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
104-29-0 1,2-Propanediol, 3-(4-chlorophenoxy)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
104986-28-9 Hexanoic acid, 6-(acetyloxy)-, ethyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1066-33-7 Carbonic acid, ammonium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
106-89-8 Oxirane, 2-(chloromethyl)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
106-97-8 Butane On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
107-35-7 Ethanesulfonic acid, 2-amino- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1077-28-7 1,2-Dithiolane-3-pentanoic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
107-88-0 1,3-Butanediol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
107-92-6 Butanoic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
108-24-7 Acetic acid, 1,1'-anhydride On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
108-30-5 2,5-Furandione, dihydro- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
109-57-9 Thiourea, N-2-propen-1-yl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
110-15-6 Butanedioic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
110-17-8 2-Butenedioic acid (2E)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
110-44-1 2,4-Hexadienoic acid, (2E,4E)-; 2,4-Hexadienoic acid, (E,E)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
110-54-3 Hexane On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1107-26-2 8'-Apo-.beta.,.psi.-carotenal On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
11096-42-7 Poly(oxy-1,2-ethanediyl), .alpha.-(nonylphenyl)-.omega.-hydroxy-, compd. with iodine On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
111019-03-5 Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-hexadecyl-.omega.-hydroxy-, phosphate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
11103-57-4 Vitamin A On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
11104-38-4 Vitamin K1 On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
111-29-5 1,5-Pentanediol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
11132-78-8 Manganese chloride On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
11138-66-2 Xanthan gum On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1115-63-5 L-Aspartic acid, potassium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
111-76-2 Ethanol, 2-butoxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
112-27-6 Ethanol, 2,2'-[1,2-ethanediylbis(oxy)]bis- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1129-47-1 Propanoic acid, 2-methyl-, cyclohexyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
115-25-3 Cyclobutane, octafluoro- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
116044-44-1 Bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, 3-(1-methylethyl)-, ethyl ester, (1R,2S,3S,4S)-rel- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
116126-82-0 Bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, 3-(1-methylethyl)-, ethyl ester, (1R,2R,3R,4S)-rel- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
117933-89-8 1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1184-64-1 Carbonic acid, copper(2+) salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
118-56-9 Benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
118-60-5 Benzoic acid, 2-hydroxy-, 2-ethylhexyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
12001-26-2 Mica-group minerals On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
12002-43-6 Gilsonite On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1203962-19-9 2-Propenoic acid, 2-methyl-, polymer with butyl 2-propenoate and methyl 2-methyl-2-propenoate, compd. with 2-amino-2-methyl-1-propanol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
12041-76-8 Benzenemethanol, dichloro- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
12069-69-1 Copper, [.mu.-[carbonato(2-)-.kappa.O:.kappa.O']]dihydroxydi- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
12124-97-9 Ammonium bromide ((NH4)Br) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
12125-02-9 Ammonium chloride ((NH4)Cl) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
121251-67-0 Spiro[bicyclo[4.1.0]heptane-2,5'-[1,3]dioxane], 2',2',3,7,7-pentamethyl-, (1R,3S,6S)-rel- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
121251-68-1 Spiro[bicyclo[4.1.0]heptane-2,5'-[1,3]dioxane], 2',2',3,7,7-pentamethyl-, (1R,3R,6S)-rel- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
121-44-8 Ethanamine, N,N-diethyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
12173-47-6 Hectorite((Mg2.67LiO.33)Si4Na0.33[F0.5-1(OH)0-0.5]2O10) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
121-79-9 Benzoic acid, 3,4,5-trihydroxy-, propyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
12198-93-5 Ozocerite On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
123-63-7 1,3,5-Trioxane, 2,4,6-trimethyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
123-77-3 1,2-Diazenedicarboxamide On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
124046-17-9 Terpenes and Terpenoids, cypress, Cupressus funebris-oil, hydroxy, acetates On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
124-04-9 Hexanedioic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
124-38-9 Carbon dioxide On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
12607-70-4 Nickel carbonate hydroxide (Ni3(CO3)(OH)4) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
126-11-4 1,3-Propanediol, 2-(hydroxymethyl)-2-nitro- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
126-13-6 .alpha.-D-Glucopyranoside, 6-O-acetyl-1,3,4-tris-O-(2-methyl-1-oxopropyl)-.beta.-D-fructofuranosyl, 6-acetate 2,3,4-tris(2-methylpropanoate) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
126-96-5 Acetic acid, sodium salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
127-09-3 Acetic acid, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
128-37-0 Phenol, 2,6-bis(1,1-dimethylethyl)-4-methyl On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
129311-52-0 Steroids, soya hydroxyl On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
129702-02-9 2-Propenoic acid, 2-methyl-, 2-methylpropyl ester, polymer with 2-propenoic acid and N-(1,1,3,3-tetramethylbutyl)-2-propenamide On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
130249-48-8 Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-[(1-oxooctadecyl)oxy]-, ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*1302-83-6/ 1317-97-1 Lazurite On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1304-76-3 Bismuth oxide (Bi2O3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1304-85-4 Bismuth hydroxide nitrate oxide (Bi5(OH)9(NO3)4O) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1305-62-0 Calcium hydroxide On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1305-78-8 Calcium Oxide On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1305-79-9 Calcium peroxide On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1306-06-5 Hydroxylapatite (Ca5(OH)(PO4)3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1308-38-9 Chromium oxide (Cr2O3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
130-89-2 Cinchonan-9-ol, 6'-methoxy-, hydrochloride (1:1), (8.alpha.,9R)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1309-37-1 Iron oxide (Fe2O3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1309-42-8 Magnesium hydroxide (Mg(OH)2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1309-48-4 Magnesium oxide (MgO) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1310-58-3 Potassium hydroxide (K(OH)) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1310-73-2 Sodium hydroxide (Na(OH)) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1312-76-1 Silicic acid, potassium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1313-13-9 Manganese oxide (MnO2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1313-82-2 Sodium sulfide (Na2S) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
131-53-3 Methanone, (2-hydroxy-4-methoxyphenyl)(2-hydroxyphenyl)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1317-38-0 Copper oxide (CuO) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1317-61-9 Iron oxide (Fe3O4) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1319-46-6 Lead, bis[carbonato(2-)]dihydroxytri- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1320-46-3 1,2,3-Propanetriol, mono(dihydrogen phosphate), manganese(2+) salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1327-39-5 Silicic acid, aluminum calcium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1327-43-1 Silicic acid, aluminum magnesium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1332-37-2 Iron oxide On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1333-82-0 Chromium oxide (CrO3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1333-86-4 Carbon black On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
133-42-6 Gluconic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1336-21-6 Ammonium hydroxide ((NH4)(OH)) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1337-33-3 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, octadecyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1338-41-6 Sorbitan, monooctadecanoate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
134-03-2 L-Ascorbic acid, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
134-09-8 Cyclohexanol, 5-methyl-2-(1-methylethyl)-, 1-(2-aminobenzoate) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
13410-01-0 Selenic acid, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1343-78-8 Cochineal (dye) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1343-88-0 Silicic acid, magnesium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1343-98-2 Silicic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1344-00-9 Silicic acid, aluminum sodium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1344-95-2 Silicic acid, calcium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1345-25-1 Iron oxide (FeO) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
13453-07-1 Gold chloride (AuCl3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
134-62-3 Benzamide, N,N-diethyl-3-methyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
13463-67-7 Titanium oxide (TiO2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
134-72-5 Benzenemethanol, .alpha.-[(1S)-1-(methylamino)ethyl]-, (.alpha.R)-, sulfate (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
134-80-5 1-Propanone, 2-(diethylamino)-1-phenyl-, hydrochloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
135620-17-6 Fatty acids, C18-36 On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
13601-19-9 Ferrate(4-), hexakis(cyano-kC)-, sodium (1:4), (OC-6-11)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
136392-67-1 2,5-Furandione, polymer with 1,9-decadiene and methoxyethene On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
136-47-0 Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester, hydrochloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
136-77-6 1,3-Benzenediol, 4-hexyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
137-40-6 Propanoic acid, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
137-66-6 L-Ascorbic acid, 6-hexadecanoate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1390-65-4 Carmine On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
139-07-1 Benzenemethanaminium, N-dodecyl-N,N-dimethyl-, chloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
139-33-3 Glycine, N,N'-1,2-ethanediylbis[N-(carboxymethyl)-, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1393-63-1 C.I. Natural Orange 4 On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1400-62-0 Orcein On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1401-55-4 Tannins On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
140-64-7 Ethanesulfonic acid, 2-hydroxy-, compd. with 4,4'-[1,5-pentanediylbis(oxy)]bis[benzenecarboximidamide] (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
141-78-6 Acetic acid ethyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
142-71-2 Acetic acid, copper(2+) salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
144-33-2 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
144-55-8 Carbonic acid sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
14475-11-7 Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, sodium salt (1:?) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
146-48-5 Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16.alpha.,17.alpha.)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
147-24-0 Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-, hydrochloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
14807-96-6 Talc (Mg3H2(SiO3)4) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
14808-60-7 Quartz (SiO2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
148-24-3 8-Quinolinol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
148-72-1 2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S,4R)-, nitrate (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
149-91-7 Benzoic acid, 3,4,5-trihydroxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
15086-94-9 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 2',4',5',7'-tetrabromo-3',6'-dihydroxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
151-21-3 Sulfuric acid monododecyl ester sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
151-50-8 Potassium cyanide (K(CN)) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
15189-51-2 Aurate(1-), tetrachloro-, sodium (1:1), (SP-4-1)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1592-23-0 Octadecanoic acid, calcium salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
16177-21-2 L-Glutamic acid, sodium salt (1:?) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
16291-96-6 Charcoal On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1633-05-2 Carbonic acid, strontium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
16423-68-0 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dihydroxy-2',4',5',7'-tetraiodo-, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
16731-55-8 Disulfurous acid, potassium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
16984-48-8 Fluoride On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*17354-14-2/ 12769-17-4 9,10-Anthracenedione, 1,4-bis(butylamino)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
17372-87-1 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 2',4',5',7'-tetrabromo-3',6'-dihydroxy-, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
18472-87-2 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 2',4',5',7'-tetrabromo-4,5,6,7-tetrachloro-3',6'-dihydroxy-, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1847-58-1 Acetic acid, 2-sulfo-, dodecyl ester, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
19317-11-4 2,6,10-Dodecatrienal, 3,7,11-trimethyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1934-21-0 1H-Pyrazole-3-carboxylic acid, 4,5-dihydro-5-oxo-1-(4-sulfophenyl)-4-[2-(4-sulfophenyl)diazenyl]-, sodium salt (1:3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
1948-33-0 1,4-Benzenediol, 2-(1,1-dimethylethyl)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
201363-52-2 Amides, coco, N-(hydroxyethyl), propoxylated On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
20461-54-5 Iodide On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
2078-54-8 Phenol, 2,6-bis(1-methylethyl)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
2174-16-5 Benzoic acid, 2-hydroxy-, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
2216-51-5 Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1R,2S,5R)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
22373-78-0 Monensin, monosodium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
22463-19-0 Ethanone, 1-(3,3-dimethyl-1-cyclohexen-1-yl)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
22494-42-4 [1,1'-Biphenyl]-3-carboxylic acid, 2',4'-difluoro-4-hydroxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
22644-09-3 4,7-Decadienal, (4Z,7Z)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
22839-47-0 L-Phenylalanine, N-L-.alpha.-aspartyl-, 1-methyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
23110-15-8 2,4,6,8-Decatetraenedioic acid, 1-[(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-buten-1-yl)-2-oxiranyl]-1-oxaspiro[2.5]oct-6-yl] ester, (2E,4E,6E,8E)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
2338-05-8 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron salt (1:?) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
2353-45-9 Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](4-hydroxy-2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, inner salt, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
23593-75-1 1H-Imidazole, 1-[(2-chlorophenyl)diphenylmethyl]- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
2445-72-9 Propanoic acid, 2-methyl-, pentyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
25013-16-5 Phenol, (1,1-dimethylethyl)-4-methoxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
25155-18-4 Benzenemethanaminium, N,N-dimethyl-N-[2-[2-[methyl-4-(1,1,3,3-tetramethylbutyl)phenoxy]ethoxy]ethyl]-, chloride On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
25322-68-3 Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
25383-99-7 Octadecanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
25395-31-7 1,2,3-Propanetriol, diacetate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
2563-07-7 Phenol, 2-ethoxy-4-methyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
25956-17-6 2-Naphthalenesulfonic acid, 6-hydroxy-5-[2-(2-methoxy-5-methyl-4-sulfophenyl)diazenyl]-, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
26027-38-3 Poly(oxy-1,2-ethanediyl), .alpha.-(4-nonylphenyl)-.omega.-hydroxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
26264-14-2 Propanediol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
26266-57-9 Sorbitan, monohexadecanoate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
26266-58-0 Sorbitan, tri-(9Z)-9-octadecenoate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
26446-35-5 1,2,3-Propanetriol, monoacetate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
26658-19-5 Sorbitan, trioctadecanoate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*26811-08-5/ 9065-13-8 Formaldehyde, polymer with 5,5-dimethyl-2,4-imidazolidinedione On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
26912-64-1 4,7-Methano-1H-indene, 3a,4,5,6,7,7a-hexahydro-5(or 6)(2-propen-1-yloxy)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
27214-00-2 1,2,3-Propanetriol, mono(dihydrogen phosphate), calcium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
27215-38-9 Dodecanoic acid, monoester with 1,2,3-propanetriol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
2724-58-5 Heptadecanoic acid, 16-methyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
27503-81-7 1H-Benzimidazole-6-sulfonic acid, 2-phenyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
2783-94-0 2-Naphthalenesulfonic acid, 6-hydroxy-5-[2-(4-sulfophenyl)diazenyl]-, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
28300-74-5 Antimonate(2-), bis[.mu.-[2,3-di(hydroxy-.kappa.O)butanedioato(4-)-.kappa.O1:.kappa.O4]]di-, potassium, hydrate (1:2:3), stereoisomer On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
29122-68-7 Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
2915-53-9 2-Butenedioic acid (2Z)-, 1,4-dioctyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
298-14-6 Carbonic acid, potassium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
299-28-5 D-Gluconic acid, calcium salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
299-29-6 Iron, bis(D-gluconato-kO1,kO2)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.1.1.3/9001-62-1 Lipase, triacylglycerol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.2.1.1 4-.alpha.-D-glucan glucanohydrolase On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.2.1.15 (1→4)-.alpha.-D-galacturonan glycanohydrolase On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.2.1.23/9031-11-2 Galactosidase, .beta.- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.2.1.26/9001-57-4 .beta.-D-fructofuranoside fructohydrolase On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.2.1.3 4-.alpha.-D-glucan glucohydrolase On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.2.1.4 4-(1,3;1,4)-.beta.-D-glucan 4-glucanohydrolase On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.2.1.41 pullulan 6-.alpha.-glucanohydrolase On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.2.1.72 3-.beta.-D-xylan xylohydrolase On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.4.21.4/9002-07-7 Trypsin On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.4.22.2 Papain On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.4.22.32/37189-34-7 Stem Bromelain On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.4.22.33/9001-00-7 Fruit Bromelain On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.4.23.1/9001-75-6 Pepsin A On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.4.23.4/9001-98-3 Chymosin On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3.4.23.23 Mucorpepsin On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3012-65-5 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ammonium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
304-59-6 Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, potassium sodium salt (1:1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
30473-39-3 1H-Imidazolium, 1-(carboxymethyl)-2-heptadecyl-4,5-dihydro-1-(2-hydroxyethyl)-, hydroxide, sodium salt (1:1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
30516-87-1 Thymidine, 3'-azido-3'-deoxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
31416-78-1 2-Butenoic acid, cyclohexyl ester, (2E)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3164-29-2 Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, ammonium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
32289-58-0 Poly(iminocarbonimidoyliminocarbonimidoylimino-1,6-hexanediyl), hydrochloride (1:?) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3251-23-8 Nitric acid, copper(2+) salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
32540-03-7 Pentanal, 4-(4-methyl-3-cyclohexen-1-ylidene)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3344-18-1 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, magnesium salt (2:3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
33673-62-0 2(3H)-Furanone, dihydro-4-methyl-5-pentyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
34552-83-5 1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-.alpha.,.alpha.-diphenyl-, hydrochloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3483-12-3 2,3-Butanediol, 1,4-dimercapto-, (2R,3R)-rel- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
35205-76-6 2-Nonenoic acid, 3-methyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
35205-77-7 3-Nonenoic acid, 3-methyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
35205-78-8 Nonanoic acid, 3-methylene- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
35285-69-9 Benzoic acid, 4-hydroxy-, propyl ester, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
352-93-2 Ethane, 1,1'-thiobis- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3539-43-3 1-Hexadecanol, 1-(dihydrogen phosphate) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3567-66-6 2,7-Naphthalenedisulfonic acid, 5-amino-4-hydroxy-3-(2-phenyldiazenyl)-, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
357-57-3 Strychnidin-10-one, 2,3-dimethoxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3615-41-6 L-Mannose, 6-deoxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
36291-32-4 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, monoester with 1,2,3-propanetriol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
36861-47-9 Bicyclo[2.2.1]heptan-2-one, 1,7,7-trimethyl-3-[(4-methylphenyl)methylene]- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
373-02-4 Acetic acid, nickel(2+) salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
3844-45-9 Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, hydroxide, inner salt, disodium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
4040-50-0 Tetradecanoic acid, aluminum salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
4065-45-6 Benzenesulfonic acid, 5-benzoyl-4-hydroxy-2-methoxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
4075-81-4 Propanoic acid, calcium salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
41340-25-4 Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
41424-36-6 Benzene, 1,3,5-tribromo-2-methoxy-4-methyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
42739-38-8 Pentanoic acid, ammonium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*43119-47-7/ 16676-75-8 3-Pyridinecarboxylic acid, (2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-yl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
4548-53-2 1-Naphthalenesulfonic acid, 3-[2-(2,4-dimethyl-5-sulfophenyl)diazenyl]-4-hydroxy-, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
458-37-7 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (1E,6E)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
4625-90-5 1-Oxaspiro[4.5]decan-2-one, 8-(1-methylethyl)-, trans- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
463-40-1 9,12,15-Octadecatrienoic acid, (9Z,12Z,15Z)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
471-34-1 Carbonic acid calcium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
471-53-4 Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3.beta.,20.beta.)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
479-61-8 Magnesium, [3,7,11,15-tetramethyl-2-hexadecenyl 9-ethenyl-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoato(2-)-N23,N24,N25,N26]-, [SP-4-2-[3S-[3a(2E,7S*,11S*),4b,21b]]]- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
482-89-3 3H-Indol-3-one, 2-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,2-dihydro- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
483-63-6 2-Butenamide, N-ethyl-N-(2-methylphenyl)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
4892-02-8 Benzoic acid, 2-mercapto-, methyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
497-19-8 Carbonic acid sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
49805-55-2 Butanal, 2-methyl-, oxime, (E)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
49805-56-3 Butanal, 2-methyl-, oxime, (1Z)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*50-21-5/ 598-82-3 Propanoic acid, 2-hydroxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
5026-62-0 Benzoic acid, 4-hydroxy-, methyl ester, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
50-28-2 Estra-1,3,5(10)-triene-3,17-diol (17.beta.)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
506-64-9 Silver cyanide (Ag(CN)) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*50-69-1/ 93781-19-2 D-Ribose On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
50-70-4 D-Glucitol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
50-81-7 L-Ascorbic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
50-98-6 Benzenemethanol, .alpha.-[(1S)-1-(methylamino)ethyl]-, hydrochloride (1:1), (.alpha.R)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
51022-70-9 1,3-Benzenedimethanol, .alpha.1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-, sulfate (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
51274-00-1 C.I. Pigment Yellow 42 On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
51-45-6 1H-Imidazole-5-ethanamine On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
514-78-3 .beta,.beta.-Carotene-4,4'-dione On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*515-98-0/ 52003-58-4 Propanoic acid, 2-hydroxy-, ammonium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
51-63-8 Benzeneethanamine, .alpha.-methyl-, (.alpha.S)-, sulfate (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
518-47-8 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dihydroxy-, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
519-62-0 Magnesium, [(2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecenyl (3S,4S,21R)-9-ethenyl-14-ethyl-13-formyl-21-(methoxycarbonyl)-4,8,18-trimethyl-20-oxo-3-phorbinepropanoato(2-)-.kappa.N23,.kappa.N24,.kappa.N25,.kappa.N26]-, (SP-4-2)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
52439-69-7 .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, acetate octadecanoate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
52557-97-8 Bicyclo[2.2.1]heptane-2-carboxylic acid, 3,3-dimethyl-,methy ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
52-68-6 Phosphonic acid, P-(2,2,2-trichloro-1-hydroxyethyl)-, dimethyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
526-94-3 Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
526-95-4 D-Gluconic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
527-07-1 D-Gluconic acid, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
527-09-3 Copper, bis(D-gluconato-.kappa.O1,.kappa.O2)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
52-89-1 L-Cysteine, hydrochloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
529-35-1 1-Naphthalenol, 5,6,7,8-tetrahydro- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
531-75-9 2H-1-Benzopyran-2-one, 6-(.beta.-D-lucopyranosyloxy)-7-hydroxy On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
532-32-1 Benzoic acid, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
53585-11-8 Pentanal, 4-(4-methyl-3-cyclohexen-1-ylidene)-, (4E)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
53585-12-9 Pentanal, 4-(4-methyl-3-cyclohexen-1-ylidene)-, (4Z)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
536-43-6 1-Propanone, 1-(4-butoxyphenyl)-3-(1-piperidinyl)-, hydrochloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
53694-17-0 2-Propen-1-aminium, N,N-dimethyl-N-2-propen-1-yl-, chloride (1:1), polymer with 2-propenoic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
54-11-5 Pyridine, 3-[(2S)-1-methyl-2-pyrrolidinyl]- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
546-93-0 Carbonic acid, magnesium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
55066-48-3 Benzenepentanol, .gamma.-methyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
55066-49-4 Benzenepentanal, .beta.-methyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
55-56-1 2,4,11,13-Tetraazatetradecanediimidamide, N,N"-bis(4-chlorophenyl)-3,12-diimino- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
55589-62-3 1,2,3-Oxathiazin-4(3H)-one, 6-methyl-, 2,2-dioxide, potassium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
556-67-2 Cyclotetrasiloxane, 2,2,4,4,6,6,8,8-octamethyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
557-04-0 Octadecanoic acid, magnesium salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
557-34-6 Acetic acid, zinc salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
5579-84-0 2-Pyridineethanamine, N-methyl-, hydrochloride (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
5595-79-9 Phenol, 2-ethoxy-4-(methoxymethyl)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
56-23-5 Methane, tetrachloro- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
56238-63-2 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-8-oxo-, sodium salt (1:1), (6R,7R)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
56265-46-4 2-Propenoic acid, 3-(4-methoxyphenyl)-,compd.with 2,2'-iminobis[ethanol] (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
56-34-8 Ethanaminium, N,N,N-triethyl-, chloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
563-63-3 Acetic acid, silver(1+) salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
56-40-6 Glycine On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
56-45-1 L-Serine On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
5655-61-8 Bicyclo[2.2.1]heptan-2-ol, 1,7,7-trimethyl-, 2-acetate, (1S,2R,4S)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
56-81-5 1,2,3-Propanetriol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
56-85-9 L-Glutamine On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
56-86-0 L-Glutamic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
56-92-8 1H-Imidazole-5-ethanamine, hydrochloride (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
57074-34-7 Ethanethioic acid, S-[1-methyl-1-[(1R,4R)-4-methyl-2-oxyocyclohexyl]ethyl] ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
57-10-3 Hexadecanoic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
57-11-4 Octadecanoic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
57129-12-1 Ethanethioic acid, S-[1-methyl-1-[(1R,4S)-4-methyl-2-oxyocyclohexyl]ethyl] ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
5743-27-1 L-Ascorbic acid, calcium salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
57455-37-5 C.I. Pigment Blue 29 On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
57-55-6 1,2-Propanediol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
57635-48-0 Poly(oxy-1,2-ethanediyl), .alpha.-(carboxymethyl)-.omega.-[(9Z)-9-octadecen-1-yloxy]- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
577-11-7 Butanedioic acid, 2-sulfo-, 1,4-bis(2-ethylhexyl) ester, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
5775-74-6 Butanal, 3-methyl-, oxime, (1E) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
5780-40-5 Butanal, 3-methyl-, oxime, (1Z)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
578-36-9 Benzoic acid, 2-hydroxy-, potassium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
57-88-5 Cholest-5-en-3-ol (3.beta.)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
5793-94-2 Octadecanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, calcium salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
58-08-2 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
582-25-2 Benzoic acid, potassium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
583-52-8 Ethanedioic acid, potassium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
584-08-7 Carbonic acid, potassium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
584-79-2 Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propen-1-yl)-, 2-methyl-4-oxo-3-(2-propen-1-yl)-2-cyclopenten-1-yl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
5858-81-1 2-Naphthalenecarboxylic acid, 3-hydroxy-4-[2-(4-methyl-2-sulfophenyl)diazenyl]-, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
585-88-6 D-Glucitol, 4-O-.alpha.-D-glucopyranosyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
58-61-7 Adenosine On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
58778-82-8 2-Propenoic acid, 2-methyl-, methyl ester, polymer with 2-propenoic acid and N-(1,1,3,3-tetramethylbutyl)-2-propenamide On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
590-00-1 2,4-Hexadienoic acid, potassium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
59-23-4 D-Galactose On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
593-29-3 Octadecanoic acid, potassium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
59-33-6 1,2-Ethanediamine, N1-[(4-methoxyphenyl)methyl]-N2,N2-dimethyl-N1-2-pyridinyl-, (2Z)-2-butenedioate (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
5949-29-1 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, monohydrate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
598-62-9 Carbonic acid, manganese(2+) salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
59-98-3 1H-Imidazole, 4,5-dihydro-2-(phenylmethyl)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
60-01-5 Butanoic acid, 1,2,3-propanetriyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
61-33-6 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
616-91-1 L-Cysteine, N-acetyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
61-73-4 Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
61-75-6 Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, 4-methylbenzenesulfonate (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
61788-95-2 Amines, (hydrogenated tallow alkyl)dimethyl On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
61789-91-1 Waxes and Waxy substances, jojoba On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
61789-99-9 Lard On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*61790-81-6/ 8051-82-9 Lanolin, ethoxylated On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
61791-42-2 Ethanesulfonic acid, 2-(methylamino)-, N-coco acyl derivs., sodium salts On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
61-90-5 L-Leucine On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
6197-30-4 2-Propenoic acid, 2-cyano-3,3-diphenyl-, 2-ethylhexyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
62-33-9 Calciate(2-), [[N,N'-1,2-ethanediylbis[N-[(carboxy-.kappa.O)methyl]glycinato-.kappa.N,.kappa.O]](4-)]-, sodium (1:2), (OC-6-21)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
62-51-1 1-Propanaminium, 2-(acetyloxy)-N,N,N-trimethyl-, chloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
62-53-3 Benzenamine On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
62-54-4 Acetic acid, calcium salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
62887-80-3 Anemone On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
63148-62-9 Siloxanes and Silicones, di-Me On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
631-61-8 Acetic acid, ammonium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
63231-60-7 Paraffin waxes and Hydrocarbon waxes, microcryst. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
63231-63-0 Ribonucleic acids On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
632-99-5 Benzenamine, 4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-2-methyl-, hydrochloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
63394-02-5 Rubber, silicone (Polydimethylsiloxane rubber) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
63-42-3 D-glucose. 4-.ortho.-.beta.-D-galactopyranosyl On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
6381-77-7 D-erythro-Hex-2-enonic acid, .gamma.-lactone, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
6381-92-6 Glycine, N,N'-1,2-ethanediylbis[N-(carboxymethyl)-, sodium salt, hydrate (1:2:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
638-23-3 L-Cysteine, S-(carboxymethyl)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
638-38-0 Acetic acid, manganese(2+) salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
64-17-5 Ethanol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
64-18-6 Formic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
64-19-7 Acetic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
64365-11-3 Charcoal, activated On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
643-79-8 1,2-Benzenedicarboxaldehyde On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
645-35-2 L-Histidine, hydrochloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
64742-51-4 Paraffin waxes (petroleum), hydrotreated On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
64742-60-5 Hydrocarbon waxes (petroleum), hydrotreated microcryst. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
6484-52-2 Nitric acid ammonium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
65-85-0 Benzoic Acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
65997-17-3 Glass, oxide, chemicals On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
67-20-9 2,4-Imidazolidinedione, 1-[[(5-nitro-2-furanyl)methylene]amino]- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
67-56-1 Methanol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
67-63-0 2-Propanol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
67-64-1 2-Propanone On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
67762-27-0 Alcohols, C16-18 On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*67846-47-3/ 173924-00-0 Poly(oxy-1,2-ethanediyl), .alpha.,.alpha'.-(dimethylsilylene)bis[.omega.- methoxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68-04-2 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, sodium salt (1:3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68333-82-4 Amides, coco, N-(2-hydroxypropyl) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
6834-92-0 Silicic acid (H2SO3), sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68391-30-0 2-Naphthalenaminium, 7-hydroxy-8-[2-(2-methoxyphenyl)diazenyl]-N,N,N-trimethyl-, chloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68391-31-1 Benzenaminium, 3-[2-(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)diazenyl]-N,N,N-trimethyl-, chloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68424-04-4 Polydextrose On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68425-17-2 Syrups, hydrolyzed starch, hydrogenated On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68440-15-3 Fatty acids, palm oil On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68515-73-1 D-Glucopyranose, oligomeric, decyl octyl glycosides On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68525-86-0 Corn, flour On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68611-44-9 Silane, dichlorodimethyl-, reaction products with silica On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68647-73-4 Oils, tea-tree On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68648-89-5 Benzene, ethenyl-, polymer with 2-methyl-1,3-butadiene, hydrogenated On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68876-77-7 Saccharomyces cerevisiae On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68908-68-9 Fatty acids, C12-20, ethoxylated On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68915-31-1 Polyphosphoric acids, sodium salts On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68917-78-2 Resins, oleo-, paprika On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68958-64-5 Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.',.alpha."-1,2,3-propanetriyltris[.omega.-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68990-63-6 Fats and Glyceridic oils, shark-liver On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
68990-67-0 Quillaja saponaria, ext. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*6915-15-7/ 617-48-1 Butanedioic acid, 2-hydroxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
69-22-7 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, mixture with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
69300-15-8 Decanenitrile,2-methyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*69430-36-0/ 65997-21-9 Keratins, hydrolyzates On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
69-57-8 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)-, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
69655-05-6 Inosine, 2',3'-dideoxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
69-65-8 D-Mannitol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
6969-49-9 Benzoic acid, 2-hydroxy-, octyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
70161-44-3 Glycine, N-(hydroxymethyl)-, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
70-18-8 Glycine, L-.gamma.-glutamyl-L-cysteinyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7028-48-0 Benzeneacetaldehyde, oxime On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
70356-09-1 1,3-Propanedione, 1-[4-(1,1-dimethylethyl)phenyl]-3-(4-methoxyphenyl)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7069-42-3 Retinol, 15-propanoate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
71010-52-1 Gellan gum On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
71298-42-5 3-Cyclohexene-1-carboxylic acid, 4-(1-methylethyl)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
71-43-2 Benzene On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
71-52-3 Carbonate, hydrogen On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
71902-01-7 Sorbitan, isooctadecanoate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
72-17-3 Propanoic acid, 2-hydroxy-, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
72183-75-6 Cyclohexanol, 1-methyl-2-(1-methylpropyl)-, 1-acetate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7235-40-7 .beta.,.beta.-Carotene On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7320-34-5 Diphosphoric acid, potassium salt (1:4) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
73-24-5 9H-Purin-6-amine On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
73-78-9 Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, hydrochloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7429-90-5 Aluminum On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7439-93-2 Lithium On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7440-06-4 Platinum On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7440-22-4 Silver On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7440-36-0 Antimony On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7440-38-2 Arsenic On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7440-44-0 Carbon On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7440-57-5 Gold On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7440-69-9 Bismuth On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7446-18-6 Sulfuric acid, thallium(1+) salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7446-19-7 Sulfuric acid, zinc salt (1:1), monohydrate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7446-20-0 Sulfuric acid, zinc salt (1:1), heptahydrate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7447-40-7 Potassium chloride (KCl) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7447-41-8 Lithium chloride (LiCl) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7481-89-2 Cytidine, 2',3'-dideoxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
74-90-8 Hydrocyanic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7492-55-9 2,4-Hexadienoic acid, calcium salt (2:1), (2E,4E)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7492-66-2 2,6-Octadiene, 1,1-diethoxy-3,7-dimethyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
74-98-6 Propane On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
75-07-0 Acetaldehyde On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
75-09-2 Methane, dichloro- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
75-15-0 Carbon disulfide On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
75-21-8 Oxirane On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
75-28-5 Propane, 2-methyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
75345-27-6 Poly[(dimethyliminio)-2-butene-1,4-diyl chloride], .alpha.-[4-[tris(2-hydroxyethyl)ammonio]-2-butenyl]-.omega.-[tris(2-hydroxyethyl)ammonio]-, dichloride On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7549-43-1 Cinchonan-9-ol, 6'-methoxy-, hydrochloride (1:?), (8.alpha.,9R)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
75-56-9 Oxirane, methyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7558-79-4 Phosphoric acid, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7558-80-7 Phosphoric acid, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7601-54-9 Phosphoric acid, sodium salt (1:3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
76095-16-4 L-Proline, N-[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl-, (2Z)-2-butenedioate (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
76-15-3 Ethane, 1-chloro-1,1,2,2,2-pentafluoro- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7631-86-9 Silica On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7631-90-5 Sulfurous acid, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7631-99-4 Nitric acid sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7632-00-0 Nitrous acid, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7646-79-9 Cobalt chloride (CoCl2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7647-01-0 Hydrochloric Acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
76-49-3 Bicyclo[2.2.1]heptan-2-ol, 1,7,7-trimethyl-, 2-acetate, (1R,2S,4R)-rel- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7664-38-2 Phosphoric Acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7664-93-9 Sulfuric acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7681-38-1 Sulfuric acid, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7681-52-9 Hypochlorous acid, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7681-57-4 Disulfurous acid, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7693-13-2 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, calcium salt (1:?) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7695-91-2 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, 6-acetate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7697-37-2 Nitric acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7699-41-4 Silicic acid (H2SiO3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7720-78-7 Sulfuric acid, iron(2+) salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7722-64-7 Permanganic acid (HMnO4), potassium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7722-76-1 Phosphoric acid, ammonium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7722-84-1 Hydrogen peroxide On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7722-88-5 Diphosphoric acid, sodium salt (1:4) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7726-95-6 Bromine On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7727-21-1 Peroxydisulfuric acid ([(HO)S(O)2]2O2), potassium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7727-37-9 Nitrogen On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7727-54-0 Peroxydisulfuric acid ([(HO)S(O)2]2O2), ammonium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7757-79-1 Nitric acid potassium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7757-82-6 Sulfuric acid sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7757-83-7 Sulfurous acid, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7757-86-0 Phosphoric acid, magnesium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7757-93-9 Phosphoric acid, calcium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7758-02-3 Potassium bromide (KBr) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7758-05-6 Iodic acid (HIO3), potassium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7758-09-0 Nitrous acid, potassium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7758-11-4 Phosphoric acid, potassium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7758-16-9 Diphosphoric acid, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7758-19-2 Chlorous acid, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7758-23-8 Phosphoric acid, calcium salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7758-29-4 Triphosphoric acid, sodium salt (1:5) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7758-87-4 Phosphoric acid, calcium salt (2:3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7772-99-8 Tin chloride (SnCl2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7775-14-6 Dithionous acid, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7778-18-9 Sulfuric acid, calcium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7778-74-7 Perchloric acid, potassium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7778-77-0 Phosphoric acid, potassium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7778-80-5 Sulfuric acid potassium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7782-41-4 Fluorine On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7782-50-5 Chlorine On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7782-99-2 Sulfurous acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7783-20-2 Sulfuric acid ammonium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7783-28-0 Phosphoric acid, ammonium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7783-86-0 Iron iodide (FeI2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7783-90-6 Silver chloride (AgCl) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7784-09-0 Phosphoric acid, silver(1+) salt (1:3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7784-25-0 Sulfuric acid, aluminum ammonium salt (2:1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7784-26-1 Sulfuric acid, aluminum ammonium salt, hydrate (2:1:1:12) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7784-28-3 Sulfuric acid, aluminum sodium salt (2:1:1), dodecahydrate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7785-84-4 Metaphosphoric acid (H3P3O9), sodium salt (1:3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7785-87-7 Sulfuric acid, manganese(2+) salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7785-88-8 Phosphoric acid, aluminum sodium salt (1:?:?) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7786-30-3 Magnesium chloride (MgCl2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7786-81-4 Sulfuric acid, nickel(2+) salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7789-00-6 Chromic acid (H2CrO4), potassium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7789-23-3 Potassium fluoride (KF) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7789-42-6 Cadmium bromide (CdBr2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7789-77-7 Phosphoric acid, calcium salt (1:1), dihydrate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7789-79-9 Phosphinic acid, calcium salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7789-80-2 Iodic acid (HIO3), calcium salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
77-92-9 1,2,3-Propanetricarboxylic acid, 2-hydroxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
77-93-0 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-triethyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7803-55-6 Vanadate (VO31-), ammonium (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
78-93-3 2-Butanone On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
79-09-4 Propanoic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
79-21-0 Ethaneperoxoic acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
79-33-4 Propanoic acid, 2-hydroxy-, (2S)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
79-43-6 Acetic acid, 2,2-dichloro- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
79-46-9 2-Nitropropane On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
79-83-4 .beta.-Alanine, N-[(2R)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl]- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8000-28-0 Oils, lavender On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*8000-34-8/ 8015-97-2 Oils, clove On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*8001-21-6/ 84776-03-4 Oils, Sunflower On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*8001-25-0/ 8060-29-5 Olive oil On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8001-26-1 Linseed oil On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8001-31-8 Coconut oil On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8001-61-4 Balsams, copaiba On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8001-75-0 Ceresin On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8001-79-4 Castor oil On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8002-23-1 Spermaceti On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8002-43-5 Lecithins On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8002-74-2 Paraffin waxes and Hydrocarbon waxes On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8003-34-7 Pyrethrins and Pyrethroids On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8006-44-8 Candelilla wax On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8006-54-0 Lanolin On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8006-75-5 Oils, dill On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8006-80-2 Oils, sassafras On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8006-87-9 Oils, sandalwood On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8008-52-4 Oils, coriander On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8008-56-8 Oils, lemon On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8009-03-8 Petrolatum On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8012-89-3 Beeswax On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8012-95-1 Paraffin oil On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8015-86-9 Carnauba wax On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8015-92-7 Oils, chamomile On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8016-94-2 Oils, vegetable, brominated On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8023-74-3 Oils, mink On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8028-89-5 Caramel (color) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8029-68-3 Ichthammol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8029-76-3 Lecithins, hydroxylated On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8042-47-5 White mineral oil (petroleum) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8047-15-2 Saponins On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8050-07-5 Frankincense On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
8050-81-5 Simethicone On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
81-07-2 1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
81161-17-3 Benzenepropanoic acid, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-, methyl ester, hydrochloride (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
814-80-2 Propanoic acid, 2-hydroxy-, calcium salt (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
81782-77-6 3-Decen-5-ol, 4-methyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
81-81-2 2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
822-16-2 Octadecanoic acid, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
83-44-3 Cholan-24-oic acid, 3,12-dihydroxy-, (3.alpha.,5.beta.,12.alpha.)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
83682-78-4 1-Propanaminium, 3,3',3"-[phosphinylidynetris(oxy)]tris[N-(3-aminopropyl)-2-hydroxy-N,N-dimethyl-, N,N',N" - tri-C6-18 acyl derivs. trichlorides On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
83863-64-3 Spiro[5.5]undecan-3-one, 7,9-dimethyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
83-88-5 Riboflavin On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
84082-80-4 St.-John's-wort, Hypericum perforatum, ext. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
84082-82-6 Willow, Salix alba, Extract On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
84282-44-0 2-Nonynoic acid, 2-methylpropyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
84625-29-6 Capsicum annuum, ext. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
84681-91-4 Bicyclo[3.2.1]octan-8-ol, 1,5,8-trimethyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
84696-15-1 Ginger, ext. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*84696-21-9/ 84776-24-9 Hydrocotyle asiatica, ext. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*84696-47-9/ 84603-93-0 Rose, Rosa canina, ext On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
84775-78-0 Ascophyllum nodosum, ext. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
84776-23-8 Calendula officinalis, ext. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
84776-67-0 Lily, Lilium candidum, ext. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
84787-68-8 Primrose, Primula veris, ext. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
84787-69-9 Rubus fruticosus, ext. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
84-80-0 1,4-Naphthalenedione, 2-methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecen-1-yl]- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
84929-61-3 Carrot, ext. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
84988-65-8 Harpagophytum procumbens, ext. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
85049-30-5 Bentonite, sodian On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
85351-04-8 Octanenitrile, 3-methyl-. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
85351-07-1 Dodecanenitrile, 3-methyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
85507-69-3 Aloe vera, ext On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
860-22-0 1H-Indole-5-sulfonic acid, 2-(1,3-dihydro-3-oxo-5-sulfo-2H-indol-2-ylidene)-2,3-dihydro-3-oxo-, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
868-14-4 Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, potassium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
868-18-8 Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, sodium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
86893-19-8 Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside 2,6-di-(9Z)-9-octadecenoate (2:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
87-28-5 Benzoic acid, 2-hydroxy-, 2-hydroxyethyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
87-69-4 Butanedioic acid, 2,3-dihydroxy- (2R,3R)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
886-86-2 Benzoic acid, 3-amino-, ethyl ester, methanesulfonate (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
89079-92-5 1-Oxaspiro[4.5]deca-3,6-diene, 2,7-dimethyl-10-(1-methylethyl)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
89-57-6 Benzoic acid, 5-amino-2-hydroxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
89-65-6 D-erythro-Hex-2-enonic acid, .gamma.lactone On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*89957-91-5/ 85049-52-1 Bergamot, ext. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9000-01-5 Gum arabic On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9000-05-9 Gum benzoin On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9000-07-1 Carrageenan On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9000-11-7 Cellulose, carboxymethyl ether On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9000-29-7 Guaiacum (resin) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9000-30-0 Guar gum On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9000-36-6 Karaya gum On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9000-40-2 Carob gum On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9000-59-3 Shellac On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9000-65-1 Gum tragacanth On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9000-69-5 Pectin On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9000-70-8 Gelatins On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9000-71-9 Caseins On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9001-32-5 Fibrinogens On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9001-42-7 Glucosidase, .alpha.- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9001-54-1 Hyaluronidase On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9002-18-0 Agar On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
90028-66-3 Evening primrose, Oenothera biennis, ext. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9002-92-0 Poly(oxy-1,2-ethanediyl), .alpha.-dodecyl-.omega.-hydroxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9003-05-8 2-Propenamide, homopolymer On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9003-13-8 Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-butyl-.omega.-hydroxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9003-39-8 2-Pyrrolidinone, 1-ethenyl-, homopolymer On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9004-32-4 Cellulose, carboxymethyl ether, sodium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9004-34-6 Cellulose On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9004-54-0 Dextran On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9004-62-0 Cellulose, 2-hydroxyethyl ether On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9004-64-2 Cellulose, 2-hydroxypropyl ether On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9004-65-3 Cellulose, 2-hydroxypropyl methyl ether On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9004-67-5 Cellulose, methyl ether On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9004-82-4 Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.-(dodecyloxy)-, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9004-99-3 Poly(oxy-1,2-ethanediyl),.alpha.-(1-oxooctadecyl)-.omega.-hydroxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9005-00-9 Poly(oxy-1,2-ethanediyl), .alpha.-octadecyl-.omega.-hydroxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9005-25-8 Starch On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9005-27-0 Starch, 2-hydroxyethyl ether On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9005-32-7 Alginic Acid On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9005-34-9 Alginic acid, ammonium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9005-35-0 Alginic acid, calcium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9005-36-1 Alginic acid, potassium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9005-37-2 Alginic acid, ester with 1,2-propanediol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9005-38-3 Alginic acid, sodium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9005-49-6 Heparin On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9005-65-6 Sorbitan, mono-(9Z)-9-octadecenoate, poly(oxy-1,2-ethanediyl) derivs. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9005-67-8 Sorbitan, monooctadecanoate, poly(oxy-1,2-ethanediyl) derivs On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9005-71-4 Sorbitan, trioctadecanoate, poly(oxy-1,2-ethanediyl) derivs. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9005-79-2 Glycogen On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9006-65-9 Dimethicone On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9007-49-2 Deoxyribonucleic acids On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*9011-14-7/ 143476-91-9 2-Propenoic acid, 2-methyl-, methyl ester, homopolymer On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9014-01-1 Subtilisin On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9016-45-9 Poly(oxy-1,2-ethanediyl), .alpha.-(nonylphenyl)-.omega.-hydroxy- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
90320-37-9 Almond, sweet, ext. On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9041-08-1 Heparin, sodium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9049-05-2 Carrageenan, calcium salt On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
9054-89-1 Dismutase, superoxide On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
90-80-2 D-Gluconic acid, .delta.-lactone On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
91031-88-8 Fatty acids, coco, esters with sucrose On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
91482-37-0 5,9-Undecadien-2-ol, 6,10-dimethyl-, 2-acetate On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
91-53-2 Quinoline, 6-ethoxy-1,2-dihydro-2,2,4-trimethyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
915-67-3 2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-[2-(4-sulfo-1-naphthalenyl)diazenyl]-, sodium salt (1:3) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
91-64-5 2H-1-Benzopyran-2-one On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
91744-66-0 Glycerides, palm-oil mono-, di- and tri-, hydrogenated On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
92044-87-6 Fatty acids, coco, 2-ethylhexyl esters On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
92113-40-1 Fats and Glyceridic oils, animal On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
92129-90-3 Whey On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
921-53-9 Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, potassium salt (1:2) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
93-60-7 3-Pyridinecarboxylic acid, methyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
94-13-3 Benzoic acid, 4-hydroxy-, propyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
94-36-0 Peroxide, dibenzoyl On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
94441-92-6 .beta.-Alanine, N-(2-carboxyethyl)-N-(2-ethylhexyl)-, sodium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
95-25-0 2(3H)-Benzoxazolone, 5-chloro- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
95-38-5 1H-Imidazole-1-ethanol, 2-(8-heptadecen-1-yl)-4,5-dihydro- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
95461-64-6 Octadecanoic acid, pentaester with decaglycerol On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
95912-86-0 Fatty acids, C8-10, C12-18-alky esters On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
97592-64-8 L-Asparagine, N-[3-(diethylamino)propyl]-, N2-(C8-18 and C18-unsatd. alkyl) derivs., monosodium salts On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
97-67-6 Butanedioic acid, 2-hydroxy-, (2S)- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
97862-72-1 Fatty acids, C10-30, esters with lanolin alcohols On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
98-92-0 3-Pyridinecarboxamide On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
99-20-7 .alpha.-D-Glucopyranoside, .alpha. -D-glucopyranosyl On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
996-31-6 Propanoic acid, 2-hydroxy-, potassium salt (1:1) On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
99-76-3 Benzoic acid, 4-hydroxy-, methyl ester On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
99-97-8 Benzenamine, N,N,4-trimethyl- On DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10025-69-1 Tin chloride (SnCl2), dihydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10025-70-4 Strontium chloride (SrCl2), hexahydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10028-24-7 Phosphoric acid, disodium salt, dihydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10031-30-8 Phosphoric acid, calcium salt, hydrate (2:1:1) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10035-04-8 Calcium chloride (CaCl2), dihydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10049-21-5 Phosphoric acid, monosodium salt, monohydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10101-41-4 Sulfuric acid, calcium salt (1:1), dihydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10101-89-0 Phosphoric acid, sodium salt, hydrate (1:3:12) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10213-79-3 Silicic acid (H2SiO3), disodium salt, pentahydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
10486-00-7 Perboric acid (HBO(O2)), sodium salt, tetrahydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
12389-15-0 Iron, bis(D-gluconato-.kappaO1,.kappa.O2)-, hydrate (1:2) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
13472-36-1 Diphosphoric acid, sodium salt, hydrate (1:4:10) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
14168-73-1 Sulfuric acid magnesium salt (1:1), monohydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
14434-22-1 Ferrate(4-), hexakis(cyano-.kappa.C)-, sodium, hydrate (1:4:10), (OC-6-11)- Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
15091-98-2 Triphosphoric acid, pentasodium salt, hexahydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
15244-36-7 Sulfuric acid, manganese(2+) salt (1:1), hydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
23389-33-5 Carbonic acid, magnesium salt (1:1), hydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
23411-34-9 Calciate(2-), [[N,N'-1,2-ethanediylbis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']-, disodium, hydrate, (OC-6-21)- Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
41372-22-9 Propanoic acid, 2-hydroxy-, calcium salt (2:1), hydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
5743-12-4 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-, hydrate (1:1) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
5743-28-2 L-Ascorbic acid, calcium salt (2:1), dihydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
*5743-47-5/ 63690-56-2/ 156733-79-8 Propanoic acid, 2-hydroxy-, calcium salt, hydrate(2:1:5) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
5785-44-4 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, calcium salt (2:3), tetrahydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
5968-11-6 Carbonic acid disodium salt, monohydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
6100-05-6 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, potassium salt, hydrate (1:3:1) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
6106-24-7 Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, sodium salt, hydrate (1:2:2) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
6131-90-4 Acetic acid, sodium salt, hydrate (1:1:3) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
6132-02-1 Carbonic acid sodium salt (1:2), hydrate (1:10) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
6132-04-3 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, sodium salt, hydrate (1:3:2) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
62974-97-4 Calcium hydroxide phosphate (Ca10(OH)2(PO4)6), hydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
63524-04-9 D-erythro-Hex-2-enonic acid, .gamma.-lactone, sodium salt, hydrate (1:1:1) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
6381-59-5 Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, potassium sodium salt, hydrate (1:1:1:4) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
6381-79-9 Carbonic acid, dipotassium salt, hydrate (2:3) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
64044-51-5 D-glucose. 4-.ortho.-.beta.-D-galactopyranosyl-, hydrate (1:1) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7048-04-6 L-Cysteine, hydrochloride, hydrate (1:1:1) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
74978-16-8 Aluminum magnesium hydroxide sulfate (Al5Mg10(OH)31(SO4)2), hydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7727-73-3 Sulfuric acid sodium salt (1:2), hydrate (1:10) Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7782-63-0 Sulfuric acid, iron(2+) salt (1:1), heptahydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7784-24-9 Sulfuric acid, aluminum potassium salt (2:1:1), dodecahydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7784-31-8 Sulfuric acid, aluminum salt (3:2), octadecahydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
7791-18-6 Magnesium chloride (MgCl2), hexahydrate Anhydrous form on DSL Removed from R-ICL to avoid redundancy with DSL Removed from R-ICL
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: